
<html lang="en"     class="pb-page"  data-request-id="690afe1e-994f-44ea-9668-ea9832472389"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.8b00685;requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2018.61.issue-12;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Potent and Highly Selective Inhibitors of the Proteasome Trypsin-like Site by Incorporation of Basic Side Chain Containing Amino Acid Derived Sulfonyl Fluorides" /></meta><meta name="dc.Creator" content="Raik  Artschwager" /></meta><meta name="dc.Creator" content="David J.  Ward" /></meta><meta name="dc.Creator" content="Susan  Gannon" /></meta><meta name="dc.Creator" content="Arwin J.  Brouwer" /></meta><meta name="dc.Creator" content="Helmus  van de Langemheen" /></meta><meta name="dc.Creator" content="Hubert  Kowalski" /></meta><meta name="dc.Creator" content="Rob M. J.  Liskamp" /></meta><meta name="dc.Description" content="A unique category of basic side chain containing amino acid derived sulfonyl fluorides (SFs) has been synthesized for incorporation into new proteasome inhibitors targeting the trypsin-like site of..." /></meta><meta name="Description" content="A unique category of basic side chain containing amino acid derived sulfonyl fluorides (SFs) has been synthesized for incorporation into new proteasome inhibitors targeting the trypsin-like site of..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 21, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b00685" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00685" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b00685" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00685" /></link>
        
    
    

<title>Potent and Highly Selective Inhibitors of the Proteasome Trypsin-like Site by Incorporation of Basic Side Chain Containing Amino Acid Derived Sulfonyl Fluorides | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00685" /></meta><meta property="og:title" content="Potent and Highly Selective Inhibitors of the Proteasome Trypsin-like Site by Incorporation of Basic Side Chain Containing Amino Acid Derived Sulfonyl Fluorides" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/large/jm-2018-00685m_0013.jpeg" /></meta><meta property="og:description" content="A unique category of basic side chain containing amino acid derived sulfonyl fluorides (SFs) has been synthesized for incorporation into new proteasome inhibitors targeting the trypsin-like site of the 20S proteasome. Masking the former α-amino functionality of the amino acid starting derivatives as an azido functionality allowed an elegant conversion to the corresponding amino acid derived sulfonyl fluorides. The inclusion of different SFs at the P1 site of a proteasome inhibitor resulted in 14 different peptidosulfonyl fluorides (PSFs) having a high potency and an excellent selectivity for the proteolytic activity of the β2 subunit over that of the β5 subunit. The results of this study strongly indicate that a free N-terminus of PSFs inhibitors is crucial for high selectivity toward the trypsin-like site of the 20S proteasome. Nevertheless, all compounds are slightly more selective for inhibition of the constitutive over the immunoproteasome." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b00685"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00685">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b00685&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b00685&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b00685&amp;href=/doi/10.1021/acs.jmedchem.8b00685" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 12</span><span class="cit-fg-pageRange">, 5395-5411</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/12" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b00625" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b00733" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Potent and Highly Selective Inhibitors of the Proteasome Trypsin-like Site by Incorporation of Basic Side Chain Containing Amino Acid Derived Sulfonyl Fluorides</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Raik Artschwager</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Raik Artschwager</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Chemistry, University of Glasgow, Joseph Black Building, University Avenue, Glasgow G12 8QQ, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Raik++Artschwager">Raik Artschwager</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">David J. Ward</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">David J. Ward</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Chemistry, University of Glasgow, Joseph Black Building, University Avenue, Glasgow G12 8QQ, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=David+J.++Ward">David J. Ward</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Susan Gannon</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Susan Gannon</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Chemistry, University of Glasgow, Joseph Black Building, University Avenue, Glasgow G12 8QQ, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Susan++Gannon">Susan Gannon</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Arwin J. Brouwer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Arwin J. Brouwer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chemical Biology and Drug Discovery, Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University, P.O. Box 80082, NL-3508 TB Utrecht, The Netherlands</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Arwin+J.++Brouwer">Arwin J. Brouwer</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Helmus van de Langemheen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Helmus van de Langemheen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Chemistry, University of Glasgow, Joseph Black Building, University Avenue, Glasgow G12 8QQ, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Helmus++van+de+Langemheen">Helmus van de Langemheen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hubert Kowalski</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hubert Kowalski</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Chemistry, University of Glasgow, Joseph Black Building, University Avenue, Glasgow G12 8QQ, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hubert++Kowalski">Hubert Kowalski</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Rob M. J. Liskamp</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rob M. J. Liskamp</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Chemistry, University of Glasgow, Joseph Black Building, University Avenue, Glasgow G12 8QQ, United Kingdom</div><div class="loa-info-affiliations-info">Chemical Biology and Drug Discovery, Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University, P.O. Box 80082, NL-3508 TB Utrecht, The Netherlands</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: +44(0)141 330 5168. E-mail: <a href="/cdn-cgi/l/email-protection#cf9da0adaabdbbe183a6bca4aea2bf8fa8a3aebca8a0b8e1aeace1baa4"><span class="__cf_email__" data-cfemail="e2b08d80879096ccae8b9189838f92a2858e8391858d95cc8381cc9789">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rob+M.+J.++Liskamp">Rob M. J. Liskamp</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8897-8975" title="Orcid link">http://orcid.org/0000-0001-8897-8975</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00685&amp;href=/doi/10.1021%2Facs.jmedchem.8b00685" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 12</span><span class="cit-pageRange">, 5395–5411</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 21, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>30 April 2018</li><li><span class="item_label"><b>Published</b> online</span>21 May 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 28 June 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b00685" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00685</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5395%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DRaik%2BArtschwager%252C%2BDavid%2BJ.%2BWard%252C%2BSusan%2BGannon%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D12%26contentID%3Dacs.jmedchem.8b00685%26title%3DPotent%2Band%2BHighly%2BSelective%2BInhibitors%2Bof%2Bthe%2BProteasome%2BTrypsin-like%2BSite%2Bby%2BIncorporation%2Bof%2BBasic%2BSide%2BChain%2BContaining%2BAmino%2BAcid%2BDerived%2BSulfonyl%2BFluorides%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5411%26publicationDate%3DJune%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b00685"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1519</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">17</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b00685" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Potent and Highly Selective Inhibitors of the Proteasome Trypsin-like Site by Incorporation of Basic Side Chain Containing Amino Acid Derived Sulfonyl Fluorides&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Raik&quot;,&quot;last_name&quot;:&quot;Artschwager&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;J. Ward&quot;},{&quot;first_name&quot;:&quot;Susan&quot;,&quot;last_name&quot;:&quot;Gannon&quot;},{&quot;first_name&quot;:&quot;Arwin&quot;,&quot;last_name&quot;:&quot;J. Brouwer&quot;},{&quot;first_name&quot;:&quot;Helmus&quot;,&quot;last_name&quot;:&quot;van de Langemheen&quot;},{&quot;first_name&quot;:&quot;Hubert&quot;,&quot;last_name&quot;:&quot;Kowalski&quot;},{&quot;first_name&quot;:&quot;Rob&quot;,&quot;last_name&quot;:&quot;M. J. Liskamp&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;21&quot;,&quot;issue&quot;:&quot;12&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;5395-5411&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b00685&quot;},&quot;abstract&quot;:&quot;A unique category of basic side chain containing amino acid derived sulfonyl fluorides (SFs) has been synthesized for incorporation into new proteasome inhibitors targeting the trypsin-like site of the 20S proteasome. Masking the former α-amino functionality of the amino acid starting derivatives as an azido functionality allowed an elegant conversion to the corresponding amino acid derived sulfonyl fluorides. The inclusion of different SFs at the P1 site of a proteasome inhibitor resulted in 14 different peptidosulfonyl fluorides (PSFs) having a high potency and an excellent selectivity for the proteolytic activity of the β2 subunit over that of the β5 subunit. The results of this study strongly indicate that a free N-terminus of PSFs inhibitors is crucial for high selectivity toward the trypsin-like site of the 20S proteasome. Nevertheless, all compounds are slightly more selective for inhibition of the constitutive over the immunoproteasome.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00685&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00685" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00685&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00685" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00685&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00685" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00685&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00685&amp;href=/doi/10.1021/acs.jmedchem.8b00685" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b00685" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b00685" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00685&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b00685%26sid%3Dliteratum%253Aachs%26pmid%3D29782167%26genre%3Darticle%26aulast%3DArtschwager%26date%3D2018%26atitle%3DPotent%2Band%2BHighly%2BSelective%2BInhibitors%2Bof%2Bthe%2BProteasome%2BTrypsin-like%2BSite%2Bby%2BIncorporation%2Bof%2BBasic%2BSide%2BChain%2BContaining%2BAmino%2BAcid%2BDerived%2BSulfonyl%2BFluorides%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D12%26spage%3D5395%26epage%3D5411%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291651" title="Anions">Anions</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290831" title="Monomers">Monomers</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/12" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/jmcmar.2018.61.issue-12/20180628/jmcmar.2018.61.issue-12.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/medium/jm-2018-00685m_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/large/jm-2018-00685m_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00685&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A unique category of basic side chain containing amino acid derived sulfonyl fluorides (SFs) has been synthesized for incorporation into new proteasome inhibitors targeting the trypsin-like site of the 20S proteasome. Masking the former α-amino functionality of the amino acid starting derivatives as an azido functionality allowed an elegant conversion to the corresponding amino acid derived sulfonyl fluorides. The inclusion of different SFs at the P<sub>1</sub> site of a proteasome inhibitor resulted in 14 different peptidosulfonyl fluorides (PSFs) having a high potency and an excellent selectivity for the proteolytic activity of the β2 subunit over that of the β5 subunit. The results of this study strongly indicate that a free N-terminus of PSFs inhibitors is crucial for high selectivity toward the trypsin-like site of the 20S proteasome. Nevertheless, all compounds are slightly more selective for inhibition of the constitutive over the immunoproteasome.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71060" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71060" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The ubiquitin–proteasome pathway (UPS) comprises the main machinery for degrading damaged, misfolded, pathogen derived, and abnormal proteins in the cell.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Therefore, the proteasome plays a crucial role in the regulation of many cell cycle processes especially involving antigen processing and apoptosis after protein quality control.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Proteolysis of the designated proteins is achieved by the 20S proteasome which consists of four stacked rings comprising 28 subunits assembled in two outer α-rings and two inner β-rings. Within the proteolytic β-rings of the 20S constitutive proteasome the β1c, β2c, and β5c subunits are found to show catalytic activity referred to as caspase-like activity (β1c), trypsin-like activity (β2c), and chymotrypsin-like activity (β5c). Upon exposure to interferon γ (IFNγ) and/or tumor necrosis factor α (TNFα) these subunits are substituted by β1i (LMP2), β2i (MECL-1), and β5i (LMP7), respectively, resulting in the so-called immunoproteasome.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Selective targeting of either constitutive or immunoproteasome subunits is a particular challenge and opens up further possibilities for the development of anticancer and anti-inflammatory therapeutic agents. This may even be extended to development of parasite-selective proteasome inhibitors.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The development of proteasome inhibitors has been an outstanding case showing that irreversible inhibitors may provide unique advantages by forming long-lived ties with their target.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></div><div class="NLM_p">Since the approval of bortezomib <b>1</b> in 2003<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> and carfilzomib <b>2</b> in 2012<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) for the treatment of multiple myeloma, many peptide based inhibitors containing different electrophilic traps have been reported.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> These next generations of inhibitors like ixazomib,<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9,10)</a> oprozomib<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> (currently in clinical trials), and LU-102 (<b>3</b>)<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12,13)</a> (in preclinical testing) clearly demonstrated that other “warheads” or electrophilic traps within a peptide based inhibitor can provide attractive alternatives.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/medium/jm-2018-00685m_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/large/jm-2018-00685m_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of bortezomib (<b>1</b>), carfilzomib (<b>2</b>), LU-102 (<b>3</b>), Cbz-Leu<sub>4</sub>-SF (<b>4</b>), β5i immunoproteasome selective PSF (<b>5</b>), and N<sub>3</sub>-Phe-Leu<sub>3</sub>-SF (<b>6</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/large/jm-2018-00685m_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00685&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We have initiated the exploration of the sulfonyl fluoride warhead for incorporation into proteasome inhibitors and other proteases inhibitors<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> leading to peptidosulfonyl fluorides (PSFs).<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15,16)</a> Since then, this electrophilic trap has undergone considerable development as it is presently denoted as a “privileged warhead” in chemical biology, partly due to its considerable aqueous stability and chemical reactivity in the respective target enzyme.<a onclick="showRef(event, 'ref26 ref17'); return false;" href="javascript:void(0);" class="ref ref26 ref17">(26,17)</a>Apart from obtaining potent proteasome inhibitors, in particular Cbz-Leu<sub>4</sub>-SF <b>4</b> with an IC<sub>50</sub> value of 7 nM for the β5c subunit of the constitutive proteasome,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> it was found that the SF-warhead also endowed proteasome inhibitor <b>5</b> with a 25-fold higher selectivity for inhibition of the β5i subunit of the immunoproteasome over the β5c subunit although with loss of potency.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> This showed clearly that SFs were not merely acting as a powerful electrophilic trap but also gave rise to higher selectivity by simply changing the electrophilic trap from an epoxyketone to a sulfonyl fluoride.</div><div class="NLM_p">Although this was an important finding, we think that selectivity for a particular proteasome subunit or in general a protease is largely determined by the character and relative position of the P<sub>1</sub> side chain with respect to the SF warhead.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Therefore, we focused our efforts on inhibitors with basic side chains at the P<sub>1</sub> position to evaluate whether this would be sufficient to confer selectivity of the resulting inhibitors for the proteasome trypsin-like site (β2) over the chymotrypsin-like site (β5). Moreover, development of β2 selective inhibitors will contribute to overcoming resistance against existing (β5) inhibitors.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12,13)</a></div><div class="NLM_p last">Recently, we found that PSF <b>6</b> was a very potent proteasome inhibitor (IC<sub>50</sub> = 110 nM for β5c).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> The known inhibitor LU-102 <b>3</b> (IC<sub>50</sub> = 3.8 nM for β2)<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> has largely the same backbone sequence but also contains a basic non-natural amino acid residue. This latter sequence was used here for incorporation of an SF warhead leading to development of the synthesis and investigation of the selectivity and potency of basic side chain containing PSF proteasome inhibitors. The required development of amino acid derived sulfonyl fluorides containing a basic side chain is described in this paper, and their incorporation in PSF proteasome inhibitors led to both potent and highly selective inhibitors of the proteasome’s trypsin-like (β2) activity.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42575" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42575" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Synthesis of Basic Side Chain Containing Amino Acid Derived Sulfonyl Fluorides</h3><div id="sec2_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i5" class="anchor-spacer"></div><h4 class="article-section__title" id="_i5"> Considerations</h4><div class="NLM_p">Synthesis of an amino acid derived sulfonyl fluoride (SF) containing a basic side chain, which upon incorporation in the remainder of the proteasome inhibitor sequence should endow the resulting molecular construct with β2-selectivity, was a significant challenge. Because of the simultaneous presence of an electrophilic site (the sulfonyl fluoride moiety) and two nucleophilic sites, that is, the former α-amino group and the basic side chain, a suitable protecting group strategy was necessary. It was known from our previous work that as long as the α-amino group is protected or protonated, it is possible to leave the SF moiety intact and ultimately incorporate it in an inhibitor construct.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> The desired amino acid derived SFs with a basic side chain for inhibitor construction are shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>. On the basis of the p<i>K</i><sub>a</sub> value of the side chain, it was expected that the guanidine functionality will always remain protonated. Therefore, it will not react with an SF moiety, not even after the final deprotection step in the synthesis of the arginine building block <b>7</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) and incorporation in PSFs <b>53</b>–<b>58</b> by peptide coupling reactions. The aromatic and benzylic amino groups obtained by deprotection after incorporation of <b>9</b> and <b>10</b>, respectively, will not be available for an intramolecular reaction. This is probably also the case for the lysine derived amino group obtained by deprotection after incorporation of <b>8</b>, which apart from being protonated at physiological pH can only give rise to the formation of an 8-membered ring. Nevertheless, there are possibilities for intermolecular reactions and/or (slow) hydrolysis (see stability experiments, <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>), and therefore amino groups of amino SF derivatives <b>8</b>–<b>10</b> remained protected also in the coupling steps leading to PSFs <b>59</b>–<b>67</b>.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/medium/jm-2018-00685m_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/large/jm-2018-00685m_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Basic side chain containing amino acid derived SFs <b>7</b>–<b>10</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/large/jm-2018-00685m_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00685&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/medium/jm-2018-00685m_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/large/jm-2018-00685m_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Arginine Derived Sulfonyl Fluoride (<b>7</b>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/large/jm-2018-00685m_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00685&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i7" class="anchor-spacer"></div><h4 class="article-section__title" id="_i7"> Synthesis</h4><div class="NLM_p">The syntheses of amino acid derived SFs <b>7</b>–<b>10</b> was carried out following our earlier described general strategy with modifications involving the fluoronating agent and in light of the considerations above (<a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a>–<a class="ref internalNav" href="#sch3" aria-label="3">3</a>).<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Starting from commercially available arginine compound <b>11</b>, which has protecting groups resistant to conditions used for the introduction of the SF warhead, it was first converted to methyl ester <b>12</b>. Reduction to alcohol <b>13</b>, preparation of mesylate <b>14</b> was followed by substitution to thioacetate <b>15</b>. After oxidation to the sulfonic acid derivative <b>16</b> the corresponding sulfonyl fluoride <b>17</b> was obtained using XtalFluor-M.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Finally, simultaneous removal of the Cbz and Mtr protective groups afforded the arginine derived SF <b>7</b> ready for coupling to the remainder of the inhibitor sequence (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><div class="NLM_p">For the synthesis of the lysine derived SF <b>8</b> and the aminophenylalanine derived SFs <b>9</b> and <b>10</b> a different synthetic strategy was necessary. To avoid manipulation of two orthogonal protecting groups present on both amino functional groups during or at the end of synthesis, it was decided to mask the α-amino group as an azide functionality until the very end, that is, after completion of the synthesis of the SF warhead (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). This strategy was successful and allowed a relatively straightforward synthesis of the side chain protected azidoamino acid derived SFs <b>40</b>, <b>41</b>, and <b>42</b>.</div><div class="NLM_p">Briefly, lysine derivative <b>18</b> and aminophenylalanine derivative <b>20</b> were converted to the corresponding α-azido derivatives <b>19</b> and <b>21</b> using the azido transfer reagent azidosulfonylimidazole in the presence of cupric sulfate.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The required aminomethylphenylalanine derivative <b>25</b> had to be prepared first in four steps from phenylalanine <b>23</b> similar to the synthesis of Geurink et al.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Compound <b>26</b> was then converted analogously to the required α-azido derivative <b>27</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). For these three α-azido derivatives <b>19</b>, <b>22</b>, and <b>27</b> an identical series of synthetic steps was followed to obtain the desired substituted amino SFs <b>8</b>–<b>10</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). The steps for introduction of the sulfonic acid moiety comprised reduction of the methyl ester to amino alcohol <b>28</b>–<b>30</b>, introduction of Ms-leaving group to mesylates <b>31</b>–<b>33</b>, followed by substitution to thioacetates <b>34</b>–<b>36</b> and finally oxidation to afford the sulfonates <b>37</b>–<b>39</b>, which were immediately converted to the corresponding SF-derivatives <b>40</b>–<b>42</b> using XtalFluor-M. The combined oxidation–SF conversion is still a considerable hurdle. Nevertheless, still decent yields of 33–42% over two steps (average 58–65% per step) were realized. Reduction of the azide group followed by protonation to the amino acid SF derivatives <b>8</b>–<b>10</b> was carried out using zinc powder in 15% TFA in AcOH.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> After purification by semipreparative HPLC, SF derivatives were obtained as TFA salts in moderate yields (54–59%). The overall yields of the SF warhead containing amino acid derivatives were quite satisfactory, i.e., 11% (7 steps) for TFA·H-Lys(Cbz)ΨCH<sub>2</sub>SO<sub>2</sub>F (<b>8</b>), 7% (9 steps) for TFA·H-Phe(4-N(H)Cbz)ΨCH<sub>2</sub>SO<sub>2</sub>F (<b>9</b>), and 2% (10 steps) for TFA·H-Phe(4-CH<sub>2</sub>N(H)CbzΨCH<sub>2</sub>SO<sub>2</sub>F (<b>10</b>).</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/medium/jm-2018-00685m_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/large/jm-2018-00685m_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Syntheses of Azido Precursor Amino Acids <b>19</b>, <b>22</b>, and <b>27</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/large/jm-2018-00685m_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00685&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/medium/jm-2018-00685m_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/large/jm-2018-00685m_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Completion of the Synthesis of Basic Side Chain Containing Amino Acid Derived SFs <b>8</b>–<b>10</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/large/jm-2018-00685m_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00685&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Incorporation of Amino SF Derivatives toward Syntheses of Peptidosulfonyl Fluorides (PSFs)</h3><div class="NLM_p">For completion of the synthesis of the desired PSFs the amino acid derived SFs had to be incorporated into suitable peptide sequences, i.e., <b>47</b> and <b>52</b>. These sequences were based on the earlier developed powerful PSF proteasome inhibitors.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Their syntheses are shown in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. Assembly of Ac-Phe-Leu-Leu-OH <b>47</b> was carried out on a 2-chlorotrityl chloride resin to afford <b>46</b> using a SPPS protocol and preparation of Boc-Phe-Leu-Leu-OH <b>51</b> was carried out in solution.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> To prevent racemization at the C-terminus, the methyl ester of <b>50</b> was saponified first before conversion of the amino terminus to an azide functionality in <b>52</b>. This azide containing precursor peptide was prepared because the most active of our earlier described proteasome inhibitors<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> contained an azide functionality at the N-terminus of PSF <b>6</b>. As it was found that PSFs require at least a capped N-terminus for selectivity toward the immunoproteasome over the constitutive proteasome, also PSFs with an acetylated and unprotected N-terminus were synthesized to investigate if this was also crucial for β2 specificity.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/medium/jm-2018-00685m_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/large/jm-2018-00685m_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Syntheses of the Peptides Necessary for Incorporation of the Amino Acid Derived SFs</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/large/jm-2018-00685m_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00685&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Introduction of SF warhead containing amino acid derivatives has always been viewed as one of the most challenging steps in the total synthesis of PSFs. First, the coupling conditions involving a nucleophilic amino group have to be selected in such a way that the SF electrophile stays as much as possible intact. Second, there is the possibility of racemization of the amino SF derivative in view of the electron-withdrawing character of the SF moiety. Therefore, several coupling reagents and conditions were attempted. These included HCTU, DIC/Oxymapure, HBTU/Oxymapure, BOP, and HATU. Using a different base, for example NMM instead of DiPEA, during the coupling step did not affect the yields. Nevertheless, DIC/Oxymapure and HATU in combination with DiPEA as a base gave the best results in series in terms of yields and racemization (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00685/suppl_file/jm8b00685_si_001.pdf" class="ext-link">Supporting Information</a>).<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24,25)</a></div><div class="NLM_p">For the final successful preparation of the basic side chain containing proteasome containing inhibitors <b>53</b>–<b>67</b>, the Cbz and Boc protecting groups leading to PSFs <b>59</b>, <b>60</b>, <b>62</b>, <b>63</b>, <b>65</b>, and <b>66</b> were removed by HBr in acetic acid (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>). These deprotection conditions led to substitution of the azide functionality in compounds like N<sub>3</sub>-Phe-Leu-Leu-Phe(4-NH<sub>2</sub>)-SF <b>64</b> by bromide. Fortuitously, a 4 M HCl solution in dioxane led to the desired deprotected proteasome inhibitor N<sub>3</sub>-Phe-Leu-Leu-Phe(4-CH<sub>2</sub>NH<sub>2</sub>)-SF <b>67</b> and N<sub>3</sub>-Phe-Leu-Leu-Lys-SF <b>61</b>. Unfortunately, this method was not successful to afford the inhibitor N<sub>3</sub>-Phe-Leu-Leu-Phe(4-NH<sub>2</sub>)-SF <b>64</b>. All PSF inhibitors containing an arginine at the P<sub>1</sub> position were coupled successfully with unprotected arginine derived SF as it was anticipated that the guanidine moiety stays protonated during the reaction and therefore would not react.</div><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/medium/jm-2018-00685m_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/large/jm-2018-00685m_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of the Peptide Sulfonyl Fluorides (PSFs) and Overview of the Structures of the Inhibitors<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/large/jm-2018-00685m_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00685&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>All amino and guanidine functionalities are protonated.</p></p></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Biological Evaluation of the PSFs</h3><div class="NLM_p">The IC<sub>50</sub> values of the in vitro structure–activity relationship (SAR) studies of the synthesized peptidosulfonyl fluorides were determined from the inhibitory curves in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> using constitutive human proteasome and are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. The residual activity of the 20S proteasome activity was measured at time points using a fluorogenic substrate where a decrease in fluorescence corresponds to lower residual proteasome activity and therefore indicating a more potent inhibitor. In total, 14 basic amino acid derived peptidosulfonyl fluorides were tested of which compounds <b>53</b>, <b>54</b>, <b>57</b>, <b>62</b>, <b>65</b>, <b>66</b>, and <b>67</b> showed IC<sub>50</sub> values below 250 nM for the trypsin-like site. Particularly compounds <b>54</b>, <b>65</b>, <b>66</b>, and <b>67</b> were the most potent inhibitors of this series with IC<sub>50</sub> values of 150 nM for <b>54</b>, 140 nM for <b>65</b>, 119 nM for <b>66</b>, and 130 nM for compound <b>67</b>. Although compounds <b>60</b> and <b>63</b> had IC<sub>50</sub> values higher than 1 μM, all other compounds had IC<sub>50</sub> values lower than 1 μM for inhibiting the trypsin-like proteasome activity. Compounds <b>59</b>, <b>65</b>, and <b>67</b> could only be obtained as a diasteromeric mixtures in which the aminosulfonyl fluoride residue had probably partially racemized; nevertheless these PSFs still had relatively low IC<sub>50</sub> values. In the arginine derived PSFs the Cbz-protecting group appeared to be beneficial for the potency when compound <b>54</b> is compared to compound <b>55</b>, <b>56</b>, <b>57</b>, or <b>58</b>. For example, changing the Boc group in PSF <b>55</b> to a Cbz protecting group in PSF <b>54</b> decreased the IC<sub>50</sub> value by more than 500 nM. Due to the synthetic strategy of the PSFs <b>59</b>–<b>67</b>, the synthesis of Cbz N-termini protected analogs in this series of lysine, aminophenylalanine, and 4-aminomethylphenylalanine derived PSFs was not feasible at this point.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Comparing compounds <b>56</b> with <b>58</b> and <b>60</b> with <b>61</b>, it becomes apparent that an azido functionality does enhance the potency of the inhibitor significantly (roughly by a factor of 2) compared to those of the acetyl capped counterparts. The lysine and aminophenylalanine derived PSFs <b>59</b>, <b>60</b>, <b>61</b>, <b>62</b>, and <b>63</b> were the least potent in this study, indicating that the presence of stronger basic side chains in the P<sub>1</sub> position was more favorable.</div><figure id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/medium/jm-2018-00685m_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/large/jm-2018-00685m_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. In vitro evaluation of PSFs using human constitutive 20S proteasome. Fluorogenic substrates were selective for the respective trypsin-like (Bz-VGR-AMC) or chymotrypsin-like (Suc-LLVY-AMC) subunit. Top: Arginine derived PSFs. Bottom: Lysine, aminophenylalanine and 4-aminomethylphenylalanine derived PSF. Left: Trypsin-like residual enzyme activity. Right: Chymotrypsin-like residual enzyme activity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/large/jm-2018-00685m_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00685&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Overview of the IC<sub>50</sub> Values of Inhibition of the Constitutive Proteasome by Synthesized PSFs<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/medium/jm-2018-00685m_0011.gif" alt="" id="gr11" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Compounds <b>59</b>, <b>65</b>, and <b>67</b> could only be obtained as a diasteromeric mixture in which the aminosulfonyl fluoride residue had probably partially racemized as was apparent from <sup>1</sup>H NMR. n.d.: not determined as compound <b>64</b> could not be synthesized. A higher IC<sub>50</sub>(β5)/IC<sub>50</sub>(β2) ratio indicates a higher β2 selectivity. In this assay synthesized LU-102 showed IC<sub>50</sub> values of  10.8 ± 2.4 nM (β2) and 2600 ± 500 nM (β5) with an IC<sub>50</sub>(β5)/IC<sub>50</sub>(β) of 241, which is agreement with the literature.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></p></div></div><div></div></div><div class="NLM_p">The key goal of this study was the development of β2 selective (trypsin-like) PSF inhibitors. It was shown that, in general, except for the aniline derived PSFs <b>62</b> and <b>63</b>, all inhibitors possessed a moderate to very high β2 selectivity. Outstanding β2-selectivity was shown by PSF inhibitors having a free terminus as in the arginine derived PSF <b>57</b> (∼600-fold selectivity), the lysine derived PSF <b>59</b> (>1000-fold selectivity), and the methylene aminophenylalanine derived PSF <b>65</b> (∼900-fold selectivity), emphasizing the essentiality of free amino terminus with respect to this.</div><div class="NLM_p">Originally, azide containing PSF ligands<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> were developed to capture possibly formed ligand/proteasome covalent adducts using the copper(I) catalyzed azide–alkyne cycloaddition (click) reaction. However, later we found that formation of covalent adduct with the proteasome active site is followed by elimination of the ligand.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Nevertheless, PSF <b>6</b> having an azido N-terminus was uncovered as one of most active β5 proteasome inhibitors,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and therefore azido containing PSF inhibitors were included in this study to evaluate whether this also would be the case for β2 inhibition. Although the azido containing inhibitors (<b>58</b>, <b>61</b>, and <b>65</b>) were slightly more active or had a similar activity that N-terminally protected PSFs, as was mentioned above, a free-amino terminus generally led to both the most potent and selective β2 compounds <b>57</b>, <b>59</b>, <b>62</b>, and <b>65</b>.</div><div class="NLM_p">Although the β5-inhibitory activity, that is, inhibition of chymotrypsin activity, of all compounds was understandably poor, perhaps with the exception of <b>62</b> and <b>63</b> (both IC<sub>50</sub> values of <1 μM), this activity improves slightly by having a protected or masked (azide) N-terminus. This finding is in accordance with earlier findings that β5-selectivity (toward the chymotrypsin-like site) requires at least a capped N-terminus of the PFSs.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Interestingly, compound <b>63</b> is the only one in this series that gave rise to stronger inhibition of β5-activity as compared to inhibition of β2 activity. This might indicate that the hydrophobic character of “aniline” side chain plays a dominant role in determination of the selectivity toward β5 inhibition.</div><div class="NLM_p">Recently<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> we found that PSFs showed selective inhibition of the immunoproteasome. Therefore, a subset of the most powerful inhibitors were taken and evaluated in an immunoproteasome assay as in shown in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> and <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>. The data showed that the selectivity of β2 inhibition PSFs is maintained. However, in contrast to earlier developed PSFs<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> selectivity for inhibition of the immunoproteasome was virtually absent. This was also the case for LU-102, which although a highly potent inhibitor, also showed selectivity for constitutive proteasome inhibition.</div><figure id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/medium/jm-2018-00685m_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/large/jm-2018-00685m_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. In vitro evaluation of PSFs using human immuno 20S proteasome. Fluorogenic substrates were selective for the respective trypsin-like (Bz-VGR-AMC) or chymotrypsin-like (Suc-LLVY-AMC) subunit. Top: Arginine derived PSFs. Bottom: Lysine, aminophenylalanine and 4-aminomethylphenylalanine derived PSF. Left: Trypsin-like residual enzyme activity. Right: Chymotrypsin-like residual enzyme activity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/large/jm-2018-00685m_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00685&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Overview of the IC<sub>50</sub> Values of Inhibition of the Immuno Proteasome by Selected PSFs<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/medium/jm-2018-00685m_0012.gif" alt="" id="gr12" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Compounds <b>59</b>, <b>65</b>, and <b>67</b> could only be obtained as a diasteromeric mixture in which the aminosulfonyl fluoride residue had probably partially racemized as was apparent from <sup>1</sup>H NMR. A higher IC<sub>50</sub>(β5)/IC<sub>50</sub>(β2) ratio indicates a higher β2 selectivity. In this assay synthesized LU-102 showed IC<sub>50</sub> values of 27.5 ± 6.9 nM (β2) and 1800 ± 2,400 nM (β5) with an IC<sub>50</sub>(β5)/IC<sub>50</sub>(β) of 241, which is agreement with the literature.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></p></div></div><div></div></div><div class="NLM_p">PSFs containing the SF-warhead comprise relatively new inhibitor ligands of which stability and reactivity properties have not been investigated as yet. In order to start determination of the former properties, we have evaluated the degree of hydrolysis of PSFs in buffers of different pHs. Therefore, stability tests of several PSFs were carried out to study the rate of hydrolysis of the SF moiety at a physiological pH (7.4) as well as at pH 6.5 and pH 8.0. Acetyl capped PSFs were chosen to prevent a possible intermolecular reaction involving the N-terminus and the SF moiety. Of course intermolecular reactions involving the amino groups in <b>60</b>, <b>63</b>, and <b>66</b> cannot be ruled out but are highly unlikely because they are largely protonated at the studied pH’s or poorly nucleophilic (<b>63</b>). An intermolecular reaction involving the guanidinium functionality in <b>56</b> is even less likely because it is virtually completely protonated at the studied pH range. So it was assumed that a possible decrease in stability of the SF moiety is due to an increased inclination toward hydrolysis. In order to study only the hydrolytic stability and to exclude nucleophilic reactions of buffer components (for example, tris(hydroxylmethyl)aminomethane in “Tris” buffer), phosphate buffered saline (PBS) was chosen as a buffer system.</div><div class="NLM_p">As anticipated, hydrolysis of PSFs was slower at slightly acidic pH (6.5) compared to physiological pH (7.4) and slightly basic pH (8.0). Even after 12 h about 75% of the initial used PSF remained unaffected at pH 6.5. After 1 h at pH 7.4 90% of the PSF was still intact. Thus, during an incubation time of 1 h for the biological evaluation of a PSF, a large majority is still available for interaction with the proteasome. After 6 h at pH 7.4, ≥50% of the PSFs were still intact. However, rapid hydrolysis was observed at pH 8.0 at which 50% of the PSFs were hydrolyzed after 2 h (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>).</div><figure id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/medium/jm-2018-00685m_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/large/jm-2018-00685m_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. PBS buffer stability test at pH 6.5, 7.4, and 8.0. Hydrolysis of selected PSFs was measured via analytical HPLC over 12 h.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/large/jm-2018-00685m_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00685&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51878" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51878" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We have shown that our general route for the preparation of amino acid derived SFs could be extended to SF derivatives containing nucleophilic groups in their side chains in the presence of the SF electrophilic trap. The route to the SF derived from arginine <b>7</b> was largely based on our earlier developed synthesis. The preparation of SF derivatives containing an amino group in their side chains was achieved using a judicious strategy masking the α-amino group as an azide functionality, thereby circumventing complicated (de)protection strategies. This resulted in the successful and convenient synthesis of lysine derived SF <b>8</b>, aminophenylalanine <b>9</b> and methylene aminophenylalanine derived SF <b>10</b> ready for incorporation in proteasome inhibitor sequences.</div><div class="NLM_p">Although incorporation of the SF warhead into a peptide inhibitor sequence remains a challenging step in the total synthesis of PSFs, we have successfully synthesized several potent and highly selective PSFs capable of inhibiting the β2 (trypsin-like) activity over the β5 (chymotrypsin-like) activity for the first time.</div><div class="NLM_p">In addition, we have established the crucial role of the N-terminus. PSFs with a free amino terminus gave rise to highly selective β2 proteasome inhibitors. Having an azide functionality as N-terminus did not lead to a tremendous enhanced potency as was found earlier with the β5-proteasome inhibitors. Although the described PSFs were less potent than, for example, LU-102, their selectivity for β2 was similar. Both PSFs and LU-102 did not show selective inhibition of the immunoproteasome. Since PSFs gave rise to permanent inhibition of the proteasome by ligand-induced cross-linking of the active site, it would be interesting to evaluate the significance of proteasome inhibition by irreversible inhibitors versus reversible inhibitors.</div><div class="NLM_p last">In view of the promising electrophilic trap properties leading to highly active and selective compounds, we embarked on initial stability studies in buffer of the SF-warhead. It was found that the stability at physiological pH was quite satisfactory. Clearly, this is just the start toward gaining insights in the behavior of these relatively novel aliphatic amino acid derived SFs and PSFs. Thus, there will be significant chemical challenges ahead with respect to modulating both reactivity and stability. This research will be guided by future studies directed toward investigations of cellular permeability and stability of the most promising PSFs described above.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Procedures</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17144" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17144" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> General Procedures</h3><div class="NLM_p last">All starting materials, reagents, and solvents were obtained from commercial sources and used as received. Dry solvents were obtained from a PureSolv 500 MD solvent purification system. Reactions requiring dry conditions were performed in heat-gun dried glassware. All reactions were performed at ambient temperature unless stated otherwise. Reactions in solution were monitored by TLC analysis on Merck precoated silica gel 60 F<sub>254</sub> (0.25 mm) glass backed plates. Spots were visualized by UV light (254 and 366 nm) and by heating plates after dipping in a ninhydrin or cerium/molybdenum solution. Column chromatography was performed on Siliaflash P60 (40–63 μm) from Silicycle (Canada). Petroleum ether (40–60 °C fraction) and <i>n</i>-hexane were used for flash column chromatography. <sup>1</sup>H NMR, <sup>13</sup>C NMR, and <sup>19</sup>F NMR spectra were recorded on a Bruker DPX 400 spectrometer or Bruker 500 spectrometer with chemical shift values reported in parts per million (ppm) relative to TMS (δ<sub>H</sub> = 0.00 and δ<sub>C</sub> = 0.0) or residual CHCl<sub>3</sub> (δ<sub>H</sub> = 7.28 and δ<sub>C</sub> = 77.16) or residual DMSO-<i>d</i><sub>6</sub> (δ<sub>H</sub> = 2.50 and δ<sub>C</sub> = 39.52) as standard. Assignments of <sup>1</sup>H and <sup>13</sup>C NMR signals are based on two-dimensional COSY, HSQC, HMBC, DEPT, and DEPTQ experiments, respectively. High-resolution electrospray ionization (ESI) mass spectra were measured on a Bruker micrOTOF-Q II in positive or negative mode and calibrated with an ESI tuning mix from Agilent Technologies. Infrared spectra were recorded using a Shimadzu FTIR 8400S apparatus. Optical rotations were determined as solutions irradiating with the sodium D line (λ = 589 nm) using an Auto pol V polarimeter. [α]<sub>D</sub> values are given in units 10<sup>–1</sup> deg cm<sup>2</sup> g<sup>–1</sup>. Semipreparative high performance liquid chromatography (HPLC) was performed on an Agilent Technologies 1260 Infinity system (12.5 mL min<sup>–1</sup>). Analytical HPLC chromatograms were recorded on a Shimadzu Prominence system (1 mL min<sup>–1</sup>). Buffers used for HPLC: buffer A (0.1% TFA in MeCN/H<sub>2</sub>O v/v 5:95) and buffer B (0.1% TFA in MeCN/H<sub>2</sub>O v/v 95:5). Semipreparative runs started with an isocratic flow of buffer A (100% for 5 min), followed by a linear gradient of buffer B (in 60 min to <i>X</i>%). Subsequently, an isocratic flow of buffer B (100% for 5 min) was performed followed by a linear gradient to buffer A (in 5 min to 100%). Runs ended with an isocratic flow of buffer A (100% for 5 min). Used columns are mentioned in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b00685/suppl_file/jm8b00685_si_001.pdf" class="ext-link">Supporting Information</a>. In addition, all HPLC chromatograms and retention times of all purified compounds are supplied in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b00685/suppl_file/jm8b00685_si_001.pdf" class="ext-link">Supporting Information</a>. All compounds have purities of ≥95%.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Proteasome Inhibitory Assays</h3><div class="NLM_p last">Inhibition of the constitutive and immuno proteasome enzymatic activity was determined using the VIVAdetect 20S assay kit PLUS (Viva bioscience, U.K.) utilizing a Clariostar microplate reader (BMG LABTECH, Germany). All working solutions were freshly prepared for each measurement. Kinetic enzyme assays were performed using 96-well Corning half-area plates using 50 μL of total amount of liquid. Incubation of all measured inhibitors was at ambient temperature on a shaker for 60 min. Fluorescence measurements were carried out at λ<sub>ex</sub> = 360 nm and λ<sub>ex</sub> = 460 nm at 25 °C for 2 h. All assays were carried out in duplicate with three repetitions. Each well contained 35 μL of VIVAdetect buffer. The final enzyme concentration in a well was 2.5 nM (5 μL of a 25 nM enzyme working solution in VIVAdetect buffer). Final substrate concentration was 100 μM (5 μL of a 1 mM substrate working solution in VIVAdetect buffer; Suc-LLVY-AMC for the chymotrypsin-like activity; Bz-VGR-AMC for the trypsin-like activity). In order to use a final minimal concentration of DMSO, stock solutions of each inhibitor were prepared: Arginine derived PSFs were dissolved in 10% DMSO/H<sub>2</sub>O, lysine derived PSFs were dissolved in 30% DMSO/H<sub>2</sub>O, 4-aminophenylalanine and 4-methyleneaminophenylalanine derived PSFs were dissolved in 50% DMSO/H<sub>2</sub>O. Dilution series of inhibitors were prepared using the appropriate stock solution. For the positive controls 5 μL of the stock DMSO-percentage solution was added instead of the respective inhibitor solution. MG132 (Cbz-Leu-Leu-leucinal) was used as a negative control with a final concentration of 5 μM (5 μL of a 50 μM working solution, supplied in the VIVAdetect 20S assay kit PLUS). Final inhibitor concentrations were 400 μM, 200 μM, 100 μM, 50 μM, 10 μM, 5 μM, 2.5 μM, 1 μM, 750 nM, 500 nM, 250 nM, 100 nM, 50 nM, 10 nM, 1 nM, 0.1 nM. The inhibitory activities of the compounds were expressed as IC<sub>50</sub> values. IC<sub>50</sub> values were obtained by plotting the residual percentage of enzymatic activity against the logarithm of the inhibitor concentrations. Experimental data were fitted to the equation % residual activity = 100/(1 + 10<sup>((logIC<sub>50</sub> log<i>c</i>(inhibitor))Hill slope)</sup>) using GraphPad Prism software version 5.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Stability Evaluation in Buffer</h3><div class="NLM_p last">Compounds <b>56</b>, <b>60</b>, and <b>61</b> were dissolved in 90 μL of DMSO and added to an aqueous 1× PBS buffer solution (prepared from 10× PBS buffer solution (Gibco) adjusted with aq 2 M HCl or 2 M NaOH solution, respectively, pH 6.5 or 7.4 or 8.0, 910 μL) resulting in a final concentration of ∼1 mM. The hydrolysis was monitored via analytical HPLC (C<sub>A3</sub>) over 12 h. 0 h was measured directly after the addition of the PBS buffer solution and was taken as the reference peak.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Synthesis</h3><div class="NLM_p last">The synthetic procedures and characterization data of crucial synthetic intermediates as well as those of the final PSFs are described below. All other synthetic procedures and characterization data are included in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b00685/suppl_file/jm8b00685_si_001.pdf" class="ext-link">Supporting Information</a>, which also contains all NMR spectra, MS data, and HLPC traces of the final PSFs.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 2HCl·H-Arg-ψ[CH<sub>2</sub>SO<sub>2</sub>]-F (<b>7</b>)</h3><div class="NLM_p last">Cbz-Arg(Mtr)-ψ[CH<sub>2</sub>SO<sub>2</sub>]-F (<b>17</b>) (310 mg, 541 μmol, 1.00 equiv) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (8 mL), and 33% HBr/AcOH solution (8 mL) was added. The reaction mixture was stirred for 1 h and the solvents removed in vacuo. H<sub>2</sub>O (20 mL) was added and the aqueous layer extracted with EtOAc (20 mL) and treated with Dowex 1X8 chloride form (777 mg) for 10 min. The mixture was filtered and freeze-dried. The crude product was obtained as a yellowish solid (166 mg, 555 μmol, 100%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>, 298 K): δ<sub>H</sub> (ppm) = 8.63 (s, 3H, NH<sub>3</sub>αC), 7.79 (t, <i>J</i> = 5.9 Hz, 1H, CN<i>H</i>CH<sub>2</sub>), 4.48 (dt, <i>J</i> = 15.5, 6.0 Hz, 1H, CH<sub>a</sub>SO<sub>2</sub>F), 4.40 (dt, <sup>3</sup><i>J</i><sub>H,H,F</sub> = 15.5, 5.5 Hz, 1H, CH<sub>b</sub>SO<sub>2</sub>F), 3.86–3.72 (m, 1H, H<sub>3</sub>NαC<i>H</i>), 3.22–3.05 (m, 2H, αCNHC<i>H</i><sub>2</sub>), 1.87–1.72 (m, 2H, αCHC<i>H</i><sub>2</sub>), 1.72–1.55 (m, 2H, αCHCH<sub>2</sub>C<i>H</i><sub>2</sub>). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>, 298 K): δ<sub>C</sub> (ppm) = 157.4 (NHCNH<sub>2</sub>), 52.3 (d, <i>J</i><sub>C,S,F</sub> = 14.8 Hz, CH<sub>2</sub>SO<sub>2</sub>F), 46.3 (αCH), 40.6 (αCNH<u class="uu">C</u>H<sub>2</sub>), 29.3 (NH<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>), 24.3 (αCNHCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>). <sup>19</sup>F NMR (471 Hz, DMSO-<i>d</i><sub>6</sub>, 298 K): δ<sub>F</sub> (ppm) = 60.3 (s, 1F, SO<sub>2</sub>F). HRMS (ESI positive) calcd for C<sub>6</sub>H<sub>16</sub>N<sub>4</sub>O<sub>2</sub>SF [M + H]<sup>+</sup> 227.0973, found 227.0971.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> TFA·H-Lys(Cbz)-ψ[CH<sub>2</sub>SO<sub>2</sub>]-F (<b>8</b>)</h3><div class="NLM_p last">N<sub>3</sub>-Lys(Cbz)-ψ[CH<sub>2</sub>SO<sub>2</sub>]-F (<b>40</b>) (300 mg, 837 μmol, 1.00 equiv) was dissolved in AcOH (12.5 mL). Next, zinc powder (547 mg, 8.37 mmol, 10.0 equiv) and TFA (1.9 mL) were added and the reaction mixture was stirred overnight at rt. The solvents were removed in vacuo, and AcOH (10 mL) was added. The crude product was purified via semipreparative HPLC (0 to 100% B, C<sub>P1</sub>), and fractions containing the pure product were pooled and lyophilized. The pure product was obtained as a white solid (212 mg, 474 μmol, 57%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 298 K): δ<sub>H</sub> (ppm) = 8.39 (s, 3H, NH<sub>3</sub><sup>+</sup>), 7.41–7.28 (m, 5H, Ar-H (Cbz)), 7.24 (t, <i>J</i> = 5.6 Hz, 1H, N<i>H</i>CH<sub>2</sub>), 5.01 (s, 2H, CH<sub>2</sub> (Cbz)), 4.41 (dt, <i>J</i> = 15.6, 5.6 Hz, 1H, CH<sub>a</sub>SO<sub>2</sub>F), 4.25 (dt, <i>J</i> = 15.6, 5.7 Hz, 1H, CH<sub>b</sub>SO<sub>2</sub>F), 3.79–3.65 (m, 1H, NH<sub>3</sub>C<i>H</i>), 3.04–2.92 (m, 2H, NHC<i>H</i><sub>2</sub>), 1.79–1.68 (m, 2H, αCHC<i>H</i><sub>2</sub>), 1.48–1.32 (m, 4H, NHCH<sub>2</sub>C<i>H</i><sub>2</sub>C<i>H</i><sub>2</sub>). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>, 298 K): δ<sub>c</sub> (ppm) = 156.6 (C═O), 137.7 (C-Ar), 128.8, 128.2, 128.2 (CH-Ar), 65.6 (CH<sub>2</sub> (Cbz)), 52.3 (d, <i>J</i><sub>C,F</sub> = 15.0 Hz, CH<sub>2</sub>SO<sub>2</sub>F), 46.6 (NH<sub>3</sub>CH), 40.3 (NHCH<sub>2</sub>), 31.8 (NH<sub>3</sub>CH<u class="uu">C</u>H<sub>2</sub>), 29.3 (CH<sub>2</sub>), 21.5 (CH<sub>2</sub>). <sup>19</sup>F NMR (471 MHz, CDCl<sub>3</sub>, 298 K): δ<sub>F</sub> (ppm) = 62.7 (SO<sub>2</sub>F). HRMS (ESI positive) calcd for C<sub>14</sub>H<sub>23</sub>N<sub>2</sub>O<sub>4</sub>SF [M + H]<sup>+</sup> 333.1279, found 333.1260.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> TFA·H-Phe(4-NHCbz)-ψ[CH<sub>2</sub>SO<sub>2</sub>]-F (<b>9</b>)</h3><div class="NLM_p last">N<sub>3</sub>-Phe(4-NHCbz)-ψ[CH<sub>2</sub>SO<sub>2</sub>]-F (<b>41</b>) (314 mg, 799 μmol, 1.00 equiv) was dissolved in AcOH (12 mL). Next, zinc powder (522 mg, 7.99 mmol, 10.0 equiv) and TFA (1.73 mL) were added and the reaction mixture was stirred overnight at rt. The solvents were removed in vacuo, and AcOH (10 mL) was added. The crude product was purified via semipreparative HPLC (0 to 100% B, C<sub>P1</sub>), and fractions containing the pure product were pooled and lyophilized. The pure product was obtained as a white solid (209 mg, 468 μmol, 59%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, 298 K): δ<sub>H</sub> (ppm) = 9.84 (s, 1H, NH), 8.20 (br s, 3H, NH<sub>3</sub><sup>+</sup>), 7.46 (d, <i>J</i> = 8.4 Hz, 2H, CH (Phe)), 7.44–7.32 (m, 5H, Ar-H (Cbz)), 7.23 (d, <i>J</i> = 8.4 Hz, 2H, CH (Phe)), 5.15 (s, 2H, CH<sub>2</sub> (Cbz)), 4.24 (app dt, <i>J</i> = 15.5, 5.3 Hz, 1H, CH<sub>a</sub>SO<sub>2</sub>F), 4.16 (app dt, <i>J</i> = 15.5, 6.0 Hz, 1H, CH<sub>b</sub>SO<sub>2</sub>F), 4.02–3.93 (m, 1H, NH<sub>3</sub><sup>+</sup>αC<i>H</i>), 3.03–2.92 (m, 2H, N<sub>3</sub>αCHC<i>H</i><sub>2</sub>). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>, 298 K): δ<sub>c</sub> (ppm) = 153.8 (C═O), 138.9 (C-Ar), 137.1 (C-Ar), 130.5 (CH-Ar (Phe)), 128.9 (CH-Ar (Cbz)), 128.6 (CH-Ar (Cbz)), 128.5 (CH-Ar (Cbz)), 128.0 (C-Ar), 119.0 (CH-Ar (Phe)), 66.2 (CH<sub>2</sub> (Cbz)), 52.2 (d, <i>J</i> = 15.7 Hz, CSO<sub>2</sub>F), 47.8 (αCH), 37.3 (αCH <u class="uu">C</u>H<sub>2</sub>). <sup>19</sup>F NMR (377 MHz, CDCl<sub>3</sub>, 298 K): δ<sub>F</sub> (ppm) = 60.6 (t, <i>J</i> = 5.8 Hz, 1F, SO<sub>2</sub>F). HRMS (ESI positive) calcd for C<sub>17</sub>H<sub>19</sub>N<sub>2</sub>O<sub>4</sub>SFNa [M + Na]<sup>+</sup> 389.0942, found 389.0926.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> TFA·H-Phe(4-CH<sub>2</sub>NHCbz)-ψ[CH<sub>2</sub>SO<sub>2</sub>]-F (<b>10</b>)</h3><div class="NLM_p last">N<sub>3</sub>-Phe(4-CH<sub>2</sub>NHCbz)-ψ[CH<sub>2</sub>SO<sub>2</sub>]-F (<b>42</b>) (62 mg, 153 μmol, 1.00 equiv) was dissolved in AcOH (2.3 mL). Next, zinc powder (99.8 mg, 1.53 mmol, 10.0 equiv) and TFA (342 μL) were added and the reaction mixture was stirred overnight at rt. Then, the solvents were removed in vacuo and AcOH (5 mL) was added. The crude product was purified via semipreparative HPLC (0 to 100% B, C<sub>P1</sub>), and fractions containing the pure product were pooled and lyophilized. The pure product was obtained as a white solid (40.9 mg, 82.7 μmol, 54%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, 298 K): δ<sub>H</sub> (ppm) = 8.53 (br s, 3H, NH<sub>3</sub><sup>+</sup>), 7.86 (t, <i>J</i> = 6.3 Hz, 1H, N<i>H</i>CH<sub>2</sub>), 7.41–7.20 (m, 9H, Ar-H (Cbz), CH (Phe)), 5.05 (s, 2H, CH<sub>2</sub> (Cbz)), 4.31–4.16 (m, 4H, NHC<i>H</i><sub>2</sub>, CH<sub>2</sub>SO<sub>2</sub>F), 4.12–3.97 (m, 1H, NH<sub>3</sub>C<i>H</i>), 3.17–2.97 (m, 2H, αCHC<i>H</i><sub>2</sub>Phe). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>, 298 K): δ<sub>c</sub> (ppm) = 156.9 (C═O), 139.5 (C-Ar), 137.6 (C-Ar), 133.3 (C-Ar), 130.0 (CH-Ar (Phe[4-CH<sub>2</sub>NHCbz])), 128.8 (CH-Ar (Cbz)), 128.3 (CH-Ar (Phe[4-CH<sub>2</sub>NHCbz])), 128.2 (CH-Ar (Cbz)), 127.9 (CH-Ar (Cbz)), 65.9 (CH<sub>2</sub> (Cbz)), 52.1 (d, <i>J</i> = 15.4 Hz, CH<sub>2</sub>SO<sub>2</sub>F), 47.7 (α<u class="uu">C</u>HCH<sub>2</sub>Phe), 43.9 (CH<sub>2</sub>NHCbz), 37.5 (αCH<u class="uu">C</u>H<sub>2</sub>Phe). <sup>19</sup>F NMR (471 MHz, DMSO-<i>d</i><sub>6</sub>, 298 K): δ<sub>F</sub> (ppm) = 60.6 (s, <i>J</i> = 5.6 Hz, SO<sub>2</sub>F). HRMS (ESI positive) calcd for C<sub>18</sub>H<sub>21</sub>N<sub>2</sub>O<sub>4</sub>SFNa [M + Na]<sup>+</sup> 403.1098, found 403.1091.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Cbz-Arg(Mtr)-ψ[CH<sub>2</sub>O]-H (<b>13</b>)</h3><div class="NLM_p last">Sodium borohydride (1.81 g, 47.9 mmol, 2.50 equiv) was added to a mixture of <i>N</i><sub>α</sub>-<i>Z</i>-<i>N</i><sub>ω</sub>-(4-methoxy-2,3,6-trimethylbenzenesulfonyl)-<span class="smallcaps smallerCapital">l</span>-arginine methyl ester <b>12</b> (10.2 g, 19.2 mmol, 1.00 equiv) and LiCl (2.03 g, 47.9 mmol, 2.50 equiv) in dry THF (40 mL) at rt and was stirred for 15 min. EtOH (55 mL) was added carefully and the resulting cloudy mixture stirred for 5 h (TLC monitored). The reaction mixture was cooled to 0 °C and quenched with saturated NH<sub>4</sub>Cl (45 mL) and H<sub>2</sub>O (13 mL). The mixture was extracted with EtOAc (3 × 100 mL), and the combined organic phases were dried over MgSO<sub>4</sub>. The solvent was removed in vacuo and the crude product purified via column chromatography (EtOAc). The pure product was obtained as a white solid (9.19 g, 18.1 mmol, 95%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 298 K): δ<sub>H</sub> (ppm) = 7.29–7.14 (m, 5H, Ar-H (Cbz)), 6.42 (s, 1H, Ar-H (Mtr)), 6.26–6.03 (m, 3H, 3 × NH (guanidine)), 5.49 (d, <i>J</i> = 8.5 Hz, 1H, <i>H</i>NαCH), 4.96 (s, 2H, OCH<sub>2</sub>Ph), 3.73 (s, 3H, OCH<sub>3</sub> (Mtr)), 3.61–3.41 (m, 3H, HNαC<i>H</i>, C<i>H</i><sub>2</sub>OH), 3.21 (br s, 1H, CH<sub>2</sub>O<i>H</i>), 3.15–3.04 (m, 2H, NHC<i>H</i><sub>2</sub>), 2.57 (s, 3H, Ar-CH<sub>3</sub> (Mtr)), 2.50 (s, 3H, Ar-CH<sub>3</sub> (Mtr)), 2.03 (s, 3H, Ar-CH<sub>3</sub> (Mtr)), 1.52–1.32 (m, 4H, αCHC<i>H</i><sub>2</sub>C<i>H</i><sub>2</sub>). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>, 298 K): δ<sub>C</sub>(ppm) = 158.5 (C═O), 157.0 (C-guanidine), 156.4 (C-Ar), 138.5 (C-Ar), 136.4 (C-Ar (Cbz)), 133.3 (C-Ar), 128.5, 128.1, 128.0 (CH-Ar (Cbz)), 124.9 (C-Ar), 111.8 (CH-Ar (Mtr)), 66.8 (CH<sub>2</sub> (Cbz)), 64.7 (CH<sub>2</sub>OH), 55.4 (OCH<sub>3</sub>), 41.0 (NHCH<sub>2</sub>), 28.5 (αCH<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>), 25.6 (αCHCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>), 24.1 CH<sub>3</sub> (Mtr)), 18.3 CH<sub>3</sub> (Mtr)), 11.9 (CH<sub>3</sub> (Mtr)). HRMS (ESI positive) calcd for C<sub>24</sub>H<sub>34</sub>N<sub>4</sub>O<sub>3</sub>S [M + Na]<sup>+</sup> 529.2091, found 529.2073.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Cbz-Arg(Mtr)-ψ[CH<sub>2</sub>O]-Ms (<b>14</b>)</h3><div class="NLM_p last">Methanesulfonyl chloride (1.72 mL, 22.2 mmol, 1.30 equiv) was added dropwise to a solution of Cbz-Arg(Mtr)-ψ[CH<sub>2</sub>O]-H (<b>13</b>) (8.64 g, 17.1 mmol, 1.00 equiv) in dry CH<sub>2</sub>Cl<sub>2</sub> (200 mL) at 0 °C. NEt<sub>3</sub> (3.1 mL, 22.2 mmol, 1.30 equiv) was added dropwise, and the reaction mixture was stirred for 2 h at rt (TLC monitored). After the reaction was finished, the organic phase was washed with an aqueous 1 M KHSO<sub>4</sub> solution (250 mL), H<sub>2</sub>O (250 mL), and brine (250 mL). The organic layer was dried over MgSO<sub>4</sub>, the solvent was removed in vacuo and the crude product obtained as a white solid (9.36 g, 16.0 mmol, 94%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 298 K): δ<sub>H</sub> (ppm) = 7.31–7.20 (m, 5H, Ar-H (Cbz)), 6.44 (s, 1H, Ar-H (Mtr)), 6.11 (br s, 2H, 2 × NH (guanidine)), 5.99 (s, 1H, NH (guanidine)), 5.46 (d, <i>J</i> = 7.7 Hz, 1H, <i>H</i>NαCH), 5.01 (d, <i>J</i> = 12.2 Hz, 1H, OCH<sub>a</sub>Ph), 4.95 (d, <i>J</i> = 12.2 Hz, 1H, OCH<sub>b</sub>Ph), 4.11 (dd, <i>J</i> = 10.3, 4.3 Hz, 1H, C<i>H</i><sub>a</sub>OSO<sub>2</sub>CH<sub>3</sub>), 4.05 (dd, <i>J</i> = 9.9, 4.3 Hz, 1H, C<i>H</i><sub>b</sub>OSO<sub>2</sub>CH<sub>3</sub>), 3.85–3.76 (m, 1H, HNαC<i>H</i>), 3.74 (s, 3H, OCH<sub>3</sub> (Mtr)), 3.17–3.05 (m, 2H, HNC<i>H</i><sub>2</sub>), 2.86 (s, 3H, SO<sub>2</sub>CH<sub>3</sub>), 2.57 (s, 3H, Ar-CH<sub>3</sub>(Mtr)), 2.50 (s, 3H, Ar-CH<sub>3</sub>(Mtr)), 2.04 (s, 3H, Ar-CH<sub>3</sub> (Mtr)), 1.57–1.37 (m, 4H, αCHCH<sub>2</sub>CH<sub>2</sub>). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>, 298 K): δ<sub>C</sub> (ppm) = 158.6 (C═O), 156.4 (C-guanidino), 156.3 (C-Ar), 138.5 (C-Ar), 136.6 (C-Ar), 136.3 (C-Ar), 128.5, 128.2, 128.0 (CH-Ar (Cbz)), 124.9 (C-Ar), 111.8 (CH-Ar (Mtr)), 71.1 (<u class="uu">C</u>H<sub>2</sub>OSO<sub>2</sub>CH<sub>3</sub>), 66.9 (OCH<sub>2</sub>(Cbz)), 55.5 (OCH<sub>3</sub>), 50.1 (αCH), 40.7 (NHCH<sub>2</sub>), 37.2 (SO<sub>2</sub>CH<sub>3</sub>), 28.1 (αCH<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>), 25.5 (αCHCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>), 24.1 (CH<sub>3</sub> (Mtr)), 18.3 (CH<sub>3</sub> (Mtr)), 12.0 (CH<sub>3</sub> (Mtr)). HRMS (ESI positive) calcd for C<sub>25</sub>H<sub>36</sub>N<sub>4</sub>O<sub>8</sub>S<sub>2</sub>Na [M + Na]<sup>+</sup> 607.1867, found 607.1853</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Cbz-Arg(Mtr)-ψ[CH<sub>2</sub>S]-Ac (<b>15</b>)</h3><div class="NLM_p last">Thioacetic acid (2.27 mL, 31.7 mmol, 2.00 equiv) was added to a suspension of Cs<sub>2</sub>CO<sub>3</sub> (5.17 g, 15.9 mmol, 1.00 equiv) in DMF (10 mL) under argon atmosphere. Most of the Cs<sub>2</sub>CO<sub>3</sub> was dissolved when added to a solution of Cbz-Arg(Mtr)-ψ[CH<sub>2</sub>O]-Ms (<b>14</b>) (9.28 g, 15.9 mmol, 1.00 equiv) in DMF (38 mL) under argon atmosphere. The reaction mixture was stirred overnight at rt with the flask covered in aluminum foil. EtOAc (160 mL) and H<sub>2</sub>O (160 mL) were added to the reaction mixture and the organic layer was washed with aq solution of 1 M KHSO<sub>4</sub> (160 mL), aq solution of 1 M NaHCO<sub>3</sub> (160 mL), brine (160 mL) and dried over MgSO<sub>4</sub>. The solvent was removed in vacuo and the crude product purified via column chromatography (EtOAc/petroleum ether v/v 8:2 → EtOAc). The pure product was obtained as a yellowish solid (6.85 g, 12.1 mmol, 76%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 298 K): δ<sub>H</sub> (ppm) = 7.30–7.15 (m, 5H, Ar-H (Cbz)), 6.43 (s, 1H, Ar-H (Mtr)), 6.27–5.97 (m, 3H, 3 × NH (guanidine)), 5.15 (d, <i>J</i> = 9.2 Hz, 1H, <i>H</i>NαCH), 5.00 (d, <i>J</i> = 12.4 Hz, 1H, OCH<sub>a</sub>Ph), 4.92 (d, <i>J</i> = 12.4 Hz, 1H, OCH<sub>b</sub>Ph), 3.72 (s, 3H, OCH<sub>3</sub> (Mtr)), 3.68–3.57 (m, 1H, HNαC<i>H</i>), 3.13–2.99 (m, 2H, HNC<i>H</i><sub>2</sub>), 2.89 (dd, <i>J</i> = 14.0, 4.7 Hz, 1H, C<i>H</i><sub>a</sub>SC(O)CH<sub>3</sub>), 2.79 (dd, <i>J</i> = 14.0, 7.9 Hz, 1H, C<i>H</i><sub>b</sub>SC(O)CH<sub>3</sub>), 2.58 (s, 3H, Ar-CH<sub>3</sub> (Mtr)), 2.51 (s, 3H, Ar-CH<sub>3</sub> (Mtr)), 2.19 (s, 3H, SC(O)CH<sub>3</sub>), 2.03 (s, 3H, Ar-CH<sub>3</sub> (Mtr)), 1.51–1.28 (m, 4H, αCHC<i>H</i><sub>2</sub>C<i>H</i><sub>2</sub>). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>, 298 K): δ<sub>C</sub> (ppm) = 196.1 (S<u class="uu">C</u>(O)CH<sub>3</sub>), 158.4 (C═O), 156.6 (C-guanidino), 156.3 (C-Ar), 138.5 (C-Ar), 136.5 (C-Ar), 136.4 (C-Ar), 133.6 (C-Ar), 128.5, 128.1, 127.8 (CH-Ar (Cbz)), 124.8 (C-Ar), 111.7 (CH-Ar (Mtr)), 66.7 (OCH<sub>2</sub> (Cbz)), 55.4 (OCH<sub>3</sub>), 51.1 (CH<sub>2</sub>S), 40.8 (NHCH<sub>2</sub>), 33.8 (NHαCH), 31.8 (αCH<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>), 30.5 (SC(O)<u class="uu">C</u>H<sub>3</sub>), 25.7 (αCHCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>), 24.1 (CH<sub>3</sub> (Mtr)), 18.3 (CH<sub>3</sub> (Mtr)), 12.0 (CH<sub>3</sub> (Mtr)). HRMS (ESI negative) calcd for C<sub>26</sub>H<sub>36</sub>N<sub>4</sub>O<sub>6</sub>S<sub>2</sub> [M – H]<sup>−</sup> 563.2003, found 563.1980.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Cbz-Arg(Mtr)-ψ[CH<sub>2</sub>SO<sub>2</sub>]-F (<b>17</b>)</h3><div class="NLM_p last">Cbz-Arg(Mtr)-ψ[CH<sub>2</sub>S]-Ac (<b>15</b>) (6.63 g, 11.7 mmol, 1.00 equiv) was dissolved in AcOH (40 mL), and 30% H<sub>2</sub>O<sub>2</sub> aq solution (13.5 mL) was added. The reaction mixture was stirred for 48 h, and additional H<sub>2</sub>O<sub>2</sub> aq solution (3.5 mL) was added. NaOAc (963 mg, 11.7 mmol, 1.00 equiv) was added and the mixture stirred for 1 h. DMF (20 mL) was added, and the solution was concentrated in vacuo until a quarter of the volume. This procedure was repeated 3 more times and finally DMF was removed completely. After coevaporation with H<sub>2</sub>O (2 × 100 mL) the crude product was lyophilized and <b>16</b> obtained as a white solid (6.82 g). The crude sodium salt <b>16</b> (600 mg, 1.01 mmol, 1.00 equiv) was dissolved in dry CH<sub>2</sub>Cl<sub>2</sub> (25 mL) under argon atmosphere, and XtalFluor-M (442 mg, 1.82 mmol, 1.80 equiv) and 3HF·NEt<sub>3</sub> (7.1 μL, 43.6 μmol, 0.04 equiv) were added. The reaction mixture was heated to 40 °C and stirred overnight. Silica was added to quench the reaction and the solvent removed in vacuo. Column chromatography (EtOAc) yielded the pure product as a white solid (320 mg, 559 μmol, 55% over two steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 298 K): δ<sub>H</sub> (ppm) = 7.37–7.24 (m, 5H, Ar-H (Cbz)), 6.51 (s, 1H, Ar-H (Mtr)), 6.36–6.04 (m, 3H, 3 × NH (guanidine)), 5.89 (br s, 1H, <i>H</i>NαCH), 5.13–4.99 (m, 2H, CH<sub>2</sub> (Cbz)), 4.20–4.00 (m, 1H, HNαC<i>H</i>), 3.80 (s, 3H, OCH<sub>3</sub> (Mtr)), 3.65 (dd, <i>J</i> = 15.2, 6.9 Hz, 1H, CH<sub>a</sub>SO<sub>2</sub>F), 3.52–3.39 (m, 1H, CH<sub>b</sub>SO<sub>2</sub>F), 3.15 (br s, 2H, HNC<i>H</i><sub>2</sub>), 2.63 (s, 3H, Ar-CH<sub>3</sub> (Mtr)), 2.56 (s, 3H, Ar-CH<sub>3</sub> (Mtr)), 2.10 (s, 3H, Ar-CH<sub>3</sub> (Mtr)), 1.79–1.38 (m, 4H, αCHC<i>H</i><sub>2</sub>C<i>H</i><sub>2</sub>). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>, 298 K): δ<sub>C</sub> (ppm) = 158.7 (C═O), 156.3 (C-guanidino), 156.0 (C-Ar), 138.4 (C-Ar), 136.6 (C-Ar), 136.1 (C-Ar), 132.9 (C-Ar), 128.5 (CH-Ar (Cbz)), 128.2 (CH-Ar (Cbz)), 127.9 (CH-Ar (Cbz)), 125.0 (C-Ar), 111.8 (CH (Mtr)), 67.1 (CH<sub>2</sub> (Cbz)), 55.4 (OCH<sub>3</sub>), 54.5 (d, <i>J</i><sub>C,F</sub> = 13.2 Hz, CH<sub>2</sub>SO<sub>2</sub>F), 47.2 (αCH), 40.4 (αCHCH<sub>2</sub>CH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>), 30.5 (αCH<u class="uu">C</u>H<sub>2</sub>), 25.6 (αCHCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub>), 24.0 (CH<sub>3</sub> (Mtr)), 18.3 (CH<sub>3</sub> (Mtr)), 11.9 (CH<sub>3</sub> (Mtr)). <sup>19</sup>F NMR (377 MHz, CDCl<sub>3</sub>, 298 K): δ<sub>F</sub> (ppm) = 61.6 (s, 1F, SO<sub>2</sub>F). HRMS (ESI positive) calcd for C<sub>24</sub>H<sub>33</sub>FN<sub>4</sub>O<sub>7</sub>S<sub>2</sub> [M + Na]<sup>+</sup> 595.1667, found 595.1670. [<b>α</b>]<sub class="stack">D</sub><sup class="stack">23</sup> +1.29 (<i>c</i> 1.14, CDCl<sub>3</sub>). IR (neat, cm<sup>–1</sup>) = 1705, 1622, 1550, 1456 (SO<sub>2</sub>), 1408, 1307, 1256, 1120, 731.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Boc-Phe(4-NHCbz)-OH (<b>20</b>)</h3><div class="NLM_p last">4-Amino-(<i>N</i>-<i>tert</i>-butoxycarbonyl)-<span class="smallcaps smallerCapital">l</span>-phenylalanine (9.95 g, 35.5 mmol, 1.00 equiv) was dissolved in a 1:1 mixture of H<sub>2</sub>O/dioxane (200 mL). Benzyloxycarbonyl chloride (6.25 mL, 43.8 mmol, 1.23 equiv) was added and the pH adjusted to 8 by addition of sodium bicarbonate. The reaction mixture was stirred overnight. Dioxane was removed in vacuo, and the aqueous layer was washed with EtOAc (2 × 200 mL). The aqueous layer was acidified with aq solution of 2 M HCl and the pH adjusted to 1. The precipitate was extracted with EtOAc (3 × 200 mL), dried over MgSO<sub>4</sub>, and filtered. The solvent was removed in vacuo, and the crude product purified by flash column chromatography (EtOAc/Hex v/v 1:1 + 1% AcOH). The pure product was obtained as a white solid (11.1 g, 26.8 mmol, 73%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 298 K): δ<sub>H</sub> (ppm) = 7.39–7.11 (m, 7H, Ar-H (Cbz), Ar-H (Phe)), 7.00 (d, <i>J</i> = 8.2 Hz, 2H, Ar-H (Phe)), 5.20–5.01 (m, 2H, CH<sub>2</sub> (Cbz)), 4.93 (d, <i>J</i> = 8.1 Hz, 1H, <i>H</i>NαCH), 4.61–4.45 (m, 1H, HNαC<i>H</i>), 3.10–2.96 (m, 2H, αCHC<i>H</i><sub>2</sub>), 1.33 (s, 9H, CH<sub>3</sub> (Boc)). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>, 298 K): δ<sub>c</sub> (ppm) = 176.3 (CO<sub>2</sub>H), 155.3 (C═O (Cbz)), 153.7 (C═O (Boc)), 136.9 (C-Ar), 136 (C-Ar), 130.8 (C-Ar), 130.1 (CH-Ar (Phe)), 128.6, 128.3, 128.3 (CH-Ar (Cbz)), 118.9 (CH-Ar (Phe)), 80.3 (<u class="uu">C</u>(CH<sub>3</sub>)<sub>3</sub>), 67.1 (CH<sub>2</sub> (Cbz)), 54.2 (αCH), 37.0 (αCH<u class="uu">C</u>H<sub>2</sub>), 28.3 (C(<u class="uu">C</u>H<sub>3</sub>)<sub>3</sub>). HRMS (ESI positive) calcd for C<sub>22</sub>H<sub>26</sub>N<sub>2</sub>O<sub>6</sub>Na [M + Na]<sup>+</sup> 437.1683, found 437.1666.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> N<sub>3</sub>-Phe(4-NHCbz)-OH (<b>21</b>)</h3><div class="NLM_p last">Boc-Phe(4-NHCbz)-OH (<b>20</b>) (11.1 g, 26.8 mmol, 1.00 equiv) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (250 mL), and TFA (250 mL) was added and the reaction mixture stirred for 1 h at rt. The solvents were removed under reduced pressure, and the residue coevaporated with toluene. The crude salt was obtained as a white solid. The crude TFA salt (11.5 g, 26.8 mmol, 1.00 equiv), N<sub>3</sub>SO<sub>2</sub>Im·HCl (6.74 g, 32.2 mmol, 1.20 equiv), CuSO<sub>4</sub>·5H<sub>2</sub>O (335 mg, 1.34 mmol, 0.05 equiv), and K<sub>2</sub>CO<sub>3</sub> (9.26 g, 67.0 mmol, 2.50 equiv) were dissolved in MeOH (88 mL) and stirred at rt. After 18 h more N<sub>3</sub>SO<sub>2</sub>Im·HCl (5.62 g, 26.8 mmol, 1.00 equiv) was added, and the reaction mixture was stirred for 2 days. The solvent was removed in vacuo and dissolved in H<sub>2</sub>O (350 mL), and the aqueous mixture was acidified with aq solution of 2 M HCl. The precipitate was extracted with EtOAc (3 × 200 mL), and the combined organic layers were dried over MgSO<sub>4</sub> and filtered. The solvent was removed in vacuo and the crude product purified by flash column chromatography (EtOAc/Hex v/v 7:3 + 1% AcOH) The pure product was obtained as a clear colorless oil (6.96 g, 20.5 mmol, 76%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 298 K): δ<sub>H</sub> (ppm) = 9.93 (s, 1H, CO<sub>2</sub>H), 7.33–7.21 (m, 7H, CH (Phe), Ar-H (Cbz)), 7.13–7.05 (m, 2H, CH (Phe)), 6.86 (s, 1H, NH) 5.11 (s, 2H, CH<sub>2</sub> (Cbz)), 4.04 (dd, <i>J</i> = 8.0, 5.4 Hz, 1H, N<sub>3</sub>αCH), 3.07 (dd, <i>J</i> = 14.1, 5.4 Hz, 1H, αCHC<i>H</i><sub>a</sub>), 2.93 (dd, <i>J</i> = 14.1, 8.0 Hz, 1H, αCHC<i>H</i><sub>b</sub>). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>, 298 K): δ<sub>c</sub> (ppm) = 174.9 (CO<sub>2</sub>H), 137.0 (C-Ar<sub>t</sub>), 135.8 (C-Ar), 130.0 (C-Ar), 128.7 (CH (Phe)), 128.4 (CH (Cbz)), 128.3 (CH (Cbz)), 128.2 (CH (Cbz)), 119.0 (CH (Phe)), 67.3 (CH<sub>2</sub> (Cbz)), 63.0 (αCH), 36.9 (αCH<u class="uu">C</u>H<sub>2</sub>). HRMS (ESI negative) calcd for C<sub>17</sub>H<sub>15</sub>N<sub>4</sub>O<sub>4</sub> [M – H]<sup>−</sup> 339.1099, found 339.1092.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> N<sub>3</sub>-Phe(4-NHCbz)-OMe (<b>22</b>)</h3><div class="NLM_p last">N<sub>3</sub>-Phe(4-NHCbz)-OH (<b>21</b>) (6.96 g, 20.5 mmol, 1.00 equiv) was dissolved in MeOH (60 mL) under N<sub>2</sub> atmosphere and cooled to −20 °C. Thionyl chloride (1.6 mL, 22.1 mmol, 1.05 equiv) was added, and the mixture was allowed to warm up to rt and stirred overnight. The solvent was removed under reduced pressure and the residue coevaporated with CHCl<sub>3</sub> (3 × 90 mL). The product was obtained as a yellow oil (7.26 g, 20.5 mmol, 100%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 298 K): δ<sub>H</sub> (ppm) = 7.44–7.30 (m, 7H, Ar-H (Cbz), Ar-H (Phe)), 7.16 (d, <i>J</i> = 8.5 Hz, 2H, Ar-H (Phe)), 6.74 (s, 1H, NH), 5.19 (s, 2H, CH<sub>2</sub> (Cbz)), 4.04 (dd, <i>J</i> = 8.6, 5.5 Hz, 1H, N<sub>3</sub>αCH), 3.76 (s, 3H, CH<sub>3</sub>), 3.12 (dd, <i>J</i> = 14.0, 5.5 Hz, 1H, αCHC<i>H</i><sub>a</sub>), 2.96 (dd, <i>J</i> = 14.0, 8.6 Hz, 1H, αCHC<i>H</i><sub>b</sub>). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>, 298 K): δ<sub>c</sub> (ppm) = 170.4 (<u class="uu">C</u>O<sub>2</sub>CH<sub>3</sub>), 153.3 (C═O (Cbz)), 137.0 (C-Ar), 136.0 (C-Ar), 130.9 (C-Ar), 129.9 (CH-Ar (Phe)), 128.6 (CH-Ar (Cbz)), 128.4 (CH-Ar (Cbz)), 128.3 (CH-Ar (Cbz)), 118.9 (CH-Ar (Phe)), 67.1 (CH<sub>2</sub> (Cbz)), 63.3 (αCH), 52.7 (CH<sub>3</sub>), 37.0 (αCH<u class="uu">C</u>H<sub>2</sub>). HRMS (ESI positive) calcd for C<sub>18</sub>H<sub>18</sub>N<sub>4</sub>O<sub>4</sub>Na [M + Na]<sup>+</sup> 377.1220, found 377.1206.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> N<sub>3</sub>-Phe(4-CH<sub>2</sub>NHCbz)-OH (<b>26</b>)</h3><div class="NLM_p last">Boc-Phe(4-CH<sub>2</sub>NHCbz)-OH (<b>25</b>) (4.93 g, 11.5 mmol, 1.00 equiv) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (60 mL), and TFA (22 mL) was added and the reaction mixture stirred for 45 min at rt. The solvents were removed in vacuo, and the residue was coevaporated with toluene (3 × 100 mL) and CHCl<sub>3</sub> (3 × 100 mL). The crude was dissolved in MeOH (38 mL), and CuSO<sub>4</sub>·5H<sub>2</sub>O (144 mg, 0.58 mmol, 0.05 equiv), K<sub>2</sub>CO<sub>3</sub> (3.98 g, 28.8 mmol, 2.50 equiv), and N<sub>3</sub>SO<sub>2</sub>Im·HCl (2.89 g, 13.8 mmol, 1.20 equiv) were added. The reaction mixture was stirred overnight at rt and the solvent removed in vacuo. H<sub>2</sub>O (200 mL) was added and the pH adjusted to 1 with aq solution of 1 M HCl. The aqueous layer was extracted with EtOAc (3 × 200 mL), and the combined organic layers were dried over MgSO<sub>4</sub>, filtered, and the solvent was removed in vacuo. The crude was purified via column chromatography (EA/petroleum ether v/v 1:1 + 1% AcOH) and the pure product was obtained as a yellowish oil (3.78 g, 10.7 mmol, 93%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>, 298 K): δ<sub>H</sub> (ppm) = 7.33–7.19 (m, 5H, Ar-H (Cbz)), 7.18–7.07 (m, 4H, Phe), 5.09 (br s, 1H, CH<sub>2</sub>N<i>H</i>Cbz), 5.06 (s, 1H, CH<sub>2</sub> (Cbz)), 4.28 (d, <i>J</i> = 5.9 Hz, 2H, C<i>H</i><sub>2</sub>NHCbz), 4.06 (dd, <i>J</i> = 8.5, 5.2 Hz, 1H, N<sub>3</sub>αCH), 3.12 (dd, <i>J</i> = 14.1, 5.2 Hz, 1H, N<sub>3</sub>αCHC<i>H</i><sub>a</sub>), 2.94 (dd, <i>J</i> = 14.1, 8.5 Hz, 1H, N<sub>3</sub>αCHC<i>H</i><sub>b</sub>). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>, 298 K): δ<sub>c</sub> (ppm) = 173.8 (C(O)OH), 156.7 (C═O), 137.4 (CH-Ar), 136.3 (CH-Ar), 135.1 (CH-Ar), 129.6 (CH-Ar (Phe)), 128.6 (CH-Ar (Cbz)), 128.3 (CH-Ar (Cbz)), 128.2 (CH-Ar (Cbz)), 127.9 (CH-Ar (Phe)), 67.1 (OCH<sub>2</sub>Ph), 63.0 (αCH), 44.8 (CH<sub>2</sub>NHCbz), 37.1 (N<sub>3</sub>αCH<i>C</i>H<sub>2</sub>). HRMS (ESI positive) calcd for C<sub>18</sub>H<sub>18</sub>N<sub>4</sub>O<sub>4</sub>Na [M + Na]<sup>+</sup> 377.1220, found 377.1212</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> N<sub>3</sub>-Phe(4-CH<sub>2</sub>NHCbz)-OMe (<b>27</b>)</h3><div class="NLM_p last">N<sub>3</sub>-Phe(4-CH<sub>2</sub>NHCbz)-OH (<b>26</b>) (3.78 g, 10.7 mmol, 1.00 equiv) was dissolved in MeOH (50 mL) and cooled to −20 °C under nitrogen atmosphere. Thionyl chloride (813 μL, 11.2 mmol, 1.05 equiv) was added dropwise, and the reaction mixture was allowed to warm up to rt and stirred overnight. The solvent was removed in vacuo and coevaporated with CHCl<sub>3</sub> (3 × 100 mL). The crude product was obtained as a white oil (3.92 g, 10.6 mmol, 99%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 298 K): δ<sub>H</sub> (ppm) = 7.41–7.28 (m, 5H, Ar-H (Cbz)), 7.25 (d, <i>J</i> = 8.3 Hz, 2H, 2 × CH (Phe)), 7.19 (d, <i>J</i> = 8.0 Hz, 2H, 2 × CH (Phe)), 5.14 (s, 2H, CH<sub>2</sub> (Cbz)), 5.08 (br s, 1H, CH<sub>2</sub>N<i>H</i>Cbz), 4.37 (d, <i>J</i> = 6.0 Hz, 2H, C<i>H</i><sub>2</sub>NHCbz), 4.06 (dd, <i>J</i> = 8.8, 5.3 Hz, 1H, N<sub>3</sub>αCH), 3.77 (s, 1H, OCH<sub>3</sub>), 3.15 (dd, <i>J</i> = 14.0, 5.3 Hz, 1H, N<sub>3</sub>αCHC<i>H</i><sub>a</sub>), 2.98 (dd, <i>J</i> = 14.0, 8.8 Hz, 1H N<sub>3</sub>αCHC<i>H</i><sub>b</sub>). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>, 298 K): δ<sub>c</sub> (ppm) = 170.3 (C(O)OMe), 156.4 (C═O), 137.5 (C-Ar), 136.5 (C-Ar), 135.2 (C-Ar), 129.5 (CH-Ar (Phe)), 128.5 (CH-Ar (Cbz)), 128.2 (CH-Ar (Cbz)), 128.2 (CH-Ar (Cbz)), 127.9 (CH-Ar (Phe)), 66.9 (OCH<sub>2</sub>Ph), 63.2 (αCH), 52.7 (OCH<sub>3</sub>), 44.8 (CH<sub>2</sub>NHCbz), 37.2 (N<sub>3</sub>αCH<u class="uu">C</u>H<sub>2</sub>). HRMS (ESI positive) calcd for C<sub>19</sub>H<sub>20</sub>N<sub>4</sub>O<sub>4</sub>Na [M + Na]<sup>+</sup> 391.1377, found 391.1368. IR (neat, cm<sup>–1</sup>) = 2110 (N<sub>3</sub>), 1742, 1720, 1516, 1244, 1043.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> TFA.Cbz-Leu<sub>3</sub>-Arg-ψ[CH<sub>2</sub>SO<sub>2</sub>]-F (<b>53</b>)</h3><div class="NLM_p last">Cbz-Leu<sub>3</sub>-OH<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> (78.3 mg, 159 μmol, 1.10 equiv) was dissolved in DMF (1.5 mL), and HBTU (60.4 mg, 159 μmol, 1.10 equiv), Oxymapure (22.6 mg, 159 μmol, 1.10 equiv), and DiPEA (25.2 μL, 145 μmol, 1.00 equiv) were added, and the reaction mixture was stirred for 5 min. Next, a solution of 2HCl·H-Arg-[CH<sub>2</sub>SO<sub>2</sub>]-F (<b>7</b>) (65.8 mg, 145 μmol, 1.00 equiv) in DMF (2 mL) was added to the reaction mixture followed by DiPEA (37.9 μL, 217 mmol, 1.50 equiv) and stirring was continued for 4 h. The solvent was removed in vacuo and the crude product purified by semipreparative HPLC (0 to 100% B, C<sub>P1</sub>). Fractions containing the product were pooled, lyophilized, and the pure product was obtained as a white solid (44.5 mg, 54.7 μmol, 37%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>, 298 K): δ<sub>H</sub> (ppm) = 8.14 (d, <i>J</i> = 8.6 Hz, 1H, N<i>H</i>αCH (Arg)), 7.98 (d, <i>J</i> = 8.1 Hz, 1H, N<i>H</i>αCH (Leu)), 7.82 (d, <i>J</i> = 8.0 Hz, 1H, N<i>H</i>αCH (Leu)), 7.57 (br s, 1H, N<i>H</i>CH<sub>2</sub> (Arg)), 7.44 (d, <i>J</i> = 8.1 Hz, 1H, N<i>H</i>αCH, (Leu)), 7.41–7.25 (m, 5H, Ar-H (Cbz)), 5.02 (s, 2H, CH<sub>2</sub> (Cbz)), 4.36–4.18 (m, 3H, 2 × NHαC<i>H</i> (Leu), NHαC<i>H</i> (Arg)), 4.15 (ddd, <i>J</i> = 15.0, 7.1, 3.4 Hz, 1H, CH<sub>a</sub>SO<sub>2</sub>F), 4.09–4.01 (m, 1H, NHαC<i>H</i> (Leu)), 3.93 (dd, <i>J</i> = 15.0, 9.2 Hz, 1H, CH<sub>b</sub>SO<sub>2</sub>F), 3.15–2.99 (m, 2H, NHC<i>H</i><sub>2</sub> (Arg)), 1.70–1.54 (m, 3H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 1.54–1.30 (m, 10H, 3 × CH<sub>2</sub> (Leu), NHCH<sub>2</sub>C<i>H</i><sub>2</sub>C<i>H</i><sub>2</sub> (Arg)), 0.95–0.73 (m, 18H, 6 × CH<sub>3</sub> (Leu)). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>, 298 K): δ<sub>c</sub> (ppm) = 171.7 (C═O), 171.1 (C═O), 171.0 (C═O), 156.1 (C (guanidine)), 155.3 (C═O (Cbz)), 136.4 (C<sub>quart</sub> (Phe)), 127.7 (CH (Phe)), 127.2 (CH (Phe)), 127.0 (CH (Phe)), 64.8 (CH2 (Cbz)), 53.2 (d, <i>J</i> = 11.3 Hz, CH<sub>2</sub>SO<sub>2</sub>F), 52.5(CbzNHα<u class="uu">C</u>H), 50.5 (NHα<u class="uu">C</u>H), 50.3 (NHα<u class="uu">C</u>H), 43.6 (αCH (Arg)), 40.0 (CH<sub>2</sub> (Leu)), 39.9 (CH<sub>2</sub> (Leu)), 39.8 (CH<sub>2</sub> (Leu)), 39.7 (NHCH<sub>2</sub> (Arg)), 30.1 (αCH<u class="uu">C</u>H<sub>2</sub> (Arg)), 24.0 (αCHCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub> (Arg)), 23.6 (CH (Leu)), 23.5 (CH (Leu)), 23.4 (CH (Leu)), 22.44 (CH<sub>3</sub>), 22.42 (CH<sub>3</sub>), 22.38 (CH<sub>3</sub>), 21.0 (CH<sub>3</sub>), 20.94 (CH<sub>3</sub>), 20.88 (CH<sub>3</sub>). <sup>19</sup>F NMR (471 MHz, DMSO-<i>d</i><sub>6</sub>, 298 K): δ<sub>F</sub> (ppm) = 59.8 (s, 1F, SO<sub>2</sub>F). HRMS (ESI positive) calcd for C<sub>32</sub>H<sub>55</sub>N<sub>7</sub>O<sub>7</sub>SF [M + H]<sup>+</sup> 700.3862, found 700.3841. <i>t</i><sub>R</sub> (0 to 100% B, 30 min, C<sub>A1</sub>) = 23.0 min.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> TFA·Cbz-Phe-Leu<sub>2</sub>-Arg-ψ[CH<sub>2</sub>SO<sub>2</sub>]-F (<b>54</b>)</h3><div class="NLM_p last">Cbz-Phe-Leu<sub>2</sub>-OH (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00685/suppl_file/jm8b00685_si_001.pdf" class="ext-link">Supporting Information</a>) (112 mg, 213 μmol, 1.10 equiv) was dissolved in DMF (1.5 mL), and HBTU (80.7 mg, 213 μmol, 1.10 equiv), Oxyma (30.3 mg, 213 μmol, 1.10 equiv), and DiPEA (33.7 μL, 194 μmol, 1.00 equiv) were added and stirred for 5 min. Next, a solution of 2HCl·H-Arg-ψ[CH<sub>2</sub>SO<sub>2</sub>]-F (<b>7</b>) (112 mg, 194 μmol, 1.00 equiv) in DMF (2.5 mL) was added to reaction mixture followed by DiPEA (50.6 μL, 290 mmol, 1.50 equiv), and stirring was continued for 6 h. The solvent was removed in vacuo, and the crude product was purified by semipreparative HPLC (0 to 100% B, C<sub>P1</sub>). Fractions containing the product were pooled, lyophilized, and the pure product was obtained as a white solid (46.6 mg, 54.9 μmol, 28%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>, 298 K): δ<sub>H</sub> (ppm) = 8.16 (d, <i>J</i> = 8.6 Hz, 1H, N<i>H</i>αCH), 8.10 (d, <i>J</i> = 8.1 Hz, 1H, N<i>H</i>αCH), 7.94 (d, <i>J</i> = 8.1 Hz, 1H, N<i>H</i>αCH), 7.62–7.56 (m, 1H, N<i>H</i>CH<sub>2</sub> (Arg)), 7.49 (d, <i>J</i> = 8.5 Hz, 1H, N<i>H</i>αCH (Phe)), 7.37–7.15 (m, 10H, Ar-H (Phe, Cbz)), 4.94 (s, 2H, CH<sub>2</sub> (Cbz)), 4.37–4.20 (m, 4H, 2 × NHαC<i>H</i> (Leu), NHαC<i>H</i> (Arg), NHαC<i>H</i> (Phe)), 4.15 (ddd, <i>J</i> = 15.0, 6.9, 3.3 Hz, 1H, CH<sub>a</sub>SO<sub>2</sub>F), 3.93 (dd, <i>J</i> = 15.0, 9.1 Hz, 1H, CH<sub>b</sub>SO<sub>2</sub>F), 3.14–3.02 (m, 2H, NHC<i>H</i><sub>2</sub> (Arg)), 2.98 (dd, <i>J</i> = 13.9, 3.8 Hz, 1H, CH<sub>a</sub> (Phe)), 2.73 (dd, <i>J</i> = 13.9, 10.7 Hz, 1H, CH<sub>b</sub> (Phe)), 1.66–1.56 (m, 2H, 2 × C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 1.56–1.37 (m, 8H, 2 × CH<sub>2</sub> (Leu), NHCHC<i>H</i><sub>2</sub>C<i>H</i><sub>2</sub> (Arg)), 0.92–0.80 (m, 12H, 4 × CH<sub>3</sub> (Leu)). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>, 298 K): δ<sub>c</sub> (ppm) = 172.19 (C═O), 172.17 (C═O), 172.0 (C═O), 157.2 (C (guanidine)), 156.3 (C═O (Cbz)), 138.5 (C-Ar), 137.4 (C-Ar), 129.6 (CH-Ar), 128.7 (CH-Ar), 128.5 (CH-Ar), 128.1 (CH-Ar), 127.9 (CH-Ar), 126.7 (CH-Ar), 65.7 (CH<sub>2</sub> (Cbz)), 56.5 (CbzNHα<u class="uu">C</u>H), 54.3 (d, <i>J</i> = 11.2 Hz, CH<sub>2</sub>SO<sub>2</sub>F), 51.6 (αCH (Leu)), 51.57 (αCH (Leu)), 44.6 (αCH (Arg)), 41.1 (CH<sub>2</sub> (Leu)), 40.9 (CH<sub>2</sub> (Leu)), 40.8 (CH<sub>2</sub>NH (Arg)), 37.7 (CH<sub>2</sub> (Phe)), 31.2 (αCH<u class="uu">C</u>H<sub>2</sub> (Arg)), 25.1 (αCHCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub> (Arg)), 24.6 (CH (Leu)), 24.5 (CH (Leu)), 23.50 (CH<sub>3</sub> (Leu)), 23.48 (CH<sub>3</sub> (Leu)), 22.2 (CH<sub>3</sub> (Leu)), 22.0 (CH<sub>3</sub> (Leu)). <sup>19</sup>F NMR (471 MHz, DMSO-<i>d</i><sub>6</sub>, 298 K): δ<sub>F</sub> (ppm) = 59.8 (s, 1F, SO<sub>2</sub>F). HRMS (ESI positive) calcd for C<sub>35</sub>H<sub>53</sub>N<sub>7</sub>O<sub>7</sub>SF [M + H]<sup>+</sup> 734.3706, found 734.3673. <i>t</i><sub>R</sub> (0 to 100% B, 30 min, C<sub>A1</sub>) = 23.2 min</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> TFA·Boc-Phe-Leu<sub>2</sub>-Arg-ψ[CH<sub>2</sub>SO<sub>2</sub>]-F (<b>55</b>)</h3><div class="NLM_p last">Boc-Phe-Leu<sub>2</sub>-OH (99.8 mg, 203 μmol, 1.10 equiv) was dissolved in DMF (2 mL) under nitrogen atmosphere, and HBTU (77.0 mg, 203 μmol, 1.10 equiv), Oxyma (29 mg, 203 μmol, 1.10 equiv), and DiPEA (32.0 μL, 184 μmol, 1.00 equiv) were added and stirred for 5 min. Next, a solution of  2HCl·H-Arg-[CH<sub>2</sub>SO<sub>2</sub>]-F (<b>7</b>) (55.0 mg, 184 μmol, 1.00 equiv) in DMF (2 mL) was added to reaction mixture followed by DiPEA (48.0 μL, 276 mmol, 1.50 equiv) and stirring was continued for 2 h. The solvent was removed in vacuo, and the crude product was purified by semipreparative HPLC (0 to 100% B, C<sub>P1</sub>). Fractions containing the product were pooled, lyophilized, and the pure product was obtained as a white solid (58.5 mg, 71.9 μmol, 39%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, 298 K): δ<sub>H</sub> (ppm) = 8.17 (d, <i>J</i> = 8.6 Hz, 1H, NH (Leu)), 7.99–7.92 (m, 2H, NH (Leu), BocNH), 7.54 (t, <i>J</i> = 5.8 Hz, 1H, N<i>H</i>CH<sub>2</sub> (Arg)), 7.34–7.16 (m, 5H, Ar-H (Phe)), 6.96 (d, <i>J</i> = 8.5 Hz, 1H, N<i>H</i>αCH (Arg)), 4.39–4.10 (m, 5H, BocNHαC<i>H</i>, 2 × NHαC<i>H</i> (Leu), NHαC<i>H</i> (Arg), CH<sub>a</sub>SO<sub>2</sub>F), 3.93 (ddd, <i>J</i> = 14.9, 9.2, 1.9 Hz, 1H, CH<sub>b</sub>SO<sub>2</sub>F), 3.14–3.00 (m, 2H, NHC<i>H</i><sub>2</sub> (Arg)), 2.94 (dd, <i>J</i> = 13.8, 4.1 Hz, 1H, CH<sub>a</sub> (Phe)), 2.72 (dd, <i>J</i> = 13.8, 10.4 Hz, 1H, CH<sub>b</sub> (Phe)), 1.68–1.55 (m, 2H, 2 × C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 1.54–1.34 (m, 8H, 2 × CH<sub>2</sub> (Leu), NHCH<sub>2</sub>C<i>H</i><sub>2</sub>C<i>H</i><sub>2</sub> (Arg)), 1.30 (s, 9H, C(CH<sub>3</sub>)<sub>3</sub>), 0.90–0.81 (m, 12H, 4 × CH<sub>3</sub> (Leu)). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>, 298 K): δ<sub>c</sub> (ppm) = 172.19 (C═O), 172.16 (C═O), 172.02 (C═O), 157.1 (C<sub>–</sub>guanidino), 155.7 (C═O (Boc)), 138.6 (C-Ar), 129.6 (CH-Ar), 128.5 (CH-Ar), 126.6 (CH-Ar), 78.6 (<u class="uu">C</u>(CH<sub>3</sub>)<sub>3</sub>), 56.1 (BocNHC), 54.3 (d, <i>J</i> = 10.8 Hz, CSO<sub>2</sub>F), 51.6 (αCH (Leu)), 51.4 (αCH (Leu)), 44.6 (αCH (Arg)), 41.3 (CH<sub>2</sub> (Leu)), 40.9 (CH<sub>2</sub> (Leu)), 40.8 (NHCH<sub>2</sub>), 37.5 (CH<sub>2</sub> (Phe)), 31.2 (αCH<u class="uu">C</u>H<sub>2</sub> (Arg)), 28.6 (C(<u class="uu">C</u>H<sub>3</sub>)<sub>3</sub>), 25.1 (αCHCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub> (Arg)), 24.5 (CH (Leu)), 24.45 (CH (Leu)), 23.6 (CH<sub>3</sub> (Leu)), 23.5 (CH<sub>3</sub> (Leu)), 22.1 (CH<sub>3</sub> (Leu)), 22.0 (CH<sub>3</sub> (Leu)). <sup>19</sup>F NMR (377 MHz, DMSO-<i>d</i><sub>6</sub>, 298 K): δ<sub>F</sub> (ppm) = 59.8 (d, <i>J</i> = 7.2 Hz, 1F, SO<sub>2</sub>F). HRMS (ESI positive) calcd for C<sub>32</sub>H<sub>55</sub>N<sub>7</sub>O<sub>7</sub>SF [M + H]<sup>+</sup> 642.3444, found 642.3414. <i>t</i><sub>R</sub> (0 to 100% B, 30 min, C<sub>A1</sub>) = 23.1 min.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> TFA·Ac-Phe-Leu<sub>2</sub>-Arg-ψ[CH<sub>2</sub>SO<sub>2</sub>]-F (<b>56</b>)</h3><div class="NLM_p last">Ac-Phe-Leu<sub>2</sub>-OH (<b>47</b>) (88.0 mg, 203 μmol, 1.10 equiv) was dissolved in DMF (2 mL) under nitrogen atmosphere, and HBTU (77.0 mg, 203 μmol, 1.10 equiv), Oxymapure (29 mg, 203 μmol, 1.10 equiv), and DiPEA (32.0 μL, 184 μmol, 1.00 equiv) were added, and the mixture was stirred for 5 min. A solution of 2HCl·H<sub>2</sub>N-Arg-ψ[CH<sub>2</sub>SO<sub>2</sub>]-F (<b>7</b>) (55.0 mg, 184 μmol, 1.00 equiv) in DMF (2 mL) was added to reaction mixture followed by DiPEA (48.0 μL, 276 mmol, 1.50 equiv), and stirring was continued for 2 h. The solvent was removed in vacuo and the crude product was purified by semipreparative HPLC (0 to 100% B, C<sub>P1</sub>). Fractions containing the product were pooled, lyophilized, and the pure product was obtained as a white solid (44.6 mg, 59.0 μmol, 32%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>, 298 K): δ<sub>H</sub> (ppm) = 8.13 (d, <i>J</i> = 8.6 Hz, 1H, N<i>H</i>αCH (Arg)), 8.09 (d, <i>J</i> = 8.1 Hz, 1H, AcNH), 8.04 (d, <i>J</i> = 8.1 Hz, 1H, NH (Leu)), 7.88 (d, <i>J</i> = 8.0 Hz, 1H, NH (Leu)), 7.52 (t, <i>J</i> = 5.7 Hz, 1H, N<i>H</i>CH<sub>2</sub> (guanidine)), 7.29–7.15 (m, 5H, Ar-H (Phe)), 4.50 (ddd, <i>J</i> = 10.0, 8.1, 4.2 Hz, 1H, AcNHαC<i>H</i>), 4.33–4.19 (m, 3H, C<i>H</i>CH<sub>2</sub>SO<sub>2</sub>F, NHαC<i>H</i> (Leu<sup>1</sup>), NHαC<i>H</i> (Leu<sup>2</sup>)), 4.14 (ddd, <i>J</i> = 14.9, 6.8, 3.4 Hz, 1H, CH<sub>b</sub>SO<sub>2</sub>F), 3.93 (dd, <i>J</i> = 14.9, 9.2 Hz, 1H, CH<sub>b</sub>SO<sub>2</sub>F), 3.14–3.00 (m, 2H, NHC<i>H</i><sub>2</sub> (guanidine)), 2.97 (dd, <i>J</i> = 14.0, 4.2 Hz, 1H, CH<sub>b</sub> (Phe)), 2.72 (dd, <i>J</i> = 14.0, 10.0 Hz, 1H, CH<sub>b</sub> (Phe)), 1.75 (s, 3H, CH<sub>3</sub>C(O)), 1.66–1.37 (m, 10H, 2 × C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>, 2 × CH<sub>2</sub> (Leu), NHCH<sub>2</sub>C<i>H</i><sub>2</sub>C<i>H</i><sub>2</sub> (Arg)), 0.89 (d, <i>J</i> = 2.6 Hz, 3H, CH<sub>3</sub>), 0.87 (d, <i>J</i> = 2.7 Hz, 2H, CH<sub>3</sub>), 0.84 (s, 3H, CH<sub>3</sub>), 0.83 (s, 3H, CH<sub>3</sub>). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>, 298 K): δ<sub>c</sub> (ppm) = 172.2 (C═O), 172.1 (C═O), 171.8 (C═O), 169.8 (C═O), 157.1 (C-guanidine), 138.4 (C-Ar), 129.6, 128.5, 126.7 (CH-Ar), 54.4 (AcNHC), 54.3 (d, <i>J</i> = 10.2 H, CH<sub>2</sub>SO<sub>2</sub>F), 51.6 (αCH (Leu)), 51.5 (αCH (Leu)), 44.6 (αCH (Arg)), 41.0 (CH<sub>2</sub> (Leu)), 40.9 (CH<sub>2</sub> (Leu)), 40.8 (CH<sub>2</sub> (Arg)), 37.7 (CH<sub>2</sub>-Phe), 31.2 (αCH<u class="uu">C</u>H<sub>2</sub> (Arg)), 25.1 (αCHCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub> (Arg)), 24.6 (CH (Leu)), 24.5 (CH (Leu)), 23.5 (CH<sub>3</sub> (Ac)), 22.9 (2 × CH<sub>3</sub> (Leu)), 22.1 (CH<sub>3</sub> (Leu)), 22.0 (CH<sub>3</sub> (Leu)). <sup>19</sup>F NMR (471 MHz, DMSO-<i>d</i><sub>6</sub>, 298 K): δ<sub>F</sub> (ppm) = 59.8 (s, 1 F, SO<sub>2</sub>F). HRMS (ESI positive) calcd for C<sub>29</sub>H<sub>49</sub>N<sub>7</sub>O<sub>6</sub>SF [M + H]<sup>+</sup> 642.3444, found 642.3414. <i>t</i><sub>R</sub> (0 to 100% B, 50 min, C<sub>A1</sub>) = 27.0 min.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 2TFA·H-Phe-Leu<sub>2</sub>-Arg-ψ[CH<sub>2</sub>SO<sub>2</sub>]-F (<b>57</b>)</h3><div class="NLM_p last">Boc-Phe-Leu<sub>2</sub>-Arg-ψ[CH<sub>2</sub>SO<sub>2</sub>]-F (<b>55</b>) (49.7 mg, 61.1 μmol, 1.00 equiv) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (5 mL), and TFA (5 mL) was added. The reaction mixture was stirred for 30 min at rt. The solvent was removed in vacuo and the crude purified by semipreparative HPLC (0 to 100% B, C<sub>P1</sub>). Fractions containing the product were pooled, lyophilized, and the pure product was obtained as a white solid (31.2 mg, 37.7 μmol, 62%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>, 298 K): δ<sub>H</sub> (ppm) = 8.63 (d, <i>J</i> = 8.4 Hz, 1H, NH (Leu)), 8.27–8.22 (m, 2H, NH (Leu), N<i>H</i>αCH (Arg)), 8.13 (s, 3H, NH<sub>3</sub><sup>+</sup>), 7.83–7.72 (m, 1H, N<i>H</i>CH<sub>2</sub> (Arg)), 7.33–7.23 (m, 5H, Ar-H (Phe)), 4.44–4.38 (m, 1H, NHαC<i>H</i> (Leu)), 4.32–4.23 (m, 2H, NHαC<i>H</i> (Leu), NHαC<i>H</i> (Arg)), 4.15 (ddd, <i>J</i> = 14.9, 6.9, 3.3 Hz, 1H, CH<sub>a</sub>SO<sub>2</sub>F), 4.12–4.04 (m, 1H, NH<sub>3</sub><sup>+</sup>C<i>H</i>), 3.94 (dd, <i>J</i> = 14.9, 9.3 Hz, 1H, CH<sub>b</sub>SO<sub>2</sub>F), 3.15–3.00 (m, 3H, NHC<i>H</i><sub>2</sub> (Arg), CH<sub>a</sub> (Phe)), 2.92 (dd, <i>J</i> = 14.2, 7.6 Hz, 1H, CH<sub>a</sub> (Phe)), 1.67–1.57 (m, 2H, 2 × C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 1.57–1.39 (m, 8H, 2 × CH<sub>2</sub> (Leu), NHCH<sub>2</sub>C<i>H</i><sub>2</sub>C<i>H</i><sub>2</sub> (Arg)), 0.92–0.88 (m, 6H, 2 × CH<sub>3</sub> (Leu)), 0.87 (d, <i>J</i> = 4.3 Hz, 3H, CH<sub>3</sub> (Leu)), 0.86 (d, <i>J</i> = 4.3 Hz, 3H, CH<sub>3</sub> (Leu)). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>, 298 K): δ<sub>c</sub> (ppm) = 171.1 (C═O), 170.6 (C═O), 167.0 (C═O), 156.2 (C-guanidino), 134.1 (C-Ar), 129.0 (CH-Ar), 127.8 (CH-Ar), 126.5 (CH-Ar), 53.2 (d, <i>J</i> = 10.8 Hz, CSO<sub>2</sub>F), 52.5 (NH<sub>3</sub><sup>+</sup>C), 50.6 (αCH (Leu)), 50.4 (αCH (Leu)), 43.6 (αCH (Arg)), 40.4 (CH<sub>2</sub> (Leu)), 39.9 (CH<sub>2</sub> (Leu)), 39.7 (CH<sub>2</sub>NH (Arg)), 36.3 (CH<sub>2</sub> (Phe)), 30.2 (αCH<u class="uu">C</u>H<sub>2</sub> (Arg)), 24.0 (αCHCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub> (Arg)), 23.5 (CH (Leu)), 23.4 (CH (Leu)), 22.5 (CH<sub>3</sub> (Leu)), 22.4 (CH<sub>3</sub> (Leu)), 21.1 (CH<sub>3</sub> (Leu)), 21.0 (CH<sub>3</sub> (Leu)). <sup>19</sup>F NMR (471 MHz, DMSO-<i>d</i><sub>6</sub>, 298 K): δ<sub>F</sub> (ppm) = 59.8 (s, 1 F, SO<sub>2</sub>F). HRMS (ESI positive) calcd for C<sub>27</sub>H<sub>47</sub>N<sub>7</sub>O<sub>5</sub>SF [M + H]<sup>+</sup> 600.3338, found 600.3321. <i>t</i><sub>R</sub> (0 to 100% B, 30 min, C<sub>A1</sub>) = 17.1 min.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> TFA·N<sub>3</sub>-Phe-Leu<sub>2</sub>-Arg-ψ[CH<sub>2</sub>SO<sub>2</sub>]-F (<b>58</b>)</h3><div class="NLM_p last">N<sub>3</sub>-Phe-Leu<sub>2</sub>-OH (<b>52</b>) (81.5 mg, 195 μmol, 1.05 equiv) was dissolved in DMF (2 mL) under nitrogen atmosphere and cooled to 0 °C. HATU (74.2 mg, 195 μmol, 1.05 equiv) was added, and stirring was continued for 20 min. 2HCl·H-Arg-ψ[CH<sub>2</sub>SO<sub>2</sub>]-F (<b>7</b>) (55.6 mg, 186 μmol, 1.00 equiv) in DMF (2 mL) was added to the reaction mixture. After 30 min DiPEA (93.7 μL, 539 μmol, 2.90 equiv) was added and stirring was continued overnight at rt. The solvent was removed in vacuo, and the crude product was purified by semipreparative HPLC (0 to 70% B, C<sub>P3</sub>). The obtained product (80 mg) required a second purification step by semipreparative HPLC (0 to 80% B, C<sub>P3</sub>). Fractions containing the product were pooled, lyophilized, and the pure product was obtained as a white solid (16.9 mg, 22.8 μmol, 12%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>, 298 K): δ<sub>H</sub> (ppm) = 8.35 (d, <i>J</i> = 8.2 Hz, 1H, NH (Leu)), 8.18 (d, <i>J</i> = 8.6 Hz, 1H, N<i>H</i>αCH (Arg)), 8.10 (d, <i>J</i> = 8.1 Hz, 1H, NH (Leu)), 7.60 (t, <i>J</i> = 5.9 Hz, 1H, N<i>H</i>CH<sub>2</sub> (guanidine)), 7.33–7.22 (m, 5H, Ar-H (Phe)), 7.01 (br s, 3H), 4.38 (app q, <i>J</i> = 7.7 Hz, 1H, NHαC<i>H</i> (Leu)), 4.31–4.20 (m, 2H, C<i>H</i>CH<sub>2</sub>SO<sub>2</sub>F, NHαC<i>H</i> (Leu)), 4.15 (ddd, <i>J</i> = 14.0, 6.9, 3.4 Hz, 1H, CH<sub>a</sub>SO<sub>2</sub>F), 4.10 (dd, <i>J</i> = 9.1, 5.1 Hz, 1H, N<sub>3</sub>CH), 3.93 (dd, <i>J</i> = 14.0, 9.5 Hz, 1H, CH<sub>b</sub>SO<sub>2</sub>F), 3.13–3.01 (m, 3H, NHC<i>H</i><sub>2</sub> (guanidine), CH<sub>a</sub> (Phe)), 2.89 (dd, <i>J</i> = 14.1, 9.1 Hz, 1H, CH<sub>b</sub> (Phe)), 1.70–1.36 (m, 10H, 2 × C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>, 2 × CH<sub>2</sub> (Leu), NHCH<sub>2</sub>C<i>H</i><sub>2</sub>C<i>H</i><sub>2</sub> (Arg)), 0.89 (d, <i>J</i> = 2.2 Hz, 3H, CH<sub>3</sub>), 0.88 (d, <i>J</i> = 2.2 Hz, 3H, CH<sub>3</sub>), 0.86 (d, <i>J</i> = 4.0 Hz, 3H, CH<sub>3</sub>), 0.84 (d, <i>J</i> = 3.9 Hz, 3H, CH<sub>3</sub>). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>, 298 K): δ<sub>c</sub> (ppm) = 171.1 (C═O), 170.7 (C═O), 168.2 (C═O), 156.1 (C-(guanidine), 136.3 (C-Ar), 128.4, 127.8, 126.1 (CH-Ar), 61.7 (N<sub>3</sub>C), 53.2 (d, <i>J</i> = 11.1 Hz, CH<sub>2</sub>SO<sub>2</sub>F), 50.6 (αCH (Leu)), 50.5 (αCH (Leu)), 43.6 (αCH (Arg)), 40.2 (CH<sub>2</sub> (Leu)), 39.8 (CH<sub>2</sub> (Leu)), 39.7 (NHCH<sub>2</sub> (Arg)), 36.2 (CH<sub>2</sub>-Phe), 30.1 (αCH<u class="uu">C</u>H<sub>2</sub> (Arg)), 24.0 (NHCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub> (Arg)), 23.5 (CH (Leu)), 23.5 (CH (Leu)), 22.4 (CH<sub>3</sub> (Leu)), 22.4 (CH<sub>3</sub> (Leu)), 21.0 (CH<sub>3</sub> (Leu)), 20.9 (CH<sub>3</sub> (Leu)). <sup>19</sup>F NMR (471 MHz, DMSO-<i>d</i><sub>6</sub>, 298 K): δ<sub>F</sub> (ppm) = 59.8 (s, 1F, SO<sub>2</sub>F). HRMS (ESI positive) calcd for C<sub>27</sub>H<sub>45</sub>N<sub>9</sub>O<sub>5</sub>SF [M + H]<sup>+</sup> 626.3243, found 626.3216. <i>t</i><sub>R</sub> (0 to 100% B, 50 min, C<sub>A3</sub>) = 33.6 min.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 2TFA·H-Phe-Leu<sub>2</sub>-Lys-ψ[CH<sub>2</sub>SO<sub>2</sub>]-F (<b>59</b>)</h3><div class="NLM_p last">BocHN-Phe-Leu<sub>2</sub>-Lys(Cbz)-ψ[CH<sub>2</sub>SO<sub>2</sub>]-F (31.8 mg, 34.6 μmol, 1.00 equiv) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (5 mL), and a 33% HBr/AcOH solution (5 mL) was added and the reaction mixture stirred for 45 min at rt. The solvent was removed in vacuo and the crude product purified by semipreparative HPLC (0 to 50% B, C<sub>P3</sub>). Fractions containing the product were pooled, lyophilized, and the pure product was obtained as a white solid (21.5 mg, 26.9 μmol, 78%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>, 298 K): δ<sub>H</sub> (ppm) = 8.66–8.60 (m, 1H, NH), 8.28 (d, <i>J</i> = 7.9 Hz, 1H, NH), 8.22–8.06 (m, 4H, NH, NH<sub>3</sub><sup>+</sup> (Phe)), 7.79 (br s, 3H, NH<sub>3</sub><sup>+</sup> (Lys)), 7.37–7.19 (m, 5H, CH-Ar), 4.42 (td, <i>J</i> = 8.7, 4.2 Hz, 1H, αCH (Leu)), 4.32–4.22 (m, 2H, αCH (Lys), αCH (Leu)), 4.14 (ddd, <i>J</i> = 15.0, 6.8, 3.3 Hz, 1H, CH<sub>a</sub>SO<sub>2</sub>F), 4.11–4.03 (m, 1H, αCH (Phe)), 3.90 (dd, <i>J</i> = 15.0, 9.1 Hz, 1H, CH<sub>b</sub>SO<sub>2</sub>F), 3.09 (dd, <i>J</i> = 14.2, 5.1 Hz, 1H, CH<sub>a</sub>Phe), 2.92 (dd, <i>J</i> = 14.2, 7.7 Hz, 1H, CH<sub>b</sub>Phe), 2.78–2.66 (m, 2H, C<i>H</i><sub>2</sub>NH<sub>3</sub><sup>+</sup>), 1.69–1.38 (m, 10H, 2 × CH (Leu), CH<sub>2</sub> (Leu), C<i>H</i><sub>2</sub> CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>NH<sub>3</sub><sup>+</sup> (Lys)), 1.38–1.21 (m, 2H, C<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>NH<sub>3</sub><sup>+</sup> (Lys)), 0.96–0.79 (m, 12H, 4 × CH<sub>3</sub> (Leu)). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>, 298 K): δ<sub>C</sub> (ppm) = 172.0, 171.7, 168.0 (C═O), 135.2 (C-Ar), 130.0, 128.9, 127.6 (CH-Ar), 54.4 (d, <i>J</i> = 10.9 Hz, CSO<sub>2</sub>F), 53.5 (αCH (Phe)), 51.6, 51.4 (αCH (Leu)), 44.5 (αCH (Lys)), 40.9, 40.8 (CH<sub>2</sub> (Leu)), 39.0 (CH<sub>2</sub>NH<sub>3</sub><sup>+</sup>), 37.4 (CH<sub>2</sub>Phe), 33.4 (<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>NH<sub>3</sub><sup>+</sup> (Lys)), 26.8 (<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>NH<sub>3</sub><sup>+</sup> (Lys)), 24.5, 24.4 (CH (Leu)), 23.6, 23.5 (CH<sub>3</sub> (Leu)), 22.1 (<u class="uu">C</u>H<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>NH<sub>3</sub><sup>+</sup> (Lys)), 22.1, 22.0 (CH<sub>3</sub> (Leu)). <sup>19</sup>F NMR (471 MHz, DMSO-<i>d</i><sub>6</sub>, 298 K): δ<sub>F</sub> (ppm) = 59.6 (s, 1F, SO<sub>2</sub>F). HRMS (ESI positive) calcd for C<sub>27</sub>H<sub>47</sub>N<sub>5</sub>O<sub>5</sub>SF [M + H]<sup>+</sup> 572.3276, found 572.3263. <i>t</i><sub>R</sub> (0 to 100% B, 50 min, C<sub>A3</sub>) = 24.6 min.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> TFA·Ac-Phe-Leu<sub>2</sub>-Lys-ψ[CH<sub>2</sub>SO<sub>2</sub>]-F (<b>60</b>)</h3><div class="NLM_p last">Ac-Phe-Leu<sub>2</sub>-Lys(Cbz)-ψ[CH<sub>2</sub>SO<sub>2</sub>]-F (20.0 mg, 23.2 μmol, 1.00 equiv) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (5 mL), and 33% HBr/AcOH solution (5 mL) was added, and the reaction mixture was stirred for 1 h at rt. The solvents were removed in vacuo, and the crude was purified by semipreparative HPLC (0 to 90% B, C<sub>P3</sub>). Fractions containing the product were pooled, lyophilized, and the pure product was obtained as a white solid (11.1 mg, 15.2 μmol, 66%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, 298 K): δ<sub>H</sub> (ppm) = 8.16–8.01 (m, 3H, 2 × N<i>H</i>αCH, N<i>H</i>αCH (Lys)), 7.93 (d, <i>J</i> = 8.1 Hz, 1H, N<i>H</i>αCH), 7.72 (br s, 3H, NH<sub>3</sub><sup>+</sup>), 7.30–7.15 (m, 5H, Ar-H (Phe)), 4.50 (ddd, <i>J</i> = 10.0, 8.1, 4.2 Hz, 1H, AcNHαC<i>H</i>), 4.36–4.17 (m, 3H, 2 × NHαC<i>H</i>, NHαC<i>H</i> (Lys)), 4.12 (ddd, <i>J</i> = 14.8, 6.8, 3.4 Hz, 1H, CH<sub>a</sub>SO<sub>2</sub>F), 3.89 (dd, <i>J</i> = 14.8, 9.1 Hz, 1H, CH<sub>b</sub>SO<sub>2</sub>F), 2.97 (dd, <i>J</i> = 13.9, 4.2 Hz, 1H, CH<sub>a</sub> (Phe)), 2.79–2.66 (m, 3H, CH<sub>b</sub> (Phe), NH<sub>3</sub><sup>+</sup>CH<sub>2</sub>), 1.75 (s, 3H, CH<sub>3</sub> (AcNH)), 1.67–1.38 (m, 10H, 2 × C<i>H</i>(CH<sub>3</sub>)<sub>2</sub> (Leu), 2 × CH<sub>2</sub> (Leu), NH<sub>3</sub><sup>+</sup>CH<sub>2</sub>C<i>H</i><sub>2</sub>, αCHC<i>H</i><sub>2</sub> (Lys)), 1.36–1.22 (m, 2H, NH<sub>3</sub><sup>+</sup>CH<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>2</sub> (Lys)), 0.89 (d, <i>J</i> = 6.6 Hz, 3H, CH<sub>3</sub> (Leu)), 0.88 (d, <i>J</i> = 6.6 Hz, 3H, CH<sub>3</sub> (Leu)), 0.84 (d, <i>J</i> = 6.5 Hz, 3H, CH<sub>3</sub> (Leu)), 0.84 (d, <i>J</i> = 6.5 Hz, 3H, CH<sub>3</sub> (Leu)). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>, 298 K): δ<sub>c</sub> (ppm) = 171.6 (C═O), 171.5 (C═O), 171.2 (C═O), 169.2 (C═O), 137.9 (C-Ar (Phe)), 129.0 (CH-Ar), 127.9 (CH-Ar), 126.1 (CH-Ar), 124.1 (CH-Ar), 53.8 (AcNHC), 53.7 (CSO<sub>2</sub>F), 51.1 (αCH (Leu)), 50.9 (αCH (Leu)), 43.9 (αCH (Lys)), 40.5 (2 × CH<sub>2</sub> (Leu)), 37.2 (CH<sub>2</sub> (Phe)), 32.8 (αCH<u class="uu">C</u>H<sub>2</sub> (Lys)), 26.2 (NHCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub> (Lys)), 24.0 (<u class="uu">C</u>H(CH<sub>3</sub>)<sub>2</sub>), 23.9 (<u class="uu">C</u>H(CH<sub>3</sub>)<sub>2</sub>), 23.0 (CH<sub>3</sub> (Leu)), 22.9 (CH<sub>3</sub> (Leu)), 22.3 (CH<sub>3</sub> (Ac)), 21.6 (αCHCH<sub>2</sub><u class="uu">C</u>H<sub>2</sub> (Lys)), 21.54 (CH<sub>3</sub> (Leu)), 21.47 (CH<sub>3</sub> (Leu)) <sup>19</sup>F NMR (377 MHz, DMSO-<i>d</i><sub>6</sub>, 298 K): δ<sub>F</sub> (ppm) = 59.6 (d, <i>J</i><sub>C,F</sub> = 6.6 Hz, 1F, SO<sub>2</sub>F). HRMS (ESI positive) calcd for C<sub>29</sub>H<sub>48</sub>N<sub>5</sub>O<sub>6</sub>SF [M + H]<sup>+</sup> 614.3382, found 614.3371. <i>t</i><sub>R</sub> (0 to 100% B, 50 min, C<sub>A3</sub>) = 29.0 min.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> TFA·N<sub>3</sub>-Phe-Leu<sub>2</sub>-Lys-ψ[CH<sub>2</sub>SO<sub>2</sub>]-F (<b>61</b>)</h3><div class="NLM_p last">N<sub>3</sub>-Phe-Leu<sub>2</sub>-Lys(Cbz)-ψ[CH<sub>2</sub>SO<sub>2</sub>]-F (20.0 mg, 23.6 μmol, 1.00 equiv) was set under nitrogen atmosphere, and 4 m HCl solution in dioxane (10 mL) was added and the reaction mixture stirred overnight at rt. The solvent was removed in vacuo, and the crude was purified by semipreparative HPLC (0 to 100% B, C<sub>P3</sub>). Fractions containing the product were pooled, lyophilized, and the pure product was obtained as a white solid (6.5 mg, 9.13 μmol, 39%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, 298 K): δ<sub>H</sub> (ppm) = 8.33 (d, <i>J</i> = 8.2 Hz, 1H, N<i>H</i>αCH (Leu)), 8.13–8.06 (m, 2H, N<i>H</i>αCH (Leu), N<i>H</i>αCH (Lys)), 7.63 (br s, 3H, NH<sub>3</sub><sup>+</sup>), 7.35–7.21 (m, 5H, Ar-H (Phe)), 4.38 (app q, <i>J</i> = 7.7 Hz, 1H, NHαC<i>H</i> (Leu)), 4.33–4.18 (m, 2H, NHαC<i>H</i> (Leu), NHαC<i>H</i> (Lys)), 4.17–4.07 (m, 2H, N<sub>3</sub>αC<i>H</i>, CH<sub>a</sub>SO<sub>2</sub>F), 3.89 (dd, <i>J</i> = 15.0, 9.1 Hz, 1H, CH<sub>b</sub>SO<sub>2</sub>F), 3.08 (dd, <i>J</i> = 14.1, 5.2 Hz, 1H, CH<sub>a</sub> (Phe)), 2.88 (dd, <i>J</i> = 14.1, 9.1 Hz, 1H, CH<sub>b</sub> (Phe)), 2.78–2.69 (m, 2H, NHCH<sub>2</sub> (Lys)), 1.67–1.39 (m, 4H, 2 × C<i>H</i>(CH<sub>3</sub>)<sub>2</sub> (Leu), αCHC<i>H</i><sub>2</sub> (Lys)), 1.33–1.19 (m, 8H, 2 × CH<sub>2</sub>, NHCH<sub>2</sub>C<i>H</i><sub>2</sub>C<i>H</i><sub>2</sub> (Lys)), 0.95–0.77 (m, 12H, 4 × CH<sub>3</sub> (Leu)). <sup>19</sup>F NMR (471 MHz, DMSO-<i>d</i><sub>6</sub>, 298 K): δ<sub>F</sub> (ppm) = 59.7 (d, <i>J</i> = 6.8 Hz, 1F, SO<sub>2</sub>F). HRMS (ESI positive) calcd for C<sub>27</sub>H<sub>45</sub>N<sub>7</sub>O<sub>5</sub>SF [M + H]<sup>+</sup> 598.3181, found 598.3157. <i>t</i><sub>R</sub> (0 to 100% B, 50 min, C<sub>A3</sub>) = 30.3 min.</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 2TFA·H-Phe-Leu<sub>2</sub>-Phe(4-NH<sub>2</sub>)-ψ[CH<sub>2</sub>SO<sub>2</sub>]-F (<b>62</b>)</h3><div class="NLM_p last">TFA·Boc-Phe-Leu<sub>2</sub>-Phe(4-NHCbz)-ψ[CH<sub>2</sub>SO<sub>2</sub>]-F (29.7 mg, 31.1 μmol, 1.00 equiv) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (10 mL), and a 33% HBr/AcOH solution (3 mL) was added and the reaction mixture stirred for 1.5 h at rt. The solvent was removed in vacuo, and the crude was purified via semipreparative HPLC (0 to 100% B, C<sub>P3</sub>). The obtained product required a second purification step by semipreparative HPLC (0 to 50% B, C<sub>P3</sub>). Fractions containing the product were pooled, lyophilized, and the pure product was obtained as a white solid (20.6 mg, 24.7 μmol, 79%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>, 298 K): δ<sub>H</sub> (ppm) = 8.65 (d, <i>J</i> = 8.3 Hz, 1H, N<i>H</i>αCH (Leu)), 8.31 (d, <i>J</i> = 8.3 Hz, 1H, N<i>H</i>αCH (4-H<sub>3</sub>N<sup>+</sup>-Phe)), 8.20 (d, <i>J</i> = 8.2 Hz, 1H, N<i>H</i>αCH (Leu)), 7.34–7.23 (m, 5H, Ar-H (Phe)), 7.14 (d, <i>J</i> = 8.0 Hz, 2H, 2 × CH (4-H<sub>3</sub>N<sup>+</sup>-Phe)), 6.95 (d, <i>J</i> = 8.0 Hz, 2H, 2 × CH (4-H<sub>3</sub>N<sup>+</sup>-Phe)), 4.46–4.35 (m, 2H, NHαC<i>H</i> (4-H<sub>3</sub>N<sup>+</sup>-Phe), NHαC<i>H</i> (Leu)), 4.31–4.19 (m, 1H, NHαC<i>H</i> (Leu)), 4.11–4.02 (m, 2H, NHαC<i>H</i> (H<sub>3</sub>N<sup>+</sup>αC<i>H</i>), CH<sub>a</sub>SO<sub>2</sub>F), 3.91 (dd, <i>J</i> = 15.4, 9.2 Hz, 1H, CH<sub>b</sub>SO<sub>2</sub>F), 3.10 (dd, <i>J</i> = 14.2, 5.0 Hz, 1H, CH<sub>a</sub> (Phe)), 2.92 (dd, <i>J</i> = 14.2, 7.7 Hz, 1H, CH<sub>b</sub> (Phe)), 2.85–2.76 (m, 2H, αCHC<i>H</i><sub>2</sub> (4-H<sub>3</sub>N<sup>+</sup>-Phe)), 1.68–1.60 (m, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub> (Leu)), 1.59–1.51 (m, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub> (Leu), 1.50–1.30 (m, 4H, 2 × CH<sub>2</sub> (Leu)), 0.91 (d, <i>J</i> = 6.6 Hz, 3H, CH<sub>3</sub> (Leu)), 0.89–0.85 (m, 6H, 2 × CH<sub>3</sub> (Leu)), 0.83 (d, <i>J</i> = 6.5 Hz, 3H, CH<sub>3</sub> (Leu)). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>, 298 K): δ<sub>c</sub> (ppm) = 171.4 (C═O), 171.0 (C═O), 167.5 (C═O), 134.6 (C-Ar), 130.2 (CH-Ar (4-H<sub>3</sub>N<sup>+</sup>-Phe)), 129.5 (CH-Ar), 128.3 (CH-Ar), 127.0 (CH-Ar), 119.2 (CH-Ar (4-H<sub>3</sub>N<sup>+</sup>-Phe)), 53.0 (d, <i>J</i> = 12.3 Hz, CSO<sub>2</sub>F), 52.96 (H<sub>3</sub>N<sup>+</sup>αCH), 50.99 (αCH (Leu)), 50.95 (αCH (Leu)), 46.1 (α<u class="uu">C</u>HCH<sub>2</sub>SO<sub>2</sub>F), 41.0 (CH<sub>2</sub> (Leu)), 40.6 (CH<sub>2</sub> (Leu)), 38.3 (αCH<u class="uu">C</u>H<sub>2</sub> (4-H<sub>3</sub>N<sup>+</sup>-Phe)), 36.8 (CH<sub>2</sub> (Phe)), 24.0 (<u class="uu">C</u>H(CH<sub>3</sub>)<sub>2</sub>), 23.9 (<u class="uu">C</u>H(CH<sub>3</sub>)<sub>2</sub>), 23.0 (CH<sub>3</sub> (Leu)), 22.9 (CH<sub>3</sub> (Leu)), 21.6 (CH<sub>3</sub> (Leu)), 21.5 (CH<sub>3</sub> (Leu)). <sup>19</sup>F NMR (471 MHz, CDCl<sub>3</sub>, 298 K): δ<sub>F</sub> (ppm) = 59.7 (d, <i>J</i> = 6.6 Hz, 1F, SO<sub>2</sub>F). HRMS (ESI positive) calcd for C<sub>30</sub>H<sub>44</sub>N<sub>5</sub>O<sub>5</sub>SFNa [M + Na]<sup>+</sup> 628.2939, found 628.2907. <i>t</i><sub>R</sub> (0 to 100% B, 30 min, C<sub>A3</sub>) = 17.1 min.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> TFA·Ac-Phe-Leu<sub>2</sub>-Phe(4-NH<sub>2</sub>)-ψ[CH<sub>2</sub>SO<sub>2</sub>]-F (<b>63</b>)</h3><div class="NLM_p last">TFA·Ac-Phe-Leu<sub>2</sub>-Phe(4-NHCbz)-ψ[CH<sub>2</sub>SO<sub>2</sub>]-F (20 mg, 22.3 μmol, 1.00 equiv) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (5 mL), and a 33% HBr/AcOH solution (5 mL) was added, and the reaction mixture was stirred for 1 h at rt. The solvents were removed in vacuo and the crude product was purified by semipreparative HPLC (0 to 100% B, C<sub>P3</sub>). Fractions containing the product were pooled, lyophilized, and the pure product was obtained as a white solid (8.7 mg, 11.4 μmol, 51%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, 298 K): δ<sub>H</sub> (ppm) = 8.21 (d, <i>J</i> = 8.3 Hz, 1H, N<i>H</i>αCH (4-H<sub>3</sub>N<sup>+</sup>-Phe)), 8.13–8.07 (m, 2H, N<i>H</i>αCH (Leu), AcN<i>H</i>αCH)), 7.81 (d, <i>J</i> = 8.3 Hz, 1H, N<i>H</i>αCH (Leu)), 7.28–7.22 (m, 4H, Ar-H (Phe)), 7.22–7.14 (m, 3H, Ar-H (Phe), Ar-H, 2 × CH (4-H<sub>3</sub>N<sup>+</sup>-Phe)), 7.01 (d, <i>J</i> = 7.8 Hz, 2H,, 2 × CH (4-H<sub>3</sub>N<sup>+</sup>-Phe)) 4.50 (ddd, <i>J</i> = 10.1, 8.2, 4.0 Hz, 1H, AcNHαC<i>H</i>), 4.45–4.33 (m, 1H, NHαC<i>H</i> (4-H<sub>3</sub>N<sup>+</sup>-Phe)), 4.29 (app q, <i>J</i> = 7.7 Hz, 1H, NHαC<i>H</i> (Leu)), 4.25–4.17 (m, 1H, NHαC<i>H</i> (Leu)), 4.07 (ddd, <i>J</i> = 14.9, 7.4, 3.1 Hz, 1H, CH<sub>a</sub>SO<sub>2</sub>F), 3.91 (dd, <i>J</i> = 14.9, 10.2 Hz, 1H, CH<sub>b</sub>SO<sub>2</sub>F), 2.97 (dd, <i>J</i> = 13.9, 4.0 Hz, 1H, CH<sub>a</sub> (Phe)), 2.81 (d, <i>J</i> = 6.7 Hz, 2H, αCHC<i>H</i><sub>2</sub> (4-H<sub>3</sub>N<sup>+</sup>-Phe)), 2.70 (dd, <i>J</i> = 13.9, 10.1 Hz, 1H, CH<sub>b</sub> (Phe)), 1.75 (s, 3H, CH<sub>3</sub> (Ac)), 1.65–1.50 (m, 2H, 2 × C<i>H</i>(CH<sub>3</sub>)<sub>2</sub> (Leu)), 1.49–1.27 (m, 4H, 2 × CH<sub>2</sub> (Leu)), 0.89 (d, <i>J</i> = 6.5 Hz, 3H, CH<sub>3</sub> (Leu)), 0.84 (d, <i>J</i> = 6.5 Hz, 6H, 2 × CH<sub>3</sub> (Leu)), 0.81 (d, <i>J</i> = 6.5 Hz, 3H, CH<sub>3</sub> (Leu)). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>, 298 K): δ<sub>c</sub> (ppm) = 171.38 (C═O), 171.35 (C═O), 171.30 (C═O), 169.2 (C═O), 137.9 (C-Ar), 130.3 (C-Ar), 130.3 (C-Ar), 129.0 (CH-Ar), 127.9 (CH-Ar), 126.1 (CH-Ar), 119.8 (CH-Ar (4-H<sub>3</sub>N<sup>+</sup>-Phe)), 53.8 (AcNHC), 53.0 (d, <i>J</i><sub>C,F</sub> = 11.5 Hz, CSO<sub>2</sub>F), 51.0 (αCH (Leu)), 50.9 (αCH (Leu)), 46.1 (αCH (4-H<sub>3</sub>N<sup>+</sup>-Phe)), 40.6 (<u class="uu">C</u>H(CH<sub>3</sub>)<sub>2</sub> (Leu)), 40.4 (<u class="uu">C</u>H(CH<sub>3</sub>)<sub>2</sub> (Leu)), 38.4 (αCH<u class="uu">C</u>H<sub>2</sub> (4-H<sub>3</sub>N<sup>+</sup>-Phe)), 37.2 (CH<sub>2</sub> (Phe)), 24.0 (<u class="uu">C</u>H(CH<sub>3</sub>)<sub>2</sub> (Leu)), 23.9 (<u class="uu">C</u>H(CH<sub>3</sub>)<sub>2</sub> (Leu)), 23.0 (CH<sub>3</sub> (Leu)), 22.9 (CH<sub>3</sub> (Leu)), 22.3 (CH<sub>3</sub> (Ac)), 21.6 (CH<sub>3</sub> (Leu)), 21.5 (CH<sub>3</sub> (Leu)). <sup>19</sup>F NMR (377 MHz, CDCl<sub>3</sub>, 298 K): δ<sub>F</sub> (ppm) = 59.7 (d, <i>J</i> = 6.8 Hz, 1F, SO<sub>2</sub>F). HRMS (ESI positive) calcd for C<sub>32</sub>H<sub>46</sub>N<sub>5</sub>O<sub>6</sub>SFNa [M + Na]<sup>+</sup> 670.3045, found 670.3016. <i>t</i><sub>R</sub> (0 to 100% B, 50 min, C<sub>A3</sub>) = 29.7 min.</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> TFA·N<sub>3</sub>-Phe-Leu<sub>2</sub>-Phe(4-NH<sub>2</sub>)-ψ[CH<sub>2</sub>SO<sub>2</sub>]-F (<b>64</b>)</h3><div class="NLM_p last">TFA·N<sub>3</sub>-Phe-Leu<sub>2</sub>-Phe(4-NHCbz)-ψ[CH<sub>2</sub>SO<sub>2</sub>]-F (14.1 mg, 16.0 μmol, 1.00 equiv) was set under nitrogen atmosphere, and 4 M HCl in dioxane (10 mL) was added and the reaction mixture stirred for 48 h at 60 °C. The solvent was removed in vacuo and the crude product purified by semipreparative HPLC (0 to 100% B, C<sub>P3</sub>). The starting material was recovered (13.0 mg), and no product could be isolated.</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 2TFA·H-Phe-Leu<sub>2</sub>-Phe(4-CH<sub>2</sub>NH<sub>2</sub>)-ψ[CH<sub>2</sub>SO<sub>2</sub>]-F (<b>65</b>)</h3><div class="NLM_p last">TFA·Boc-Phe-Leu<sub>2</sub>-Phe(4-CH<sub>2</sub>NH<sub>2</sub>)-ψ[CH<sub>2</sub>SO<sub>2</sub>]-F (12.7 mg, 13.1 μmol, 1.00 equiv) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (5 mL), and 33% HBr/AcOH solution (5 mL) was added, and the reaction mixture was stirred for 45 min at rt. The solvent was removed in vacuo, and the crude product was purified by semipreparative HPLC (0 to 60% B, C<sub>P2</sub>). Fractions containing the product were pooled, lyophilized, and the pure product was obtained as a white solid (7.5 mg, 8.84 μmol, 68%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>, 298 K): δ<sub>H</sub> (ppm) = 8.68 (d, <i>J</i> = 8.0 Hz, 0.5H, NH rotamer), 8.62 (d, <i>J</i> = 8.3 Hz, 0.5H, NH rotamer), 8.39–8.30 (m, 2H, 2 × NH), 8.22–8.14 (m, 3H, NH<sub>3</sub><sup>+</sup>), 8.09 (br s, 3H, NH<sub>3</sub><sup>+</sup>), 7.40–7.21 (m, 9H, Ar-H), 4.51–4.38 (m, 2H, αCH (Leu), αCH (PheCH<sub>2</sub>NH<sub>3</sub><sup>+</sup>)), 4.31–4.12 (m, 2H αCH (Leu), CH<sub>a</sub>SO<sub>2</sub>F), 4.11–4.02 (m, 1H, αCH (Phe)), 4.02–3.90 (m, 3H, CH<sub>b</sub>SO<sub>2</sub>F, CH<sub>2</sub>NH<sub>3</sub><sup>+</sup>), 3.09 (dd, <i>J</i> = 14.3, 4.8 Hz, 1H, CH<sub>a</sub>Phe), 2.98–2.78 (m, 3H, CH<sub>b</sub>Phe, (C<i>H</i><sub>2</sub>PheCH<sub>2</sub>NH<sub>3</sub><sup>+</sup>)), 1.68–1.51 (m, 1H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>), 1.50–1.39 (m, 3H, C<i>H</i>(CH<sub>3</sub>)<sub>2</sub>, CH<sub>2</sub> (Leu)), 1.38–1.28 (m, 1H, CH<sub>2</sub>–a (Leu)), 1.29–1.14 (m, 1H, CH<sub>2</sub>–b (Leu)), 0.93–0.74 (m, 12H, CH<sub>3</sub> (Leu)). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>, 298 K): δ<sub>C</sub> (ppm) = 171.9, 171.6, 168.2 (C═O), 137.9, 135.2, 132.8 (C-Ar), 130.0, 129.4, 129.1, 129.0, 127.6 (CH-Ar), 53.6 (d, <i>J</i> = 12.0 Hz, CSO<sub>2</sub>F), 53.4 (NH<sub>3</sub><sup>+</sup>αCH), 51.5, 51.4 (2 × αCH), 46.7 (αCH (PheCH<sub>2</sub>NH<sub>3</sub><sup>+</sup>)), 42.5 (CH<sub>3</sub>NH<sub>3</sub><sup>+</sup>), 41.5, 41.2 (2 × CH<sub>2</sub> (Leu)), 39.2 (<u class="uu">C</u>H<sub>2</sub>PheCH<sub>2</sub>NH<sub>3</sub><sup>+</sup>), 37.5 (CH<sub>2</sub>Phe), 24.6, 24.5 (2 × CH (Leu)), 23.5, 23.4, 22.1, 22.0 (4 × CH<sub>3</sub> (Leu)). <sup>19</sup>F NMR (471 MHz, DMSO-<i>d</i><sub>6</sub>, 298 K): δ<sub>F</sub> (ppm) = 59.8 (d, <i>J</i> = 5.9 Hz, SO<sub>2</sub>F). HRMS (ESI positive) calcd for C<sub>31</sub>H<sub>47</sub>N<sub>5</sub>O<sub>5</sub>SF [M + H]<sup>+</sup> 620.3276, found 620.3275. <i>t</i><sub>R</sub> (0 to 100% B, 50 min, C<sub>A1</sub>) = 40.5 min.</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> TFA·Ac-Phe-Leu<sub>2</sub>-Phe(4-CH<sub>2</sub>NH<sub>2</sub>)-ψ[CH<sub>2</sub>SO<sub>2</sub>]-F (<b>66</b>)</h3><div class="NLM_p last">TFA·Ac-Phe-Leu<sub>2</sub>-Phe(4-CH<sub>2</sub>NHCbz)-ψ[CH<sub>2</sub>SO<sub>2</sub>]-F (24.7 mg, 27.2 μmol, 1.00 equiv) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (5 mL), and a 33% HBr/AcOH solution (5 mL) was added, and the reaction mixture was stirred for 1 h at rt. The solvent was removed in vacuo and the crude product purified via semipreparative HPLC (0 to 100% B, C<sub>P3</sub>). The obtained product (15.5 mg) required a second purification step by semi-HPLC (0 to 50% B, C<sub>P3</sub>). Fractions containing the product were pooled, lyophilized, and the pure product was obtained as a white solid (6.2 mg, 8.0 μmol, 29%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>, 298 K): δ<sub>H</sub> (ppm) = 8.27 (d, <i>J</i> = 8.4 Hz, 1H, N<i>H</i>αCH (4-H<sub>3</sub>N<sup>+</sup>CH<sub>2</sub>-Phe)), 8.16 (br s, 3H, NH<sub>3</sub><sup>+</sup>), 8.12–8.06 (m, 2H, AcN<i>H</i>αCH, N<i>H</i>αCH (Leu)), 7.78 (d, <i>J</i> = 8.3 Hz, 1H, N<i>H</i>αCH (Leu)), 7.37 (d, <i>J</i> = 7.9 Hz, 2H, Ar-H (4-H<sub>3</sub>N<sup>+</sup>CH<sub>2</sub>-Phe)), 7.31–7.14 (m, 7H, 5 × Ar-H (Phe), 2 × Ar-H (4-H<sub>3</sub>N<sup>+</sup>CH<sub>2</sub>-Phe)), 4.49 (ddd, <i>J</i> = 10.1, 8.1, 4.0 Hz, 1H, AcNHαC<i>H</i>), 4.47–4.39 (m, 1H, αC<i>H</i>CH<sub>2</sub>SO<sub>2</sub>F), 4.32–4.25 (m, 1H, NHαC<i>H</i> (Leu)), 4.22 (ddd, <i>J</i> = 10.2, 8.3, 5.0 Hz, 1H, NHαC<i>H</i> (Leu)), 4.08–3.98 (m, 3H, CH<sub>a</sub>SO<sub>2</sub>F, C<i>H</i><sub>2</sub>NH<sub>3</sub><sup>+</sup>), 3.95 (dd, <i>J</i> = 14.1, 9.1 Hz, 1H, CH<sub>b</sub>SO<sub>2</sub>F), 2.97 (dd, <i>J</i> = 14.0, 4.0 Hz, 1H, CH<sub>a</sub> (Phe)), 2.87 (d, <i>J</i> = 6.9 Hz, 2H, C<i>H</i><sub>2</sub>Phe(4-CH<sub>2</sub>NH<sub>3</sub><sup>+</sup>)), 2.70 (dd, <i>J</i> = 14.0, 10.1 Hz, 1H, CH<sub>b</sub> (Phe)), 1.75 (s, 3H, CH<sub>3</sub> (Ac)), 1.63–1.51 (m, 2H, 2 × C<i>H</i>(CH<sub>3</sub>)<sub>2</sub> (Leu)), 1.49–1.38 (m, 3H, CH<sub>2</sub> (Leu), CH<sub>a</sub> (Leu)), 1.33 (ddd, <i>J</i> = 13.7, 9.0, 5.0 Hz, 1H, CH<sub>b</sub> (Leu)), 0.89 (d, <i>J</i> = 6.6 Hz, 3H, CH<sub>3</sub> (Leu)), 0.85 (d, <i>J</i> = 6.5 Hz, 3H, CH<sub>3</sub> (Leu)), 0.84 (d, <i>J</i> = 6.5 Hz, 3H, CH<sub>3</sub> (Leu)), 0.81 (d, <i>J</i> = 6.5 Hz, 3H, CH<sub>3</sub> (Leu)). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>, 298 K): δ<sub>C</sub> (ppm) = 171.98 (C═O), 171.95 (C═O), 171.88 (C═O), 169.8 (C═O), 138.5 (C-Ar), 137.9 (C-Ar), 132.7 (C-Ar), 130.0 (CH-Ar), 129.6 (CH-Ar), 129.3 (CH-Ar), 128.5 (CH-Ar), 126.7 (CH-Ar)), 54.4 (AcNHαC), 53.8 (d, <i>J</i><sub>C,F</sub> = 11.7 Hz, CSO<sub>2</sub>F), 51.6 (αCH (Leu)), 51.4 (αCH (Leu)), 46.6 (α<u class="uu">C</u>HCH<sub>2</sub>SO<sub>2</sub>F), 42.5 (CH<sub>2</sub>NH<sub>3</sub><sup>+</sup>), 41.2 (CH<sub>2</sub> (Leu)), 41.0 (CH<sub>2</sub> (Leu)), 39.3 (CH<sub>2</sub>Phe), 37.7 (<u class="uu">C</u>H<sub>2</sub>Phe[4-CH<sub>2</sub>NH<sub>3</sub><sup>+</sup>]), 24.6 (<u class="uu">C</u>H(CH<sub>3</sub>)<sub>2</sub>), 24.4 (<u class="uu">C</u>H(CH<sub>3</sub>)<sub>2</sub>), 23.6 (CH<sub>3</sub> (Leu)), 23.5 (CH<sub>3</sub> (Leu)), 22.9 (CH<sub>3</sub> (Ac)), 22.1 (CH<sub>3</sub> (Leu)), 22.0 (CH<sub>3</sub> (Leu)). <sup>19</sup>F NMR (471 MHz, DMSO-<i>d</i><sub>6</sub>, 298 K): δ<sub>F</sub> (ppm) = 59.8 (d, <i>J</i> = 6.0 Hz, SO<sub>2</sub>F). HRMS (ESI positive) calcd for C<sub>33</sub>H<sub>49</sub>N<sub>5</sub>O<sub>6</sub>SF [M + H]<sup>+</sup> 662.3382, found 662.3370. <i>t</i><sub>R</sub> (0 to 100% B, 50 min, C<sub>A3</sub>) = 29.6 min.</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> TFA·N<sub>3</sub>-Phe-Leu<sub>2</sub>-Phe(4-CH<sub>2</sub>NH<sub>2</sub>)-ψ[CH<sub>2</sub>SO<sub>2</sub>]-F (<b>67</b>)</h3><div class="NLM_p last">TFA·N<sub>3</sub>-Phe-Leu<sub>2</sub>-Phe(4-CH<sub>2</sub>NHCbz)-ψ[CH<sub>2</sub>SO<sub>2</sub>]-F (21.0 mg, 23.5 μmol, 1.00 equiv) was placed under nitrogen atmosphere, and 4 M HCl solution in dioxane (10 mL) was added, and the reaction mixture was stirred for 30 h at 50 °C. The solvent was removed in vacuo, and the crude product was purified via semipreparative HPLC (0 to 50% B, C<sub>P3</sub>). Fractions containing the product were pooled, lyophilized, and the pure product was obtained as a white solid (9.8 mg, 12.9 μmol, 55%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>, 298 K): δ<sub>H</sub> (ppm) = 8.37 (d, <i>J</i> = 8.3 Hz, 1H, N<i>H</i>αCH (Leu)), 8.30 (d, <i>J</i> = 8.4 Hz, 1H, N<i>H</i>αCH (Phe[4-CH<sub>2</sub>NH<sub>3</sub><sup>+</sup>])), 8.16 (br s, 3H, CH<sub>2</sub>N<i>H</i><sub>3</sub><sup>+</sup>), 8.00 (d, <i>J</i> = 8.3 Hz, 1H, N<i>H</i>αCH (Leu)), 7.37 (d, <i>J</i> = 7.9 Hz, 2H, Ar-H (Phe[4-CH<sub>2</sub>NH<sub>3</sub><sup>+</sup>])), 7.33–7.21 (m, 7H, Ar-H (Phe), 2 × Ar-H (Phe[4-CH<sub>2</sub>NH<sub>3</sub><sup>+</sup>])), 4.49–4.41 (m, 1H, NHαC<i>H</i> (Phe[4-CH<sub>2</sub>NH<sub>3</sub><sup>+</sup>])), 4.40–4.33 (m, 1H, NHαC<i>H</i> (Leu)), 4 4.26–4.19 (m, 1H, NHαC<i>H</i> (Leu)), 4.10 (dd, <i>J</i> = 9.3, 5.0 Hz, 1H, N<sub>3</sub>αC<i>H</i>), 4.08–3.91 (m, 4H, C<i>H</i><sub>2</sub>NH<sub>3</sub><sup>+</sup>, CH<sub>2</sub>SO<sub>2</sub>F), 3.08 (dd, <i>J</i> = 14.1, 5.0 Hz, 1H, N<sub>3</sub>αCHC<i>H</i><sub>a</sub>), 2.91–2.84 (m, 2H, N<sub>3</sub>αCHC<i>H</i><sub>b</sub>, C<i>H</i><sub>2</sub>Phe(4-CH<sub>2</sub>NH<sub>3</sub><sup>+</sup>)), 1.62–1.50 (m, 2H, 2 × C<i>H</i>(CH<sub>3</sub>)<sub>2</sub> (Leu)), 1.50–1.27 (m, 4H, 2 × CH<sub>2</sub> (Leu)), 0.89 (d, <i>J</i> = 6.7 Hz, 3H, CH<sub>3</sub> (Leu)), 0.87–0.84 (m, 6H, 2 × CH<sub>3</sub> (Leu)), 0.82 (d, <i>J</i> = 6.5 Hz, 3H, CH<sub>3</sub> (Leu)). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>, 298 K): δ<sub>C</sub> (ppm) = 171.4 (C═O), 171.0 (C═O), 168. Seven (C═O), 137.3 (C-Ar), 136.8 (C-Ar), 132.1 (C-Ar), 129.4 (CH-Ar), 128.9 (CH-Ar), 128.8 (CH-Ar), 128.3 (CH-Ar), 126.6 (CH-Ar), 62.2 (N<sub>3</sub>αC), 53.2 (d, <i>J</i><sub>C,F</sub> = 12.4 Hz, CSO<sub>2</sub>F), 51.0 (αCH (Leu)), 50.9 (αCH (Leu)), 46.1 (α<u class="uu">C</u>HCH<sub>2</sub>SO<sub>2</sub>F), 41.9 (<u class="uu">C</u>H<sub>2</sub>NH<sub>3</sub><sup>+</sup>), 40.64 (CH<sub>2</sub> (Leu)), 40.58 (CH<sub>2</sub> (Leu)), 38.7 (<u class="uu">C</u>H<sub>2</sub>Phe[4-CH<sub>2</sub>NH<sub>3</sub><sup>+</sup>]), 36.7 (N<sub>3</sub>αCH<u class="uu">C</u>H<sub>2</sub>), 24.0 (<u class="uu">C</u>H(CH<sub>3</sub>)<sub>2</sub>), 23.9 (<u class="uu">C</u>H(CH<sub>3</sub>)<sub>2</sub>), 23.0 (CH<sub>3</sub> (Leu), 22.9 (CH<sub>3</sub> (Leu), 21.5 (2 × CH<sub>3</sub> (Leu)). <sup>19</sup>F NMR (471 MHz, DMSO-<i>d</i><sub>6</sub>, 298 K): δ<sub>F</sub> (ppm) = 59.8 (d, <i>J</i> = 5.9 Hz, SO<sub>2</sub>F). HRMS (ESI positive) calcd for C<sub>31</sub>H<sub>45</sub>N<sub>7</sub>O<sub>5</sub>SF [M + H]<sup>+</sup> 646.3181, found 646.3161. <i>t</i><sub>R</sub> (0 to 100% B, 50 min, C<sub>A1</sub>) = 34.3 min, 34.6 min.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i50"><a href="/doi/suppl/10.1021/acs.jmedchem.8b00685" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38107" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38107" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b00685" class="ext-link">10.1021/acs.jmedchem.8b00685</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Analytical and preparative HPLC-columns; synthesis of peptides required for incorporation of aminosulfonyl fluoride derivatives; synthesis of precursors of aminosulfonyl fluorides (<b>28</b>–<b>30</b>, <b>32</b>–<b>36</b>); synthesis of aminosulfonyl fluorides (<b>40</b>–<b>42</b>); synthesis of protected peptide sulfonyl fluorides; proton, carbon, and fluoride NMR spectra; HPLC traces of peptide sulfonyl fluorides (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00685/suppl_file/jm8b00685_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00685/suppl_file/jm8b00685_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00685/suppl_file/jm8b00685_si_001.pdf">jm8b00685_si_001.pdf (10.43 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00685/suppl_file/jm8b00685_si_002.csv">jm8b00685_si_002.csv (2.6 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b00685" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24548" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24548" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rob M. J. Liskamp</span> - <span class="hlFld-Affiliation affiliation">School
of Chemistry, University of Glasgow, Joseph Black Building, University
Avenue, Glasgow G12 8QQ, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">Chemical
Biology and Drug Discovery, Department of Pharmaceutical Sciences,
Faculty of Science, Utrecht University, P.O. Box 80082, NL-3508 TB Utrecht, The Netherlands</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8897-8975" title="Orcid link">http://orcid.org/0000-0001-8897-8975</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#0b5964696e797f25476278606a667b4b6c676a786c647c256a68257e60"><span class="__cf_email__" data-cfemail="b8ead7daddcacc96f4d1cbd3d9d5c8f8dfd4d9cbdfd7cf96d9db96cdd3">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Raik Artschwager</span> - <span class="hlFld-Affiliation affiliation">School
of Chemistry, University of Glasgow, Joseph Black Building, University
Avenue, Glasgow G12 8QQ, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David J. Ward</span> - <span class="hlFld-Affiliation affiliation">School
of Chemistry, University of Glasgow, Joseph Black Building, University
Avenue, Glasgow G12 8QQ, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Susan Gannon</span> - <span class="hlFld-Affiliation affiliation">School
of Chemistry, University of Glasgow, Joseph Black Building, University
Avenue, Glasgow G12 8QQ, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Arwin J. Brouwer</span> - <span class="hlFld-Affiliation affiliation">Chemical
Biology and Drug Discovery, Department of Pharmaceutical Sciences,
Faculty of Science, Utrecht University, P.O. Box 80082, NL-3508 TB Utrecht, The Netherlands</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Helmus van de Langemheen</span> - <span class="hlFld-Affiliation affiliation">School
of Chemistry, University of Glasgow, Joseph Black Building, University
Avenue, Glasgow G12 8QQ, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hubert Kowalski</span> - <span class="hlFld-Affiliation affiliation">School
of Chemistry, University of Glasgow, Joseph Black Building, University
Avenue, Glasgow G12 8QQ, United Kingdom</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i52">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06630" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06630" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This research was funded by the University of Glasgow.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">BOP</td><td class="NLM_def"><p class="first last">(benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate;</p></td></tr><tr><td class="NLM_term">HCTU</td><td class="NLM_def"><p class="first last">2-(6-chloro-1<i>H</i>-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last">1-[bis(dimethylamino)methylene]-1<i>H</i>-1,2,3-triazolo[4,5-<i>b</i>]pyridinium 3-oxide hexafluorophosphate</p></td></tr><tr><td class="NLM_term">HBTU</td><td class="NLM_def"><p class="first last">2-(1<i>H</i>-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">DiPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">Boc</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyloxycarbonyl</p></td></tr><tr><td class="NLM_term">Cbz</td><td class="NLM_def"><p class="first last">carboxybenzyl</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">Hex</td><td class="NLM_def"><p class="first last"><i>n</i>-hexane</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i54">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55474" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55474" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 29 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weissman, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shabek, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciechanover, A.</span></span> <span> </span><span class="NLM_article-title">The predator becomes the prey: regulating the ubiquitin system by ubiquitylation and degradation</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">605</span>– <span class="NLM_lpage">620</span>, <span class="refDoi"> DOI: 10.1038/nrm3173</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=10.1038%2Fnrm3173" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=21860393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVGlu7fO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=605-620&author=A.+M.+Weissmanauthor=N.+Shabekauthor=A.+Ciechanover&title=The+predator+becomes+the+prey%3A+regulating+the+ubiquitin+system+by+ubiquitylation+and+degradation&doi=10.1038%2Fnrm3173"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The predator becomes the prey: regulating the ubiquitin system by ubiquitylation and degradation</span></div><div class="casAuthors">Weissman, Allan M.; Shabek, Nitzan; Ciechanover, Aaron</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">605-620</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Ubiquitination regulates essentially all of the intracellular processes in eukaryotes through highly specific modification of numerous cellular proteins, which is often tightly regulated in a spatial and temporal manner.  Although most often assocd. with proteasomal degrdn., ubiquitination frequently serves non-proteolytic functions.  In light of its central roles in cellular regulation, it has not been surprising to find that many of the components of the ubiquitin system itself are regulated by ubiquitination.  This observation has broad implications for pathophysiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGEQ3hfu3FRbVg90H21EOLACvtfcHk0lgsag0W7uh72g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVGlu7fO&md5=56c961541e0de728154db71ff2797e41</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrm3173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm3173%26sid%3Dliteratum%253Aachs%26aulast%3DWeissman%26aufirst%3DA.%2BM.%26aulast%3DShabek%26aufirst%3DN.%26aulast%3DCiechanover%26aufirst%3DA.%26atitle%3DThe%2520predator%2520becomes%2520the%2520prey%253A%2520regulating%2520the%2520ubiquitin%2520system%2520by%2520ubiquitylation%2520and%2520degradation%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2011%26volume%3D12%26spage%3D605%26epage%3D620%26doi%3D10.1038%2Fnrm3173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferrington, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregerson, D. S.</span></span> <span> </span><span class="NLM_article-title">Immunoproteasomes: Structure, function, and antigen presentation</span>. <i>Prog. Mol. Biol. Transl. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">75</span>– <span class="NLM_lpage">112</span>, <span class="refDoi"> DOI: 10.1016/B978-0-12-397863-9.00003-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=10.1016%2FB978-0-12-397863-9.00003-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=22727420" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsF2jtr7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=75-112&author=D.+A.+Ferringtonauthor=D.+S.+Gregerson&title=Immunoproteasomes%3A+Structure%2C+function%2C+and+antigen+presentation&doi=10.1016%2FB978-0-12-397863-9.00003-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Immunoproteasomes: structure, function, and antigen presentation</span></div><div class="casAuthors">Ferrington, Deborah A.; Gregerson, Dale S.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Molecular Biology and Translational Science</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">Proteasomal System in Aging and Disease</span>),
    <span class="NLM_cas:pages">75-112, 1 plate</span>CODEN:
                <span class="NLM_cas:coden">PNARC5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Immunoproteasomes contain replacements for the three catalytic subunits of std. proteasomes.  In most cells, oxidative stress and proinflammatory cytokines are stimuli that lead to elevated prodn. of immunoproteasomes.  Immune system cells, esp. antigen-presenting cells, express a higher basal level of immunoproteasomes.  A well-described function of immunoproteasomes is to generate peptides with a hydrophobic C terminus that can be processed to fit in the groove of MHC class I mols.  This display of peptides on the cell surface allows surveillance by CD8 T cells of the adaptive immune system for pathogen-infected cells.  Functions of immunoproteasomes, other than generating peptides for antigen presentation, are emerging from studies in immunoproteasome-deficient mice, and are complemented by recently described diseases linked to mutations or single-nucleotide polymorphisms in immunoproteasome subunits.  Thus, this growing body of literature suggests a more pleiotropic role in cell function for the immunoproteasome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB-ms47z5YWbVg90H21EOLACvtfcHk0lgsag0W7uh72g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsF2jtr7E&md5=dbddd6a20fe829739bb2acd037619376</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-397863-9.00003-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-397863-9.00003-1%26sid%3Dliteratum%253Aachs%26aulast%3DFerrington%26aufirst%3DD.%2BA.%26aulast%3DGregerson%26aufirst%3DD.%2BS.%26atitle%3DImmunoproteasomes%253A%2520Structure%252C%2520function%252C%2520and%2520antigen%2520presentation%26jtitle%3DProg.%2520Mol.%2520Biol.%2520Transl.%2520Sci.%26date%3D2012%26volume%3D109%26spage%3D75%26epage%3D112%26doi%3D10.1016%2FB978-0-12-397863-9.00003-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Groettrup, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirk, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basler, M.</span></span> <span> </span><span class="NLM_article-title">Proteasomes in immune cells: more than peptide producers?</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">73</span>– <span class="NLM_lpage">78</span>, <span class="refDoi"> DOI: 10.1038/nri2687</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=10.1038%2Fnri2687" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=20010787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFChtbnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=73-78&author=M.+Groettrupauthor=C.+J.+Kirkauthor=M.+Basler&title=Proteasomes+in+immune+cells%3A+more+than+peptide+producers%3F&doi=10.1038%2Fnri2687"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Proteasomes in immune cells: more than peptide producers?</span></div><div class="casAuthors">Groettrup, Marcus; Kirk, Christopher J.; Basler, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-78</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  When cells are stimulated with pro-inflammatory cytokines, most of their constitutively expressed proteasomes are replaced with immunoproteasomes, which increase the prodn. of peptides for presentation on MHC class I mols.  In addn., cortical thymic epithelial cells selectively express a type of proteasome known as the thymoproteasome that is required for the pos. selection of thymocytes.  Here, we discuss how these specialized types of proteasome shape the T cell receptor repertoire of cytotoxic T lymphocytes and propose that immunoproteasomes have functions, in addn. to antigen processing, that influence cytokine prodn. and T cell differentiation, survival and function.  We also discuss how inhibitors of immunoproteasomes can suppress undesired T cell responses in autoimmune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomQzel5QNbpbVg90H21EOLACvtfcHk0lgsag0W7uh72g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFChtbnI&md5=e11dedb3a06970299bc4c69b92edaf8a</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnri2687&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2687%26sid%3Dliteratum%253Aachs%26aulast%3DGroettrup%26aufirst%3DM.%26aulast%3DKirk%26aufirst%3DC.%2BJ.%26aulast%3DBasler%26aufirst%3DM.%26atitle%3DProteasomes%2520in%2520immune%2520cells%253A%2520more%2520than%2520peptide%2520producers%253F%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2010%26volume%3D10%26spage%3D73%26epage%3D78%26doi%3D10.1038%2Fnri2687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donoghue, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Linden, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foe, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tilley, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Fonseca, P. C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogyo, M.</span></span> <span> </span><span class="NLM_article-title">Structure- and function-based design of Plasmodium-selective proteasome inhibitors</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>530</i></span>,  <span class="NLM_fpage">233</span>– <span class="NLM_lpage">236</span>, <span class="refDoi"> DOI: 10.1038/nature16936</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=10.1038%2Fnature16936" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=26863983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=1%3ACAS%3A528%3ADC%252BC28XisVyrsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=530&publication_year=2016&pages=233-236&author=H.+Liauthor=A.+J.+O%E2%80%99Donoghueauthor=W.+A.+van+der+Lindenauthor=S.+C.+Xieauthor=E.+Yooauthor=I.+T.+Foeauthor=L.+Tilleyauthor=C.+S.+Craikauthor=P.+C.+A.+da+Fonsecaauthor=M.+Bogyo&title=Structure-+and+function-based+design+of+Plasmodium-selective+proteasome+inhibitors&doi=10.1038%2Fnature16936"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Structure- and function-based design of Plasmodium-selective proteasome inhibitors</span></div><div class="casAuthors">Li, Hao; O'Donoghue, Anthony J.; van der Linden, Wouter A.; Xie, Stanley C.; Yoo, Euna; Foe, Ian T.; Tilley, Leann; Craik, Charles S.; da Fonseca, Paula C. A.; Bogyo, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">530</span>
        (<span class="NLM_cas:issue">7589</span>),
    <span class="NLM_cas:pages">233-236</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The proteasome is a multi-component protease complex responsible for regulating key processes such as the cell cycle and antigen presentation.  Compds. that target the proteasome are potentially valuable tools for the treatment of pathogens that depend on proteasome function for survival and replication.  In particular, proteasome inhibitors have been shown to be toxic for the malaria parasite Plasmodium falciparum at all stages of its life cycle.  Most compds. that have been tested against the parasite also inhibit the mammalian proteasome, resulting in toxicity that precludes their use as therapeutic agents.  Therefore, better definition of the substrate specificity and structural properties of the Plasmodium proteasome could enable the development of compds. with sufficient selectivity to allow their use as anti-malarial agents.  To accomplish this goal, here the authors use a substrate profiling method to uncover differences in the specificities of the human and P. falciparum proteasome.  The authors design inhibitors based on amino-acid preferences specific to the parasite proteasome, and find that they preferentially inhibit the β2-subunit.  The authors det. the structure of the P. falciparum 20S proteasome bound to the inhibitor using cryo-electron microscopy and single-particle anal., to a resoln. of 3.6 Å.  These data reveal the unusually open P. falciparum β2 active site and provide valuable information about active-site architecture that can be used to further refine inhibitor design.  Furthermore, consistent with the recent finding that the proteasome is important for stress pathways assocd. with resistance of artemisinin family anti-malarials, the authors observe growth inhibition synergism with low doses of this β2-selective inhibitor in artemisinin-sensitive and -resistant parasites.  Finally, the authors demonstrate that a parasite-selective inhibitor could be used to attenuate parasite growth in vivo without appreciable toxicity to the host.  Thus, the Plasmodium proteasome is a chem. tractable target that could be exploited by next-generation anti-malarial agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriK0Li_WncVrVg90H21EOLACvtfcHk0ljUJhK5YjwgPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisVyrsr8%253D&md5=f24a562efb64dd533a7dbcfeff4171af</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnature16936&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature16936%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26aulast%3DO%25E2%2580%2599Donoghue%26aufirst%3DA.%2BJ.%26aulast%3Dvan%2Bder%2BLinden%26aufirst%3DW.%2BA.%26aulast%3DXie%26aufirst%3DS.%2BC.%26aulast%3DYoo%26aufirst%3DE.%26aulast%3DFoe%26aufirst%3DI.%2BT.%26aulast%3DTilley%26aufirst%3DL.%26aulast%3DCraik%26aufirst%3DC.%2BS.%26aulast%3Dda%2BFonseca%26aufirst%3DP.%2BC.%2BA.%26aulast%3DBogyo%26aufirst%3DM.%26atitle%3DStructure-%2520and%2520function-based%2520design%2520of%2520Plasmodium-selective%2520proteasome%2520inhibitors%26jtitle%3DNature%26date%3D2016%26volume%3D530%26spage%3D233%26epage%3D236%26doi%3D10.1038%2Fnature16936" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guterman, L.</span></span> <span> </span><span class="NLM_article-title">Covalent drugs form long-lived ties</span>. <i>Chem. Eng. News</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>89</i></span> (<span class="NLM_issue">36</span>),  <span class="NLM_fpage">19</span>– <span class="NLM_lpage">26</span>, <span class="refDoi"> DOI: 10.1021/cen-v089n036.p019</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cen-v089n036.p019" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2011&pages=19-26&issue=36&author=L.+Guterman&title=Covalent+drugs+form+long-lived+ties&doi=10.1021%2Fcen-v089n036.p019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fcen-v089n036.p019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcen-v089n036.p019%26sid%3Dliteratum%253Aachs%26aulast%3DGuterman%26aufirst%3DL.%26atitle%3DCovalent%2520drugs%2520form%2520long-lived%2520ties%26jtitle%3DChem.%2520Eng.%2520News%26date%3D2011%26volume%3D89%26issue%3D36%26spage%3D19%26epage%3D26%26doi%3D10.1021%2Fcen-v089n036.p019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hideshima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K. C.</span></span> <span> </span><span class="NLM_article-title">Bortezomib (PS-341): A novel, first-in-class proteasome inhibitor for the treatment of multiple myeloma and other cancers</span>. <i>Cancer Control</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">361</span>– <span class="NLM_lpage">369</span>, <span class="refDoi"> DOI: 10.1177/107327480301000502</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=10.1177%2F107327480301000502" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=361-369&issue=5&author=P.+Richardsonauthor=T.+Hideshimaauthor=K.+C.+Anderson&title=Bortezomib+%28PS-341%29%3A+A+novel%2C+first-in-class+proteasome+inhibitor+for+the+treatment+of+multiple+myeloma+and+other+cancers&doi=10.1177%2F107327480301000502"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1177%2F107327480301000502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F107327480301000502%26sid%3Dliteratum%253Aachs%26aulast%3DRichardson%26aufirst%3DP.%26aulast%3DHideshima%26aufirst%3DT.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26atitle%3DBortezomib%2520%2528PS-341%2529%253A%2520A%2520novel%252C%2520first-in-class%2520proteasome%2520inhibitor%2520for%2520the%2520treatment%2520of%2520multiple%2520myeloma%2520and%2520other%2520cancers%26jtitle%3DCancer%2520Control%26date%3D2003%26volume%3D10%26issue%3D5%26spage%3D361%26epage%3D369%26doi%3D10.1177%2F107327480301000502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Demo, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirk, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aujay, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchholz, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dajee, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laidig, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parlati, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shenk, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smyth, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vallone, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woo, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molineaux, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, M. K.</span></span> <span> </span><span class="NLM_article-title">Antitumor activity of PR-171, a novel irreversible inhibitor of the proteasome</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>67</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">6383</span>– <span class="NLM_lpage">6391</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-06-4086</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=10.1158%2F0008-5472.CAN-06-4086" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=17616698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnsVyqtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=6383-6391&issue=13&author=S.+D.+Demoauthor=C.+J.+Kirkauthor=M.+A.+Aujayauthor=T.+J.+Buchholzauthor=M.+Dajeeauthor=M.+N.+Hoauthor=J.+Jiangauthor=G.+J.+Laidigauthor=E.+R.+Lewisauthor=F.+M.+Parlatiauthor=K.+D.+Shenkauthor=M.+S.+Smythauthor=C.+M.+Sunauthor=M.+K.+Valloneauthor=T.+M.+Wooauthor=C.+J.+Molineauxauthor=M.+K.+Bennett&title=Antitumor+activity+of+PR-171%2C+a+novel+irreversible+inhibitor+of+the+proteasome&doi=10.1158%2F0008-5472.CAN-06-4086"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor Activity of PR-171, a Novel Irreversible Inhibitor of the Proteasome</span></div><div class="casAuthors">Demo, Susan D.; Kirk, Christopher J.; Aujay, Monette A.; Buchholz, Tonia J.; Dajee, Maya; Ho, Mark N.; Jiang, Jing; Laidig, Guy J.; Lewis, Evan R.; Parlati, Francesco; Shenk, Kevin D.; Smyth, Mark S.; Sun, Congcong M.; Vallone, Marcy K.; Woo, Tina M.; Molineaux, Christopher J.; Bennett, Mark K.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6383-6391</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Clin. studies with bortezomib have validated the proteasome as a therapeutic target for the treatment of multiple myeloma and non-Hodgkin's lymphoma.  However, significant toxicities have restricted the intensity of bortezomib dosing.  Here we describe the antitumor activity of PR-171, a novel epoxyketone-based irreversible proteasome inhibitor that is currently in clin. development.  In comparison to bortezomib, PR-171 exhibits equal potency but greater selectivity for the chymotrypsin-like activity of the proteasome.  In cell culture, PR-171 is more cytotoxic than bortezomib following brief treatments that mimic the in vivo pharmacokinetics of both mols.  Hematol. tumor cells exhibit the greatest sensitivity to brief exposure, whereas solid tumor cells and nontransformed cell types are less sensitive to such treatments.  Cellular consequences of PR-171 treatment include the accumulation of proteasome substrates and induction of cell cycle arrest and/or apoptosis.  Administration of PR-171 to animals results in the dose-dependent inhibition of the chymotrypsin-like proteasome activity in all tissues examd. with the exception of the brain.  PR-171 is well tolerated when administered for either 2 or 5 consecutive days at doses resulting in >80% proteasome inhibition in blood and most tissues.  In human tumor xenograft models, PR-171 mediates an antitumor response that is both dose and schedule dependent.  The antitumor efficacy of PR-171 delivered on 2 consecutive days is stronger than that of bortezomib administered on its clin. dosing schedule.  These studies show the tolerability, efficacy, and dosing flexibility of PR-171 and provide validation for the clin. testing of PR-171 in the treatment of hematol. malignancies using dose-intensive schedules.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquzP-VJ4DNRbVg90H21EOLACvtfcHk0ljB0-3iv_44Bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnsVyqtLY%253D&md5=301bcab3e60cbfd518b2f88fb479fa79</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-06-4086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-06-4086%26sid%3Dliteratum%253Aachs%26aulast%3DDemo%26aufirst%3DS.%2BD.%26aulast%3DKirk%26aufirst%3DC.%2BJ.%26aulast%3DAujay%26aufirst%3DM.%2BA.%26aulast%3DBuchholz%26aufirst%3DT.%2BJ.%26aulast%3DDajee%26aufirst%3DM.%26aulast%3DHo%26aufirst%3DM.%2BN.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DLaidig%26aufirst%3DG.%2BJ.%26aulast%3DLewis%26aufirst%3DE.%2BR.%26aulast%3DParlati%26aufirst%3DF.%2BM.%26aulast%3DShenk%26aufirst%3DK.%2BD.%26aulast%3DSmyth%26aufirst%3DM.%2BS.%26aulast%3DSun%26aufirst%3DC.%2BM.%26aulast%3DVallone%26aufirst%3DM.%2BK.%26aulast%3DWoo%26aufirst%3DT.%2BM.%26aulast%3DMolineaux%26aufirst%3DC.%2BJ.%26aulast%3DBennett%26aufirst%3DM.%2BK.%26atitle%3DAntitumor%2520activity%2520of%2520PR-171%252C%2520a%2520novel%2520irreversible%2520inhibitor%2520of%2520the%2520proteasome%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26issue%3D13%26spage%3D6383%26epage%3D6391%26doi%3D10.1158%2F0008-5472.CAN-06-4086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ettari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Previti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bitto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grasso, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zappalà, M.</span></span> <span> </span><span class="NLM_article-title">Immunoproteasome-selective inhibitors: a promising strategy tot treat hematologic malignancies, autoimmune and inflammatory diseases</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1217</span>– <span class="NLM_lpage">1238</span>, <span class="refDoi"> DOI: 10.2174/0929867323666160318173706</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=10.2174%2F0929867323666160318173706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=26965184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=1%3ACAS%3A528%3ADC%252BC28XnvFantL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=1217-1238&author=R.+Ettariauthor=S.+Previtiauthor=A.+Bittoauthor=S.+Grassoauthor=M.+Zappal%C3%A0&title=Immunoproteasome-selective+inhibitors%3A+a+promising+strategy+tot+treat+hematologic+malignancies%2C+autoimmune+and+inflammatory+diseases&doi=10.2174%2F0929867323666160318173706"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Immunoproteasome-Selective Inhibitors: A Promising Strategy to Treat Hematologic Malignancies, Autoimmune and Inflammatory Diseases</span></div><div class="casAuthors">Ettari, Roberta; Previti, Santo; Bitto, Alessandra; Grasso, Silvana; Zappala, Maria</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1217-1238</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The immunoproteasome is predominantly expressed in monocytes and lymphocytes and is responsible for the generation of antigenic peptides for cell-mediated immunity.  Upon the exposure of inflammatory cytokines IFN- and TNF-, constitutive subunits can be replaced by the synthesis of the immuno-core particles 1i, 2i and 5i.  Recent studies demonstrated that the immunoproteasome function is not only limited to MHC class I presentation, but it is also implicated in a no. of pathol. disorders including hematol. malignancies, inflammatory and autoimmune diseases.  At present the com. available proteasome inhibitors Bortezomib and Carfilzomib, which have been validated in multiple myeloma and other diseases, appear to target both the constitutive and immunoproteasomes indiscriminately.  This lack of specificity may, in part, explain some of the side effects of these agents.  In contrast, by selectively targeting the immunoproteasome, it may be possible to keep the antimyeloma and antilymphoma efficacy unchanged and, at the same time, to increase the therapeutic index.  The aim of this review article is to discuss the most promising immunoproteasome core particle-selective inhibitors which have been developed in the recent years, with a particular attention to their structural features, mechanism of action and therapeutic application.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5l0W-68DjTrVg90H21EOLACvtfcHk0ljB0-3iv_44Bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnvFantL8%253D&md5=cf860690368abed30995bff82044750e</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2174%2F0929867323666160318173706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867323666160318173706%26sid%3Dliteratum%253Aachs%26aulast%3DEttari%26aufirst%3DR.%26aulast%3DPreviti%26aufirst%3DS.%26aulast%3DBitto%26aufirst%3DA.%26aulast%3DGrasso%26aufirst%3DS.%26aulast%3DZappal%25C3%25A0%26aufirst%3DM.%26atitle%3DImmunoproteasome-selective%2520inhibitors%253A%2520a%2520promising%2520strategy%2520tot%2520treat%2520hematologic%2520malignancies%252C%2520autoimmune%2520and%2520inflammatory%2520diseases%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2016%26volume%3D23%26spage%3D1217%26epage%3D1238%26doi%3D10.2174%2F0929867323666160318173706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bensinger, W. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmerman, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reeder, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berenson, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Bacco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niesvizky, R.</span></span> <span> </span><span class="NLM_article-title">Phase 1 study of weekly dosing with the investigational oral proteasome inhibitor ixazomib in relapsed/refractory multiple myeloma</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>124</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1047</span>– <span class="NLM_lpage">1055</span>, <span class="refDoi"> DOI: 10.1182/blood-2014-01-548941</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=10.1182%2Fblood-2014-01-548941" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2014&pages=1047-1055&issue=7&author=S.+K.+Kumarauthor=W.+I.+Bensingerauthor=T.+M.+Zimmermanauthor=C.+B.+Reederauthor=J.+R.+Berensonauthor=D.+Bergauthor=A.-M.+Huiauthor=N.+Guptaauthor=A.+Di+Baccoauthor=J.+Yuauthor=Y.+Shouauthor=R.+Niesvizky&title=Phase+1+study+of+weekly+dosing+with+the+investigational+oral+proteasome+inhibitor+ixazomib+in+relapsed%2Frefractory+multiple+myeloma&doi=10.1182%2Fblood-2014-01-548941"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1182%2Fblood-2014-01-548941&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2014-01-548941%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DS.%2BK.%26aulast%3DBensinger%26aufirst%3DW.%2BI.%26aulast%3DZimmerman%26aufirst%3DT.%2BM.%26aulast%3DReeder%26aufirst%3DC.%2BB.%26aulast%3DBerenson%26aufirst%3DJ.%2BR.%26aulast%3DBerg%26aufirst%3DD.%26aulast%3DHui%26aufirst%3DA.-M.%26aulast%3DGupta%26aufirst%3DN.%26aulast%3DDi%2BBacco%26aufirst%3DA.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DShou%26aufirst%3DY.%26aulast%3DNiesvizky%26aufirst%3DR.%26atitle%3DPhase%25201%2520study%2520of%2520weekly%2520dosing%2520with%2520the%2520investigational%2520oral%2520proteasome%2520inhibitor%2520ixazomib%2520in%2520relapsed%252Frefractory%2520multiple%2520myeloma%26jtitle%3DBlood%26date%3D2014%26volume%3D124%26issue%3D7%26spage%3D1047%26epage%3D1055%26doi%3D10.1182%2Fblood-2014-01-548941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghazarian, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luderer, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusdono, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azab, A. K.</span></span> <span> </span><span class="NLM_article-title">Spotlight on ixazomib: potential in the treatment of multiple myeloma</span>. <i>Drug Des., Dev. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">217</span>– <span class="NLM_lpage">226</span>, <span class="refDoi"> DOI: 10.2147/DDDT.S93602</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=10.2147%2FDDDT.S93602" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=26811670" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmtFOntbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2016&pages=217-226&author=B.+Muzauthor=R.+N.+Ghazarianauthor=M.+Ouauthor=M.+J.+Ludererauthor=H.+D.+Kusdonoauthor=A.+K.+Azab&title=Spotlight+on+ixazomib%3A+potential+in+the+treatment+of+multiple+myeloma&doi=10.2147%2FDDDT.S93602"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Spotlight on ixazomib: potential in the treatment of multiple myeloma</span></div><div class="casAuthors">Muz, Barbara; Ghazarian, Rachel Nicole; Ou, Monica; Luderer, Micah John; Kusdono, Hubert Daniel; Azab, Abdel Kareem</div><div class="citationInfo"><span class="NLM_cas:title">Drug Design, Development and Therapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">217-226</span>CODEN:
                <span class="NLM_cas:coden">DDDTAQ</span>;
        ISSN:<span class="NLM_cas:issn">1177-8881</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Despite the significant therapeutic advances achieved with proteasome inhibitors (PIs) such as bortezomib and carfilzomib in prolonging the survival of patients with multiple myeloma, the development of drug resistance, peripheral neuropathy, and pharmacokinetic limitations continue to pose major challenges when using these compds.  Ixazomib is a second-generation PI with improved activity over other PIs.  Unlike bortezomib and carfilzomib, which are administered by injection, ixazomib is the first oral PI approved by US Food and Drug Administration.  This review discusses the biochem. properties, mechanisms of action, preclin. efficacy, and clin. trial results leading to the US Food and Drug Administration approval of ixazomib.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_kCBu0zA5zbVg90H21EOLACvtfcHk0ljwE59V1Gx9iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmtFOntbw%253D&md5=44626d99cf4fadac652b833b953028d1</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2147%2FDDDT.S93602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FDDDT.S93602%26sid%3Dliteratum%253Aachs%26aulast%3DMuz%26aufirst%3DB.%26aulast%3DGhazarian%26aufirst%3DR.%2BN.%26aulast%3DOu%26aufirst%3DM.%26aulast%3DLuderer%26aufirst%3DM.%2BJ.%26aulast%3DKusdono%26aufirst%3DH.%2BD.%26aulast%3DAzab%26aufirst%3DA.%2BK.%26atitle%3DSpotlight%2520on%2520ixazomib%253A%2520potential%2520in%2520the%2520treatment%2520of%2520multiple%2520myeloma%26jtitle%3DDrug%2520Des.%252C%2520Dev.%2520Ther.%26date%3D2016%26volume%3D10%26spage%3D217%26epage%3D226%26doi%3D10.2147%2FDDDT.S93602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Infante, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendelson, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burris, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bendell, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolcher, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillenwater, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arastu-Kapur, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papadopoulos, K. P.</span></span> <span> </span><span class="NLM_article-title">A first-in-human dose-escalation study of the oral proteasome inhibitor oprozomib in patients with advanced solid tumors</span>. <i>Invest. New Drugs</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">216</span>– <span class="NLM_lpage">224</span>, <span class="refDoi"> DOI: 10.1007/s10637-016-0327-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=10.1007%2Fs10637-016-0327-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=26924128" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=1%3ACAS%3A528%3ADC%252BC28XjslCrtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2016&pages=216-224&author=J.+R.+Infanteauthor=D.+S.+Mendelsonauthor=H.+A.+Burrisauthor=J.+C.+Bendellauthor=A.+W.+Tolcherauthor=M.+S.+Gordonauthor=H.+H.+Gillenwaterauthor=S.+Arastu-Kapurauthor=H.+S.+Wongauthor=K.+P.+Papadopoulos&title=A+first-in-human+dose-escalation+study+of+the+oral+proteasome+inhibitor+oprozomib+in+patients+with+advanced+solid+tumors&doi=10.1007%2Fs10637-016-0327-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">A first-in-human dose-escalation study of the oral proteasome inhibitor oprozomib in patients with advanced solid tumors</span></div><div class="casAuthors">Infante, Jeffrey R.; Mendelson, David S.; Burris, Howard A., III; Bendell, Johanna C.; Tolcher, Anthony W.; Gordon, Michael S.; Gillenwater, Heidi H.; Arastu-Kapur, Shirin; Wong, Hansen L.; Papadopoulos, Kyriakos P.</div><div class="citationInfo"><span class="NLM_cas:title">Investigational New Drugs</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">216-224</span>CODEN:
                <span class="NLM_cas:coden">INNDDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-6997</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">To det. the dose-limiting toxicities (DLTs), max. tolerated dose (MTD), safety, and pharmacokinetic and pharmacodynamic profiles of the tripeptide epoxyketone proteasome inhibitor oprozomib in patients with advanced refractory or recurrent solid tumors.  Patients received escalating once daily (QD) or split doses of oprozomib on days 1-5 of 14-day cycles (C).  The split-dose arm was implemented and compared in fasted (C1) and fed (C2) states.  Pharmacokinetic samples were collected during C1 and C2.  Proteasome inhibition was evaluated in red blood cells and peripheral blood mononuclear cells.  Forty-four patients (QD, n = 25; split dose, n = 19) were enrolled.  The most common primary tumor types were non-small cell lung cancer (18 %) and colorectal cancer (16%).  In the 180-mg QD cohort, two patients experienced DLTs: grade 3 vomiting and dehydration; grade 3 hypophosphatemia (n = 1 each).  In the split-dose group, three DLTs were obsd. 180-mg cohort: grade 3 hypophosphatemia; 210-mg cohort: grade 5 gastrointestinal hemorrhage and grade 3 hallucinations (n = 1 each).  In the QD and split-dose groups, the MTD was 150 and 180 mg, resp.  Common adverse events (all grades) included nausea (91%), vomiting (86%), and diarrhea (61%).  Peak concns. and total exposure of oprozomib generally increased with the increasing dose.  Oprozomib induced dose-dependent proteasome inhibition.  Best response was stable disease.  While generally low-grade, clin. relevant gastrointestinal toxicities occurred frequently with this oprozomib formulation.  Despite dose-dependent increases in pharmacokinetics and pharmacodynamics, single-agent oprozomib had minimal antitumor activity in this patient population with advanced solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrW2c034hrkubVg90H21EOLACvtfcHk0ljwE59V1Gx9iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjslCrtr0%253D&md5=e54838bb160c0886d08c5d0b8cb81a6a</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs10637-016-0327-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10637-016-0327-x%26sid%3Dliteratum%253Aachs%26aulast%3DInfante%26aufirst%3DJ.%2BR.%26aulast%3DMendelson%26aufirst%3DD.%2BS.%26aulast%3DBurris%26aufirst%3DH.%2BA.%26aulast%3DBendell%26aufirst%3DJ.%2BC.%26aulast%3DTolcher%26aufirst%3DA.%2BW.%26aulast%3DGordon%26aufirst%3DM.%2BS.%26aulast%3DGillenwater%26aufirst%3DH.%2BH.%26aulast%3DArastu-Kapur%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DH.%2BS.%26aulast%3DPapadopoulos%26aufirst%3DK.%2BP.%26atitle%3DA%2520first-in-human%2520dose-escalation%2520study%2520of%2520the%2520oral%2520proteasome%2520inhibitor%2520oprozomib%2520in%2520patients%2520with%2520advanced%2520solid%2520tumors%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2016%26volume%3D34%26spage%3D216%26epage%3D224%26doi%3D10.1007%2Fs10637-016-0327-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bader, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geurink, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weyburne, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirabella, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silzle, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shabaneh, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Linden, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Bruin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haile, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Rooden, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appenzeller, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kisselev, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overkleeft, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Driessen, C.</span></span> <span> </span><span class="NLM_article-title">The novel β2-selective proteasome inhibitor LU-102 synergizes with bortezomib and carfilzomib to overcome proteasome inhibitor resistance of myeloma cells</span>. <i>Haematologica</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>100</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1350</span>– <span class="NLM_lpage">1360</span>, <span class="refDoi"> DOI: 10.3324/haematol.2014.109421</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=10.3324%2Fhaematol.2014.109421" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2015&pages=1350-1360&issue=10&author=M.+Krausauthor=J.+Baderauthor=P.+P.+Geurinkauthor=E.+S.+Weyburneauthor=A.+C.+Mirabellaauthor=T.+Silzleauthor=T.+B.+Shabanehauthor=W.+A.+van+der+Lindenauthor=G.+de+Bruinauthor=S.+R.+Haileauthor=E.+van+Roodenauthor=C.+Appenzellerauthor=N.+Liauthor=A.+F.+Kisselevauthor=H.+Overkleeftauthor=C.+Driessen&title=The+novel+%CE%B22-selective+proteasome+inhibitor+LU-102+synergizes+with+bortezomib+and+carfilzomib+to+overcome+proteasome+inhibitor+resistance+of+myeloma+cells&doi=10.3324%2Fhaematol.2014.109421"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.3324%2Fhaematol.2014.109421&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3324%252Fhaematol.2014.109421%26sid%3Dliteratum%253Aachs%26aulast%3DKraus%26aufirst%3DM.%26aulast%3DBader%26aufirst%3DJ.%26aulast%3DGeurink%26aufirst%3DP.%2BP.%26aulast%3DWeyburne%26aufirst%3DE.%2BS.%26aulast%3DMirabella%26aufirst%3DA.%2BC.%26aulast%3DSilzle%26aufirst%3DT.%26aulast%3DShabaneh%26aufirst%3DT.%2BB.%26aulast%3Dvan%2Bder%2BLinden%26aufirst%3DW.%2BA.%26aulast%3Dde%2BBruin%26aufirst%3DG.%26aulast%3DHaile%26aufirst%3DS.%2BR.%26aulast%3Dvan%2BRooden%26aufirst%3DE.%26aulast%3DAppenzeller%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DKisselev%26aufirst%3DA.%2BF.%26aulast%3DOverkleeft%26aufirst%3DH.%26aulast%3DDriessen%26aufirst%3DC.%26atitle%3DThe%2520novel%2520%25CE%25B22-selective%2520proteasome%2520inhibitor%2520LU-102%2520synergizes%2520with%2520bortezomib%2520and%2520carfilzomib%2520to%2520overcome%2520proteasome%2520inhibitor%2520resistance%2520of%2520myeloma%2520cells%26jtitle%3DHaematologica%26date%3D2015%26volume%3D100%26issue%3D10%26spage%3D1350%26epage%3D1360%26doi%3D10.3324%2Fhaematol.2014.109421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besse, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bader, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geurink, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Bruin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kisselev, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overkleeft, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Driessen, C.</span></span> <span> </span><span class="NLM_article-title">The novel β2-selective proteasome inhibitor LU-102 decreases phosphorylation of I kappa B and induces highly synergistic cytotoxicity in combination with ibrutinib in multiple myeloma cells</span>. <i>Cancer Chemother. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">383</span>– <span class="NLM_lpage">396</span>, <span class="refDoi"> DOI: 10.1007/s00280-015-2801-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=10.1007%2Fs00280-015-2801-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=26099967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFSjsb%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2015&pages=383-396&author=J.+Krausauthor=M.+Krausauthor=N.+Liuauthor=L.+Besseauthor=J.+Baderauthor=P.+P.+Geurinkauthor=G.+de+Bruinauthor=A.+F.+Kisselevauthor=H.+Overkleeftauthor=C.+Driessen&title=The+novel+%CE%B22-selective+proteasome+inhibitor+LU-102+decreases+phosphorylation+of+I+kappa+B+and+induces+highly+synergistic+cytotoxicity+in+combination+with+ibrutinib+in+multiple+myeloma+cells&doi=10.1007%2Fs00280-015-2801-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The novel β2-selective proteasome inhibitor LU-102 decreases phosphorylation of I kappa B and induces highly synergistic cytotoxicity in combination with ibrutinib in multiple myeloma cells</span></div><div class="casAuthors">Kraus, Johannes; Kraus, Marianne; Liu, Nora; Besse, Lenka; Bader, Jurgen; Geurink, Paul P.; de Bruin, Gerjan; Kisselev, Alexei F.; Overkleeft, Herman; Driessen, Christoph</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">383-396</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: Proteasome-inhibiting drugs (PI) are gaining importance in hematol. oncol.  The proteasome carries three proteolytically active subunits (β1, β2, β5).  All established PI (bortezomib and carfilzomib), as well as exptl. drugs in the field (dalanzomib, oprozomib, and ixazomib), by design target the rate-limiting β5 subunit.  It is unknown whether β2-selective proteasome inhibition can also be exploited toward anticancer treatment.  Combining PI with the pan B-cell-directed Bruton tyrosine kinase inhibitor ibrutinib appears a natural option for future improved treatment of multiple myeloma (MM) and B-cell lymphomas.  However, bortezomib induces phosphorylation of IκB and activation of NF-κB in MM cells, while ibrutinib inhibits the IκB/NF-κB axis, suggesting antagonistic signaling.  A β2-selective proteasome inhibitor may lack such antagonistic signaling effects.  Methods: We recently introduced LU-102, the first β2-selective PI available for preclin. testing.  We here compare bortezomib with carfilzomib and LU-102 in MM and MCL in vitro with regard to their effects on pIκB/NF-κB signaling and their cytotoxic activity in combination with ibrutinib.  Results: LU-102 reduced phosphorylation of IκB, in contrast to bortezomib and carfilzomib, and was a superior inhibitor of NF-κB activation in MM cells.  This translated into highly synergistic cytotoxicity between LU-102 and ibrutinib, which was able to overcome BTZ resistance and CFZ resistance.  By contrast, BTZ lacked consistent synergistic cytotoxicity with ibrutinib.  Conclusion: Ibrutinib is highly synergistic with β2-selective proteasome inhibition against MM and MCL in vitro.  Novel β2-selective proteasome inhibitors may be exploited to overcome bortezomib/carfilzomib resistance and boost the activity of BTK inhibitors against B-cell-derived malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEpYl5-cKkhbVg90H21EOLACvtfcHk0ljwE59V1Gx9iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFSjsb%252FE&md5=f3492abb2e88fcf0b401dfaaaa9d4d84</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1007%2Fs00280-015-2801-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-015-2801-0%26sid%3Dliteratum%253Aachs%26aulast%3DKraus%26aufirst%3DJ.%26aulast%3DKraus%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DBesse%26aufirst%3DL.%26aulast%3DBader%26aufirst%3DJ.%26aulast%3DGeurink%26aufirst%3DP.%2BP.%26aulast%3Dde%2BBruin%26aufirst%3DG.%26aulast%3DKisselev%26aufirst%3DA.%2BF.%26aulast%3DOverkleeft%26aufirst%3DH.%26aulast%3DDriessen%26aufirst%3DC.%26atitle%3DThe%2520novel%2520%25CE%25B22-selective%2520proteasome%2520inhibitor%2520LU-102%2520decreases%2520phosphorylation%2520of%2520I%2520kappa%2520B%2520and%2520induces%2520highly%2520synergistic%2520cytotoxicity%2520in%2520combination%2520with%2520ibrutinib%2520in%2520multiple%2520myeloma%2520cells%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2015%26volume%3D76%26spage%3D383%26epage%3D396%26doi%3D10.1007%2Fs00280-015-2801-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Brouwer, A.
J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceylan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonker, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Linden, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liskamp, R. M. J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of novel irreversible serine protease inhibitors using amino acid based sulfonyl fluorides as an electrophilic trap</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2397</span>– <span class="NLM_lpage">2406</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2011.02.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=10.1016%2Fj.bmc.2011.02.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=21421320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvFehtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=2397-2406&author=A.%0AJ.+Brouwerauthor=T.+Ceylanauthor=A.+M.+Jonkerauthor=T.+van+der+Lindenauthor=R.+M.+J.+Liskamp&title=Synthesis+and+biological+evaluation+of+novel+irreversible+serine+protease+inhibitors+using+amino+acid+based+sulfonyl+fluorides+as+an+electrophilic+trap&doi=10.1016%2Fj.bmc.2011.02.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14a</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of novel irreversible serine protease inhibitors using amino acid based sulfonyl fluorides as an electrophilic trap</span></div><div class="casAuthors">Brouwer, Arwin J.; Ceylan, Tarik; Jonker, Anika M.; van der Linden, Tima; Liskamp, Rob M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2397-2406</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We have designed and synthesized novel irreversible serine protease inhibitors contg. aliph. sulfonyl fluorides as an electrophilic trap.  These substituted taurine sulfonyl fluorides derived from taurine or protected amino acids were conveniently synthesized from β-aminoethanesulfonyl chlorides using KF/18-crown-6 or from β-aminoethanesulfonates using DAST.  Their potency of irreversible inhibition of serine proteases is described in different enzyme assays using chymotrypsin leading to binding affinities up to 22 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4DO41CYAqhbVg90H21EOLACvtfcHk0ljdOTXNYevF3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvFehtb4%253D&md5=866261a6647666a422a1c21cd373ea09</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2011.02.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2011.02.014%26sid%3Dliteratum%253Aachs%26aulast%3DBrouwer%26aufirst%3DA.%2BJ.%26aulast%3DCeylan%26aufirst%3DT.%26aulast%3DJonker%26aufirst%3DA.%2BM.%26aulast%3Dvan%2Bder%2BLinden%26aufirst%3DT.%26aulast%3DLiskamp%26aufirst%3DR.%2BM.%2BJ.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520irreversible%2520serine%2520protease%2520inhibitors%2520using%2520amino%2520acid%2520based%2520sulfonyl%2520fluorides%2520as%2520an%2520electrophilic%2520trap%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D2397%26epage%3D2406%26doi%3D10.1016%2Fj.bmc.2011.02.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Brouwer, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceylan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Linden, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liskamp, R. M. J.</span></span> <span> </span><span class="NLM_article-title">Synthesis of β-aminoethane sulfonyl fluorides or 2-substituted taurine sulfonyl fluorides as potential protease inhibitors</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">3391</span>– <span class="NLM_lpage">3393</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2009.02.130</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=10.1016%2Fj.tetlet.2009.02.130" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=3391-3393&author=A.+J.+Brouwerauthor=T.+Ceylanauthor=T.+van+der+Lindenauthor=R.+M.+J.+Liskamp&title=Synthesis+of+%CE%B2-aminoethane+sulfonyl+fluorides+or+2-substituted+taurine+sulfonyl+fluorides+as+potential+protease+inhibitors&doi=10.1016%2Fj.tetlet.2009.02.130"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2009.02.130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2009.02.130%26sid%3Dliteratum%253Aachs%26aulast%3DBrouwer%26aufirst%3DA.%2BJ.%26aulast%3DCeylan%26aufirst%3DT.%26aulast%3Dvan%2Bder%2BLinden%26aufirst%3DT.%26aulast%3DLiskamp%26aufirst%3DR.%2BM.%2BJ.%26atitle%3DSynthesis%2520of%2520%25CE%25B2-aminoethane%2520sulfonyl%2520fluorides%2520or%25202-substituted%2520taurine%2520sulfonyl%2520fluorides%2520as%2520potential%2520protease%2520inhibitors%26jtitle%3DTetrahedron%2520Lett.%26date%3D2009%26volume%3D50%26spage%3D3391%26epage%3D3393%26doi%3D10.1016%2Fj.tetlet.2009.02.130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brouwer, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werkhoven, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallastegui, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemmink, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florea, B. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groll, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overkleeft, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liskamp, R. M. J.</span></span> <span> </span><span class="NLM_article-title">Peptido sulfonyl fluorides as new powerful proteasome inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">10995</span>– <span class="NLM_lpage">11003</span>, <span class="refDoi"> DOI: 10.1021/jm301443r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301443r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslalurjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10995-11003&author=A.+J.+Brouwerauthor=A.+Jonkerauthor=P.+Werkhovenauthor=E.+Kuoauthor=N.+Liauthor=N.+Gallasteguiauthor=J.+Kemminkauthor=B.+I.+Floreaauthor=M.+Grollauthor=H.+S.+Overkleeftauthor=R.+M.+J.+Liskamp&title=Peptido+sulfonyl+fluorides+as+new+powerful+proteasome+inhibitors&doi=10.1021%2Fjm301443r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Peptido sulfonyl fluorides as new powerful proteasome inhibitors</span></div><div class="casAuthors">Brouwer, Arwin J.; Jonker, Anika; Werkhoven, Paul; Kuo, Ethan; Li, Nan; Gallastegui, Nerea; Kemmink, Johan; Florea, Bogdan I.; Groll, Michael; Overkleeft, Herman S.; Liskamp, Rob M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10995-11003</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new class of potent proteasome inhibitors is described, of which the members contain an amino acid inspired sulfonyl fluoride as the electrophilic trap.  In total, 24 peptido sulfonyl fluoride inhibitors have been designed and synthesized, which were inspired by the backbone sequences of the proteasome inhibitors bortezomib, epoxomicin, and Cbz-Leu3-aldehyde.  Nine of them were very potent proteasome inhibitors, the best of which had an IC50 of 7 nM.  A no. of the peptido sulfonyl fluoride inhibitors were found to be highly selective for the β5 proteasome subunit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMpjkcOVPvyLVg90H21EOLACvtfcHk0ljdOTXNYevF3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslalurjE&md5=e84873c90746c6642013c03b51b40bcf</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm301443r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301443r%26sid%3Dliteratum%253Aachs%26aulast%3DBrouwer%26aufirst%3DA.%2BJ.%26aulast%3DJonker%26aufirst%3DA.%26aulast%3DWerkhoven%26aufirst%3DP.%26aulast%3DKuo%26aufirst%3DE.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DGallastegui%26aufirst%3DN.%26aulast%3DKemmink%26aufirst%3DJ.%26aulast%3DFlorea%26aufirst%3DB.%2BI.%26aulast%3DGroll%26aufirst%3DM.%26aulast%3DOverkleeft%26aufirst%3DH.%2BS.%26aulast%3DLiskamp%26aufirst%3DR.%2BM.%2BJ.%26atitle%3DPeptido%2520sulfonyl%2520fluorides%2520as%2520new%2520powerful%2520proteasome%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10995%26epage%3D11003%26doi%3D10.1021%2Fjm301443r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dubiella, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gersch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brouwer, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sieber, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krüger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liskamp, R. M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groll, M.</span></span> <span> </span><span class="NLM_article-title">Selective inhibition of the immunoproteasome by ligand-induced crosslinking of the active site</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">11969</span>– <span class="NLM_lpage">11973</span>, <span class="refDoi"> DOI: 10.1002/anie.201406964</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=10.1002%2Fanie.201406964" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslOkurfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=11969-11973&author=C.+Dubiellaauthor=H.+Cuiauthor=M.+Gerschauthor=A.+J.+Brouwerauthor=S.+A.+Sieberauthor=A.+Kr%C3%BCgerauthor=R.+M.+J.+Liskampauthor=M.+Groll&title=Selective+inhibition+of+the+immunoproteasome+by+ligand-induced+crosslinking+of+the+active+site&doi=10.1002%2Fanie.201406964"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Inhibition of the Immunoproteasome by Ligand-Induced Crosslinking of the Active Site</span></div><div class="casAuthors">Dubiella, Christian; Cui, Haissi; Gersch, Malte; Brouwer, Arwin J.; Sieber, Stephan A.; Krueger, Achim; Liskamp, Rob M. J.; Groll, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">11969-11973</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The concept of proteasome inhibition ranks among the latest achievements in the treatment of blood cancer and represents a promising strategy for modulating autoimmune diseases.  In this study, we describe peptidic sulfonyl fluoride inhibitors that selectively block the catalytic β5 subunit of the immunoproteasome by inducing only marginal cytotoxic effects.  Structural and mass spectrometric analyses revealed a novel reaction mechanism involving polarity inversion and irreversible crosslinking of the proteasomal active site.  We thus identified the sulfonyl fluoride headgroup for the development and optimization of immunoproteasome selective compds. and their possible application in autoimmune disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnN6CJub2ORrVg90H21EOLACvtfcHk0li-QevYiovOhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslOkurfM&md5=00d726fdbc6f2e391f9650516b2d6c30</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2Fanie.201406964&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201406964%26sid%3Dliteratum%253Aachs%26aulast%3DDubiella%26aufirst%3DC.%26aulast%3DCui%26aufirst%3DH.%26aulast%3DGersch%26aufirst%3DM.%26aulast%3DBrouwer%26aufirst%3DA.%2BJ.%26aulast%3DSieber%26aufirst%3DS.%2BA.%26aulast%3DKr%25C3%25BCger%26aufirst%3DA.%26aulast%3DLiskamp%26aufirst%3DR.%2BM.%2BJ.%26aulast%3DGroll%26aufirst%3DM.%26atitle%3DSelective%2520inhibition%2520of%2520the%2520immunoproteasome%2520by%2520ligand-induced%2520crosslinking%2520of%2520the%2520active%2520site%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26spage%3D11969%26epage%3D11973%26doi%3D10.1002%2Fanie.201406964" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Narayanan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, L. H.</span></span> <span> </span><span class="NLM_article-title">Sulfonyl fluorides as privileged warheads in chemical biology</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">2650</span>– <span class="NLM_lpage">2659</span>, <span class="refDoi"> DOI: 10.1039/C5SC00408J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=10.1039%2FC5SC00408J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=28706662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=1%3ACAS%3A528%3ADC%252BC2MXksVamurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=2650-2659&author=A.+Narayananauthor=L.+H.+Jones&title=Sulfonyl+fluorides+as+privileged+warheads+in+chemical+biology&doi=10.1039%2FC5SC00408J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfonyl fluorides as privileged warheads in chemical biology</span></div><div class="casAuthors">Narayanan, Arjun; Jones, Lyn H.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2650-2659</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Sulfonyl fluoride electrophiles have found significant utility as reactive probes in chem. biol. and mol. pharmacol.  As warheads they possess the right balance of biocompatibility (including aq. stability) and protein reactivity.  Their functionality is privileged in this regard as they are known to modify not only reactive serines (resulting in their common use as protease inhibitors), but also context-specific threonine, lysine, tyrosine, cysteine and histidine residues.  This review describes the application of sulfonyl fluoride probes across various areas of research and explores new approaches that could further enhance the chem. biol. toolkit.  We believe that sulfonyl fluoride probes will find greater utility in areas such as covalent enzyme inhibition, target identification and validation, and the mapping of enzyme binding sites, substrates and protein-protein interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAuadIMxOl2bVg90H21EOLACvtfcHk0li-QevYiovOhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXksVamurc%253D&md5=0009feb4068e912b4784fb8411cdb702</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1039%2FC5SC00408J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5SC00408J%26sid%3Dliteratum%253Aachs%26aulast%3DNarayanan%26aufirst%3DA.%26aulast%3DJones%26aufirst%3DL.%2BH.%26atitle%3DSulfonyl%2520fluorides%2520as%2520privileged%2520warheads%2520in%2520chemical%2520biology%26jtitle%3DChem.%2520Sci.%26date%3D2015%26volume%3D6%26spage%3D2650%26epage%3D2659%26doi%3D10.1039%2FC5SC00408J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fadeyi, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parikh, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kyne, R. E.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Doherty, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niessen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinrich, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kath, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, R. P.</span></span> <span> </span><span class="NLM_article-title">Chemoselective preparation of clickable aryl sulfonyl fluoride monomers: a toolbox of highly functionalized intermediates for chemical biology probe synthesis</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1925</span>– <span class="NLM_lpage">1930</span>, <span class="refDoi"> DOI: 10.1002/cbic.201600427</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=10.1002%2Fcbic.201600427" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=27504718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlSgtrbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=1925-1930&author=O.+Fadeyiauthor=M.+D.+Parikhauthor=M.+Z.+Chenauthor=R.+E.+Kyneauthor=A.+P.+Taylorauthor=I.+O%E2%80%99Dohertyauthor=S.+E.+Kaiserauthor=S.+Barbasauthor=S.+Niessenauthor=M.+Shiauthor=S.+L.+Weinrichauthor=J.+C.+Kathauthor=L.+H.+Jonesauthor=R.+P.+Robinson&title=Chemoselective+preparation+of+clickable+aryl+sulfonyl+fluoride+monomers%3A+a+toolbox+of+highly+functionalized+intermediates+for+chemical+biology+probe+synthesis&doi=10.1002%2Fcbic.201600427"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Chemoselective Preparation of "Clickable" Aryl Sulfonyl Fluoride Monomers:A Toolbox of Highly Functionalized Intermediates for Chemical Biology Probe Synthesis</span></div><div class="casAuthors">Fadeyi, Olugbeminiyi; Parikh, Mihir; Chen, Ming; Kyne, Robert, Jr.; Taylor, Alexandria; O'Doherty, Inish; Kaiser, Stephen; Barbas, Sabrina; Niessen, Sherry; Shi, Manli; Weinrich, Scott L.; Kath, John; Jones, Lyn; Robinson, Ralph Pelton</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">1925-1930</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Sulfonyl fluoride (SF)-based activity probes have become important tools in chem. biol.  Herein, exploiting the relative chem. stability of SF to carry out a no. of unprecedented SF-sparing functional group manipulations, we report the chemoselective synthesis of a toolbox of highly functionalized aryl SF monomers that we have used to quickly prep. SF chem. biol. probes.  In addn. to SF, the monomers bear an embedded click handle (a terminal alkyne that can perform copper(I)-mediated azide alkyne cycloaddn.).  The monomers can be used either as fragments to prep. clickable SF analogs of drugs (biol. active compds.) bearing an aryl ring or, alternatively, attached to drugs as "minimalist" clickable aryl SF substituents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1JOeVX049cbVg90H21EOLACvtfcHk0lheNYv9tuyg8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlSgtrbF&md5=e22b5d1593713c1a5547d02b9c25db20</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201600427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201600427%26sid%3Dliteratum%253Aachs%26aulast%3DFadeyi%26aufirst%3DO.%26aulast%3DParikh%26aufirst%3DM.%2BD.%26aulast%3DChen%26aufirst%3DM.%2BZ.%26aulast%3DKyne%26aufirst%3DR.%2BE.%26aulast%3DTaylor%26aufirst%3DA.%2BP.%26aulast%3DO%25E2%2580%2599Doherty%26aufirst%3DI.%26aulast%3DKaiser%26aufirst%3DS.%2BE.%26aulast%3DBarbas%26aufirst%3DS.%26aulast%3DNiessen%26aufirst%3DS.%26aulast%3DShi%26aufirst%3DM.%26aulast%3DWeinrich%26aufirst%3DS.%2BL.%26aulast%3DKath%26aufirst%3DJ.%2BC.%26aulast%3DJones%26aufirst%3DL.%2BH.%26aulast%3DRobinson%26aufirst%3DR.%2BP.%26atitle%3DChemoselective%2520preparation%2520of%2520clickable%2520aryl%2520sulfonyl%2520fluoride%2520monomers%253A%2520a%2520toolbox%2520of%2520highly%2520functionalized%2520intermediates%2520for%2520chemical%2520biology%2520probe%2520synthesis%26jtitle%3DChemBioChem%26date%3D2016%26volume%3D17%26spage%3D1925%26epage%3D1930%26doi%3D10.1002%2Fcbic.201600427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geurink, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Linden, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirabella, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallastegui, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Bruin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blom, A. E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voges, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mock, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florea, B. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Marel, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Driessen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der
Stelt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groll, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overkleeft, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kisselev, A. F.</span></span> <span> </span><span class="NLM_article-title">Incorporation of non-natural amino acids improves cell permeability and potency of specific inhibitors of proteasome trypsin-like sites</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">1262</span>– <span class="NLM_lpage">1275</span>, <span class="refDoi"> DOI: 10.1021/jm3016987</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3016987" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=1%3ACAS%3A528%3ADC%252BC3sXns1elsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1262-1275&author=P.+P.+Geurinkauthor=W.+A.+van+der+Lindenauthor=A.+C.+Mirabellaauthor=N.+Gallasteguiauthor=G.+de+Bruinauthor=A.+E.+M.+Blomauthor=M.+J.+Vogesauthor=E.+D.+Mockauthor=B.+I.+Floreaauthor=G.+A.+van+der+Marelauthor=C.+Driessenauthor=M.+van+der%0ASteltauthor=M.+Grollauthor=H.+S.+Overkleeftauthor=A.+F.+Kisselev&title=Incorporation+of+non-natural+amino+acids+improves+cell+permeability+and+potency+of+specific+inhibitors+of+proteasome+trypsin-like+sites&doi=10.1021%2Fjm3016987"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Incorporation of non-natural amino acids improves cell permeability and potency of specific inhibitors of proteasome trypsin-like sites</span></div><div class="casAuthors">Geurink, Paul P.; van der Linden, Wouter A.; Mirabella, Anne C.; Gallastegui, Nerea; de Bruin, Gerjan; Blom, Annet E. M.; Voges, Mathias J.; Mock, Elliot D.; Florea, Bogdan I.; van der Marel, Gijs A.; Driessen, Christoph; van der Stelt, Mario; Groll, Michael; Overkleeft, Herman S.; Kisselev, Alexei F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1262-1275</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Proteasomes degrade the majority of proteins in mammalian cells by a concerted action of three distinct pairs of active sites.  The chymotrypsin-like sites are targets of antimyeloma agents bortezomib and carfilzomib.  Inhibitors of the trypsin-like site sensitize multiple myeloma cells to these agents.  Here we describe systematic effort to develop inhibitors with improved potency and cell permeability, yielding azido-Phe-Leu-Leu-4-aminomethyl-Phe-Me vinyl sulfone (I), LU-102, and a fluorescent activity-based probe for this site.  X-ray structures of I and related inhibitors complexed with yeast proteasomes revealed the structural basis for specificity.  Nontoxic to myeloma cells when used as a single agent, I sensitized them to bortezomib and carfilzomib.  This sensitizing effect was much stronger than the synergistic effects of histone acetylase inhibitors or additive effects of doxorubicin and dexamethasone, raising the possibility that combinations of inhibitors of the trypsin-like site with bortezomib or carfilzomib would have stronger antineoplastic activity than combinations currently used clin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxViO9vvFJBrVg90H21EOLACvtfcHk0lg2pNWG8Z16IA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXns1elsQ%253D%253D&md5=e33ffb2dfb4b09bb9342cd0b63d31add</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm3016987&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3016987%26sid%3Dliteratum%253Aachs%26aulast%3DGeurink%26aufirst%3DP.%2BP.%26aulast%3Dvan%2Bder%2BLinden%26aufirst%3DW.%2BA.%26aulast%3DMirabella%26aufirst%3DA.%2BC.%26aulast%3DGallastegui%26aufirst%3DN.%26aulast%3Dde%2BBruin%26aufirst%3DG.%26aulast%3DBlom%26aufirst%3DA.%2BE.%2BM.%26aulast%3DVoges%26aufirst%3DM.%2BJ.%26aulast%3DMock%26aufirst%3DE.%2BD.%26aulast%3DFlorea%26aufirst%3DB.%2BI.%26aulast%3Dvan%2Bder%2BMarel%26aufirst%3DG.%2BA.%26aulast%3DDriessen%26aufirst%3DC.%26aulast%3Dvan%2Bder%2BStelt%26aufirst%3DM.%26aulast%3DGroll%26aufirst%3DM.%26aulast%3DOverkleeft%26aufirst%3DH.%2BS.%26aulast%3DKisselev%26aufirst%3DA.%2BF.%26atitle%3DIncorporation%2520of%2520non-natural%2520amino%2520acids%2520improves%2520cell%2520permeability%2520and%2520potency%2520of%2520specific%2520inhibitors%2520of%2520proteasome%2520trypsin-like%2520sites%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D1262%26epage%3D1275%26doi%3D10.1021%2Fjm3016987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brouwer, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrero Álvarez, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciaffoni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van de Langemheen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liskamp, R. M. J.</span></span> <span> </span><span class="NLM_article-title">Proteasome inhibition by new dual warhead containing peptido vinyl sulfonyl fluorides</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3429</span>– <span class="NLM_lpage">3435</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.05.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=10.1016%2Fj.bmc.2016.05.042" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=3429-3435&author=A.+J.+Brouwerauthor=N.+Herrero+%C3%81lvarezauthor=A.+Ciaffoniauthor=H.+van+de+Langemheenauthor=R.+M.+J.+Liskamp&title=Proteasome+inhibition+by+new+dual+warhead+containing+peptido+vinyl+sulfonyl+fluorides&doi=10.1016%2Fj.bmc.2016.05.042"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.05.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.05.042%26sid%3Dliteratum%253Aachs%26aulast%3DBrouwer%26aufirst%3DA.%2BJ.%26aulast%3DHerrero%2B%25C3%2581lvarez%26aufirst%3DN.%26aulast%3DCiaffoni%26aufirst%3DA.%26aulast%3Dvan%2Bde%2BLangemheen%26aufirst%3DH.%26aulast%3DLiskamp%26aufirst%3DR.%2BM.%2BJ.%26atitle%3DProteasome%2520inhibition%2520by%2520new%2520dual%2520warhead%2520containing%2520peptido%2520vinyl%2520sulfonyl%2520fluorides%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D3429%26epage%3D3435%26doi%3D10.1016%2Fj.bmc.2016.05.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gilfillan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artschwager, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harkiss, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liskamp, R. M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis of pyrazole containing α-amino acids <i>via</i> a highly regio-selective condensation/aza-Michael reaction of β-aryl α,β-unsaturated ketones</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">4514</span>– <span class="NLM_lpage">4523</span>, <span class="refDoi"> DOI: 10.1039/C5OB00364D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=10.1039%2FC5OB00364D" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2015&pages=4514-4523&author=L.+Gilfillanauthor=R.+Artschwagerauthor=A.+H.+Harkissauthor=R.+M.+J.+Liskampauthor=A.+Sutherland&title=Synthesis+of+pyrazole+containing+%CE%B1-amino+acids+via+a+highly+regio-selective+condensation%2Faza-Michael+reaction+of+%CE%B2-aryl+%CE%B1%2C%CE%B2-unsaturated+ketones&doi=10.1039%2FC5OB00364D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1039%2FC5OB00364D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5OB00364D%26sid%3Dliteratum%253Aachs%26aulast%3DGilfillan%26aufirst%3DL.%26aulast%3DArtschwager%26aufirst%3DR.%26aulast%3DHarkiss%26aufirst%3DA.%2BH.%26aulast%3DLiskamp%26aufirst%3DR.%2BM.%2BJ.%26aulast%3DSutherland%26aufirst%3DA.%26atitle%3DSynthesis%2520of%2520pyrazole%2520containing%2520%25CE%25B1-amino%2520acids%2520via%2520a%2520highly%2520regio-selective%2520condensation%252Faza-Michael%2520reaction%2520of%2520%25CE%25B2-aryl%2520%25CE%25B1%252C%25CE%25B2-unsaturated%2520ketones%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2015%26volume%3D13%26spage%3D4514%26epage%3D4523%26doi%3D10.1039%2FC5OB00364D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goddard-Borger, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stick, R. V.</span></span> <span> </span><span class="NLM_article-title">An efficient, inexpensive, and shelf-stable diazotransfer reagent: imidazole-1-sulfonyl azide hydrochloride</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">3797</span>– <span class="NLM_lpage">800</span>, <span class="refDoi"> DOI: 10.1021/ol701581g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol701581g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsVeltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=3797-800&issue=19&author=E.+D.+Goddard-Borgerauthor=R.+V.+Stick&title=An+efficient%2C+inexpensive%2C+and+shelf-stable+diazotransfer+reagent%3A+imidazole-1-sulfonyl+azide+hydrochloride&doi=10.1021%2Fol701581g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">An Efficient, Inexpensive, and Shelf-Stable Diazotransfer Reagent: Imidazole-1-sulfonyl Azide Hydrochloride</span></div><div class="casAuthors">Goddard-Borger, Ethan D.; Stick, Robert V.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3797-3800</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The design and synthesis of a new diazotransfer reagent, imidazole-1-sulfonyl azide hydrochloride, are reported.  This reagent has proven to equal triflyl azide in its ability to act as a "diazo donor" in the conversion of both primary amines into azides and activated methylene substrates into diazo compds.  Crucially, this reagent can be prepd. in a one-pot reaction on a large scale from inexpensive materials, is shelf-stable, and is conveniently cryst.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp47A7S4vCoO7Vg90H21EOLACvtfcHk0liKGB7yZk0HSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsVeltro%253D&md5=f664d543b21303c0101ddedd9cc37744</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fol701581g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol701581g%26sid%3Dliteratum%253Aachs%26aulast%3DGoddard-Borger%26aufirst%3DE.%2BD.%26aulast%3DStick%26aufirst%3DR.%2BV.%26atitle%3DAn%2520efficient%252C%2520inexpensive%252C%2520and%2520shelf-stable%2520diazotransfer%2520reagent%253A%2520imidazole-1-sulfonyl%2520azide%2520hydrochloride%26jtitle%3DOrg.%2520Lett.%26date%3D2007%26volume%3D9%26issue%3D19%26spage%3D3797%26epage%3D800%26doi%3D10.1021%2Fol701581g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kirk, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, M. A.</span></span> <span> </span><span class="NLM_article-title">D-homo-steroids. Part III. The preparation of D-homoandrostane derivatives: a study of the reactions of steroidal C(17)-spiro-oxirans and their derivatives</span>. <i>J. Chem. Soc. C</i> <span class="NLM_year" style="font-weight: bold;">1971</span>,  <span class="NLM_fpage">414</span>, <span class="refDoi"> DOI: 10.1039/j39710000414</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=10.1039%2Fj39710000414" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=1%3ACAS%3A528%3ADyaE3MXhtFahu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1971&pages=414&author=D.+N.+Kirkauthor=M.+A.+Wilson&title=D-homo-steroids.+Part+III.+The+preparation+of+D-homoandrostane+derivatives%3A+a+study+of+the+reactions+of+steroidal+C%2817%29-spiro-oxirans+and+their+derivatives&doi=10.1039%2Fj39710000414"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">D-Homo steroids.  III.  Preparation of D-homoandrostane derivatives: reactions of steroidal C 17 spirooxiranes and their derivatives</span></div><div class="casAuthors">Kirk, David N.; Wilson, Malcolm Alan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Chemical Society [Section] C:  Organic</span>
        (<span class="NLM_cas:date">1971</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">414-24</span>CODEN:
                <span class="NLM_cas:coden">JSOOAX</span>;
        ISSN:<span class="NLM_cas:issn">0022-4952</span>.
    </div><div class="casAbstract">In HCONMe2-B(OH)3, epoxides react with azide ions to give hydroxy azides, which are reduced by Zn dust or Cr(II) to amine salts in acid media.  C-17 spirooxiranes (e.g. I) by these reactions gave hydroxy amines which were converted to D-homosteroids (e.g. II, R1 = O, R2 = H2; R1 = H2, R2 = O) by HNO2.  The ketone mixt. (III, R1 = O, R2 = H2, R3 = β-OH,H; R1 = H2, R2 = O, R3 = β-OH,H) was prepd. similarly and reduced (Huang-Minlon), and the product oxidized to D-homo-5α-androstan-7-one (III, R1 = R2 = H2, R3 = O).  Also prepd. was D-homodehydroepiandrosterone.  I with guanidine gave an iminospirooxazolidinone (IV); I with benzylamine gave 20-(benzylamino)-21-nor-17α-pregn-5-ene-3β,-17β-diol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBbXWWbjIL4rVg90H21EOLACvtfcHk0ljpDmAv_frKVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3MXhtFahu78%253D&md5=8ef253bef91d9e4993c498deb55e9494</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1039%2Fj39710000414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fj39710000414%26sid%3Dliteratum%253Aachs%26aulast%3DKirk%26aufirst%3DD.%2BN.%26aulast%3DWilson%26aufirst%3DM.%2BA.%26atitle%3DD-homo-steroids.%2520Part%2520III.%2520The%2520preparation%2520of%2520D-homoandrostane%2520derivatives%253A%2520a%2520study%2520of%2520the%2520reactions%2520of%2520steroidal%2520C%252817%2529-spiro-oxirans%2520and%2520their%2520derivatives%26jtitle%3DJ.%2520Chem.%2520Soc.%2520C%26date%3D1971%26spage%3D414%26doi%3D10.1039%2Fj39710000414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">El-Faham, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al Marhoon, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Megeed, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albericio, F.</span></span> <span> </span><span class="NLM_article-title">OxymaPure/DIC: An efficient reagent for the synthesis of a novel Series of 4-[2-(2-acetylaminophenyl)-2-oxo-acetylamino] benzoyl amino acid ester derivatives</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">14747</span>– <span class="NLM_lpage">14759</span>, <span class="refDoi"> DOI: 10.3390/molecules181214747</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=10.3390%2Fmolecules181214747" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=14747-14759&author=A.+El-Fahamauthor=Z.+Al+Marhoonauthor=A.+Abdel-Megeedauthor=F.+Albericio&title=OxymaPure%2FDIC%3A+An+efficient+reagent+for+the+synthesis+of+a+novel+Series+of+4-%5B2-%282-acetylaminophenyl%29-2-oxo-acetylamino%5D+benzoyl+amino+acid+ester+derivatives&doi=10.3390%2Fmolecules181214747"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.3390%2Fmolecules181214747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules181214747%26sid%3Dliteratum%253Aachs%26aulast%3DEl-Faham%26aufirst%3DA.%26aulast%3DAl%2BMarhoon%26aufirst%3DZ.%26aulast%3DAbdel-Megeed%26aufirst%3DA.%26aulast%3DAlbericio%26aufirst%3DF.%26atitle%3DOxymaPure%252FDIC%253A%2520An%2520efficient%2520reagent%2520for%2520the%2520synthesis%2520of%2520a%2520novel%2520Series%2520of%25204-%255B2-%25282-acetylaminophenyl%2529-2-oxo-acetylamino%255D%2520benzoyl%2520amino%2520acid%2520ester%2520derivatives%26jtitle%3DMolecules%26date%3D2013%26volume%3D18%26spage%3D14747%26epage%3D14759%26doi%3D10.3390%2Fmolecules181214747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">El-Faham, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albericio, F.</span></span> <span> </span><span class="NLM_article-title">Peptide coupling reagents, more than a letter soup</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">6557</span>– <span class="NLM_lpage">6602</span>, <span class="refDoi"> DOI: 10.1021/cr100048w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr100048w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVyhu7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2011&pages=6557-6602&author=A.+El-Fahamauthor=F.+Albericio&title=Peptide+coupling+reagents%2C+more+than+a+letter+soup&doi=10.1021%2Fcr100048w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide Coupling Reagents, More than a Letter Soup</span></div><div class="casAuthors">El-Faham, Ayman; Albericio, Fernando</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">6557-6602</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The prepn. and uses of carbodiimides, anhydrides (sym. and mixed), active esters, acylazoles, acyl azides, acid halides, acid fluorides, phosphonium salts, aminium/uronium salts, organophosphorus compds., organosulfur compds., triazine reagents, pyridinium reagents, polymer-supported reagents as coupling reagents in peptide synthesis are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9DDv3PT7yrLVg90H21EOLACvtfcHk0ljuLTxS9q3wuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVyhu7zO&md5=461d8c78dffcbf16a390fc78abd33cac</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fcr100048w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr100048w%26sid%3Dliteratum%253Aachs%26aulast%3DEl-Faham%26aufirst%3DA.%26aulast%3DAlbericio%26aufirst%3DF.%26atitle%3DPeptide%2520coupling%2520reagents%252C%2520more%2520than%2520a%2520letter%2520soup%26jtitle%3DChem.%2520Rev.%26date%3D2011%26volume%3D111%26spage%3D6557%26epage%3D6602%26doi%3D10.1021%2Fcr100048w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="note"><p class="first last">Several transformations (e.g., oxidation, reduction, hydrolysis, etc.) can be carried out in the presence of an aromatic SF moiety, which is indicative of the difference in stability of aliphatic and aromatic SFs.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="note"><p class="first last">Recently it was found in peptidovinyl sulfonyl fluorides (PVSFs) that although a PVSF may be more reactive than a peptidosulfonyl fluoride (PSF), the sulfonyl fluoride warhead part may occupy a less favorable P<sub>1</sub>′ position because it is further positioned from the P<sub>1</sub> side chain, leading to a reduced inhibition.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="note"><p class="first last">There was no specific reason for synthesis of one tripeptide on the solid phase and the other tripeptide in solution. Either method can be used for both tripeptides.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="note"><p class="first last">The final deprotection step was removal of the side-chain Cbz-protecting group of the amino protected sulfonyl fluoride, which also would remove any terminal Cbz-protecting group.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14a','cit14b'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':[],'ref27':[],'ref28':[],'ref29':[]}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 17 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Shuheng Xu, <span class="NLM_string-name hlFld-ContribAuthor">Sunliang Cui</span>. </span><span class="cited-content_cbyCitation_article-title">SuFExable Isocyanides for Ugi Reaction: Synthesis of Sulfonyl Fluoro Peptides. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021,</strong> <em>23 </em>
                                    (13)
                                     , 5197-5202. <a href="https://doi.org/10.1021/acs.orglett.1c01734" title="DOI URL">https://doi.org/10.1021/acs.orglett.1c01734</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.1c01734&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.1c01734%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DSuFExable%252BIsocyanides%252Bfor%252BUgi%252BReaction%25253A%252BSynthesis%252Bof%252BSulfonyl%252BFluoro%252BPeptides%26aulast%3DXu%26aufirst%3DShuheng%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D23052021%26date%3D22062021%26volume%3D23%26issue%3D13%26spage%3D5197%26epage%3D5202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dong-yu Zhu, Xue-jing Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Ming Yan</span>. </span><span class="cited-content_cbyCitation_article-title">Enantioselective Addition of Azlactones to Ethylene Sulfonyl Fluoride via Dual Catalysis. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021,</strong> <em>23 </em>
                                    (11)
                                     , 4228-4232. <a href="https://doi.org/10.1021/acs.orglett.1c01193" title="DOI URL">https://doi.org/10.1021/acs.orglett.1c01193</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.1c01193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.1c01193%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DEnantioselective%252BAddition%252Bof%252BAzlactones%252Bto%252BEthylene%252BSulfonyl%252BFluoride%252Bvia%252BDual%252BCatalysis%26aulast%3DZhu%26aufirst%3DDong-yu%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D07042021%26date%3D24052021%26volume%3D23%26issue%3D11%26spage%3D4228%26epage%3D4232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jie Chen, Bao-qin Huang, Zeng-qing Wang, Xue-jing Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Ming Yan</span>. </span><span class="cited-content_cbyCitation_article-title">Asymmetric Conjugate Addition of Ethylene Sulfonyl Fluorides to 3-Amido-2-oxindoles: Synthesis of Chiral Spirocyclic Oxindole Sultams. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (23)
                                     , 9742-9746. <a href="https://doi.org/10.1021/acs.orglett.9b03911" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b03911</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b03911&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b03911%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DAsymmetric%252BConjugate%252BAddition%252Bof%252BEthylene%252BSulfonyl%252BFluorides%252Bto%252B3-Amido-2-oxindoles%25253A%252BSynthesis%252Bof%252BChiral%252BSpirocyclic%252BOxindole%252BSultams%26aulast%3DChen%26aufirst%3DJie%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D01112019%26date%3D14112019%26volume%3D21%26issue%3D23%26spage%3D9742%26epage%3D9746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Gaochan Wu, Tong Zhao, Dongwei Kang, Jian Zhang, Yuning Song, Vigneshwaran Namasivayam, Jacob Kongsted, Christophe Pannecouque, Erik De Clercq, Vasanthanathan Poongavanam, Xinyong Liu, <span class="NLM_string-name hlFld-ContribAuthor">Peng Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Overview of Recent Strategic Advances in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (21)
                                     , 9375-9414. <a href="https://doi.org/10.1021/acs.jmedchem.9b00359" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00359</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00359%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOverview%252Bof%252BRecent%252BStrategic%252BAdvances%252Bin%252BMedicinal%252BChemistry%26aulast%3DWu%26aufirst%3DGaochan%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D26022019%26date%3D28052019%26date%3D03052019%26volume%3D62%26issue%3D21%26spage%3D9375%26epage%3D9414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Bo-Tao Xin, Eva M. Huber, Gerjan de Bruin, Wolfgang Heinemeyer, Elmer Maurits, Christofer Espinal, Yimeng Du, Marissa Janssens, Emily S. Weyburne, Alexei F. Kisselev, Bogdan I. Florea, Christoph Driessen, Gijsbert A. van der Marel, Michael Groll, <span class="NLM_string-name hlFld-ContribAuthor">Herman S. Overkleeft</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design of Inhibitors Selective for Human Proteasome β2c or β2i Subunits. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (3)
                                     , 1626-1642. <a href="https://doi.org/10.1021/acs.jmedchem.8b01884" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01884</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01884%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDesign%252Bof%252BInhibitors%252BSelective%252Bfor%252BHuman%252BProteasome%252B%2525CE%2525B22c%252Bor%252B%2525CE%2525B22i%252BSubunits%26aulast%3DXin%26aufirst%3DBo-Tao%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D30112018%26date%3D05022019%26date%3D18012019%26volume%3D62%26issue%3D3%26spage%3D1626%26epage%3D1642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tao  Zhong</span>, <span class="hlFld-ContribAuthor ">Ji-Tao  Yi</span>, <span class="hlFld-ContribAuthor ">Zhi-Da  Chen</span>, <span class="hlFld-ContribAuthor ">Quan-Can  Zhuang</span>, <span class="hlFld-ContribAuthor ">Yong-Zhao  Li</span>, <span class="hlFld-ContribAuthor ">Gui  Lu</span>, <span class="hlFld-ContribAuthor ">Jiang  Weng</span>. </span><span class="cited-content_cbyCitation_article-title">Photoredox-catalyzed aminofluorosulfonylation of unactivated olefins. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2021,</strong> <em>12 </em>
                                    (27)
                                     , 9359-9365. <a href="https://doi.org/10.1039/D1SC02503A" title="DOI URL">https://doi.org/10.1039/D1SC02503A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1SC02503A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1SC02503A%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DPhotoredox-catalyzed%252Baminofluorosulfonylation%252Bof%252Bunactivated%252Bolefins%26aulast%3DZhong%26aufirst%3DTao%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D27%26spage%3D9359%26epage%3D9365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabian H.  Knaup</span>, <span class="hlFld-ContribAuthor ">Christian  Meyners</span>, <span class="hlFld-ContribAuthor ">Anna  Charalampidou</span>, <span class="hlFld-ContribAuthor ">Patryk  Krajczy</span>, <span class="hlFld-ContribAuthor ">Patrick L.  Purder</span>, <span class="hlFld-ContribAuthor ">Tatjana  Ross</span>, <span class="hlFld-ContribAuthor ">Felix  Hausch</span>. </span><span class="cited-content_cbyCitation_article-title">Med Chem Remote: The Frontiers in Medicinal Chemistry 2021. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>157 </em><a href="https://doi.org/10.1002/cmdc.202100355" title="DOI URL">https://doi.org/10.1002/cmdc.202100355</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202100355&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202100355%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DMed%252BChem%252BRemote%25253A%252BThe%252BFrontiers%252Bin%252BMedicinal%252BChemistry%252B2021%26aulast%3DKnaup%26aufirst%3DFabian%2BH.%26date%3D2021%26date%3D2021%26volume%3D157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi-Nan  Li</span>, <span class="hlFld-ContribAuthor ">Xin  Chang</span>, <span class="hlFld-ContribAuthor ">Qi  Xiong</span>, <span class="hlFld-ContribAuthor ">Xiu-Qin  Dong</span>, <span class="hlFld-ContribAuthor ">Chun-Jiang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Cu-catalyzed endo-selective asymmetric 1,3-dipolar cycloaddition of azomethine ylides with ethenesulfonyl fluorides: efficient access to chiral pyrrolidine-3-sulfonyl fluorides. </span><span class="cited-content_cbyCitation_journal-name">Chinese Chemical Letters</span><span> <strong>2021,</strong> <em>25 </em><a href="https://doi.org/10.1016/j.cclet.2021.05.063" title="DOI URL">https://doi.org/10.1016/j.cclet.2021.05.063</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cclet.2021.05.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cclet.2021.05.063%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Chemical%2520Letters%26atitle%3DCu-catalyzed%252Bendo-selective%252Basymmetric%252B1%25252C3-dipolar%252Bcycloaddition%252Bof%252Bazomethine%252Bylides%252Bwith%252Bethenesulfonyl%252Bfluorides%25253A%252Befficient%252Baccess%252Bto%252Bchiral%252Bpyrrolidine-3-sulfonyl%252Bfluorides%26aulast%3DLi%26aufirst%3DYi-Nan%26date%3D2021%26volume%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hong-Ru  Chen</span>, <span class="hlFld-ContribAuthor ">Zhen-Yu  Hu</span>, <span class="hlFld-ContribAuthor ">Hua-Li  Qin</span>, <span class="hlFld-ContribAuthor ">Haolin  Tang</span>. </span><span class="cited-content_cbyCitation_article-title">A novel three-component reaction for constructing indolizine-containing aliphatic sulfonyl fluorides. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2021,</strong> <em>8 </em>
                                    (6)
                                     , 1185-1189. <a href="https://doi.org/10.1039/D0QO01430C" title="DOI URL">https://doi.org/10.1039/D0QO01430C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0QO01430C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0QO01430C%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DA%252Bnovel%252Bthree-component%252Breaction%252Bfor%252Bconstructing%252Bindolizine-containing%252Baliphatic%252Bsulfonyl%252Bfluorides%26aulast%3DChen%26aufirst%3DHong-Ru%26date%3D2021%26date%3D2021%26volume%3D8%26issue%3D6%26spage%3D1185%26epage%3D1189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xingliang  Nie</span>, <span class="hlFld-ContribAuthor ">Tianxiao  Xu</span>, <span class="hlFld-ContribAuthor ">Jinshuai  Song</span>, <span class="hlFld-ContribAuthor ">Anandkumar  Devaraj</span>, <span class="hlFld-ContribAuthor ">Bolun  Zhang</span>, <span class="hlFld-ContribAuthor ">Yong  Chen</span>, <span class="hlFld-ContribAuthor ">Saihu  Liao</span>. </span><span class="cited-content_cbyCitation_article-title">Radical Fluorosulfonylation: Accessing Alkenyl Sulfonyl Fluorides from Alkenes. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2021,</strong> <em>60 </em>
                                    (8)
                                     , 3956-3960. <a href="https://doi.org/10.1002/anie.202012229" title="DOI URL">https://doi.org/10.1002/anie.202012229</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.202012229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.202012229%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DRadical%252BFluorosulfonylation%25253A%252BAccessing%252BAlkenyl%252BSulfonyl%252BFluorides%252Bfrom%252BAlkenes%26aulast%3DNie%26aufirst%3DXingliang%26date%3D2021%26date%3D2020%26volume%3D60%26issue%3D8%26spage%3D3956%26epage%3D3960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xingliang  Nie</span>, <span class="hlFld-ContribAuthor ">Tianxiao  Xu</span>, <span class="hlFld-ContribAuthor ">Jinshuai  Song</span>, <span class="hlFld-ContribAuthor ">Anandkumar  Devaraj</span>, <span class="hlFld-ContribAuthor ">Bolun  Zhang</span>, <span class="hlFld-ContribAuthor ">Yong  Chen</span>, <span class="hlFld-ContribAuthor ">Saihu  Liao</span>. </span><span class="cited-content_cbyCitation_article-title">Radical Fluorosulfonylation: Accessing Alkenyl Sulfonyl Fluorides from Alkenes. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2021,</strong> <em>133 </em>
                                    (8)
                                     , 4002-4006. <a href="https://doi.org/10.1002/ange.202012229" title="DOI URL">https://doi.org/10.1002/ange.202012229</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.202012229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.202012229%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DRadical%252BFluorosulfonylation%25253A%252BAccessing%252BAlkenyl%252BSulfonyl%252BFluorides%252Bfrom%252BAlkenes%26aulast%3DNie%26aufirst%3DXingliang%26date%3D2021%26date%3D2020%26volume%3D133%26issue%3D8%26spage%3D4002%26epage%3D4006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xu  Zhang</span>, <span class="hlFld-ContribAuthor ">Wan‐Yin  Fang</span>, <span class="hlFld-ContribAuthor ">Ravindar  Lekkala</span>, <span class="hlFld-ContribAuthor ">Wenjian  Tang</span>, <span class="hlFld-ContribAuthor ">Hua‐Li  Qin</span>. </span><span class="cited-content_cbyCitation_article-title">An Easy, General and Practical Method for the Construction of Alkyl Sulfonyl Fluorides. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2020,</strong> <em>362 </em>
                                    (16)
                                     , 3358-3363. <a href="https://doi.org/10.1002/adsc.202000515" title="DOI URL">https://doi.org/10.1002/adsc.202000515</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.202000515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.202000515%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DAn%252BEasy%25252C%252BGeneral%252Band%252BPractical%252BMethod%252Bfor%252Bthe%252BConstruction%252Bof%252BAlkyl%252BSulfonyl%252BFluorides%26aulast%3DZhang%26aufirst%3DXu%26date%3D2020%26date%3D2020%26volume%3D362%26issue%3D16%26spage%3D3358%26epage%3D3363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nahlah  Ahmed Al-Hadhrami</span>, <span class="hlFld-ContribAuthor ">Angelique  Ladwig</span>, <span class="hlFld-ContribAuthor ">Adeyemi  Rahman</span>, <span class="hlFld-ContribAuthor ">Isabel  Rozas</span>, <span class="hlFld-ContribAuthor ">J.  Paul G. Malthouse</span>, <span class="hlFld-ContribAuthor ">Paul  Evans</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 2-guanidinyl pyridines and their trypsin inhibition and docking. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (16)
                                     , 115612. <a href="https://doi.org/10.1016/j.bmc.2020.115612" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115612</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115612&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115612%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Bof%252B2-guanidinyl%252Bpyridines%252Band%252Btheir%252Btrypsin%252Binhibition%252Band%252Bdocking%26aulast%3DAhmed%2BAl-Hadhrami%26aufirst%3DNahlah%26date%3D2020%26volume%3D28%26issue%3D16%26spage%3D115612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel  Stubba</span>, <span class="hlFld-ContribAuthor ">Dennis  Bensinger</span>, <span class="hlFld-ContribAuthor ">Janika  Steinbacher</span>, <span class="hlFld-ContribAuthor ">Lilia  Proskurjakov</span>, <span class="hlFld-ContribAuthor ">Álvaro  Salcedo Gómez</span>, <span class="hlFld-ContribAuthor ">Uwe  Schmidt</span>, <span class="hlFld-ContribAuthor ">Stefan  Roth</span>, <span class="hlFld-ContribAuthor ">Katja  Schmitz</span>, <span class="hlFld-ContribAuthor ">Boris  Schmidt</span>. </span><span class="cited-content_cbyCitation_article-title">Cell‐Based Optimization of Covalent Reversible Ketoamide Inhibitors Bridging the Unprimed to the Primed Site of the Proteasome β5 Subunit. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2019,</strong> <em>14 </em>
                                    (23)
                                     , 2005-2022. <a href="https://doi.org/10.1002/cmdc.201900472" title="DOI URL">https://doi.org/10.1002/cmdc.201900472</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201900472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201900472%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DCell%2525E2%252580%252590Based%252BOptimization%252Bof%252BCovalent%252BReversible%252BKetoamide%252BInhibitors%252BBridging%252Bthe%252BUnprimed%252Bto%252Bthe%252BPrimed%252BSite%252Bof%252Bthe%252BProteasome%252B%2525CE%2525B25%252BSubunit%26aulast%3DStubba%26aufirst%3DDaniel%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D23%26spage%3D2005%26epage%3D2022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ruting  Xu</span>, <span class="hlFld-ContribAuthor ">Tianxiao  Xu</span>, <span class="hlFld-ContribAuthor ">Mingcheng  Yang</span>, <span class="hlFld-ContribAuthor ">Tianpeng  Cao</span>, <span class="hlFld-ContribAuthor ">Saihu  Liao</span>. </span><span class="cited-content_cbyCitation_article-title">A rapid access to aliphatic sulfonyl fluorides. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2019,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-019-11805-6" title="DOI URL">https://doi.org/10.1038/s41467-019-11805-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-019-11805-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-019-11805-6%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DA%252Brapid%252Baccess%252Bto%252Baliphatic%252Bsulfonyl%252Bfluorides%26aulast%3DXu%26aufirst%3DRuting%26date%3D2019%26date%3D2019%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianjun  Xi</span>, <span class="hlFld-ContribAuthor ">Rangxiao  Zhuang</span>, <span class="hlFld-ContribAuthor ">Limin  Kong</span>, <span class="hlFld-ContribAuthor ">Ruoyu  He</span>, <span class="hlFld-ContribAuthor ">Huajian  Zhu</span>, <span class="hlFld-ContribAuthor ">Jiankang  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Immunoproteasome-selective inhibitors: An overview of recent developments as potential drugs for hematologic malignancies and autoimmune diseases. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>182 </em>, 111646. <a href="https://doi.org/10.1016/j.ejmech.2019.111646" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111646</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111646&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111646%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DImmunoproteasome-selective%252Binhibitors%25253A%252BAn%252Boverview%252Bof%252Brecent%252Bdevelopments%252Bas%252Bpotential%252Bdrugs%252Bfor%252Bhematologic%252Bmalignancies%252Band%252Bautoimmune%252Bdiseases%26aulast%3DXi%26aufirst%3DJianjun%26date%3D2019%26volume%3D182%26spage%3D111646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">D.J.  Ward</span>, <span class="hlFld-ContribAuthor ">H.  Van de Langemheen</span>, <span class="hlFld-ContribAuthor ">E.  Koehne</span>, <span class="hlFld-ContribAuthor ">A.  Kreidenweiss</span>, <span class="hlFld-ContribAuthor ">R.M.J.  Liskamp</span>. </span><span class="cited-content_cbyCitation_article-title">Highly tunable thiosulfonates as a novel class of cysteine protease inhibitors with anti-parasitic activity against Schistosoma mansoni. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (13)
                                     , 2857-2870. <a href="https://doi.org/10.1016/j.bmc.2019.05.014" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.05.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.05.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.05.014%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DHighly%252Btunable%252Bthiosulfonates%252Bas%252Ba%252Bnovel%252Bclass%252Bof%252Bcysteine%252Bprotease%252Binhibitors%252Bwith%252Banti-parasitic%252Bactivity%252Bagainst%252BSchistosoma%252Bmansoni%26aulast%3DWard%26aufirst%3DD.J.%26date%3D2019%26volume%3D27%26issue%3D13%26spage%3D2857%26epage%3D2870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/medium/jm-2018-00685m_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/large/jm-2018-00685m_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00685&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/medium/jm-2018-00685m_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/large/jm-2018-00685m_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of bortezomib (<b>1</b>), carfilzomib (<b>2</b>), LU-102 (<b>3</b>), Cbz-Leu<sub>4</sub>-SF (<b>4</b>), β5i immunoproteasome selective PSF (<b>5</b>), and N<sub>3</sub>-Phe-Leu<sub>3</sub>-SF (<b>6</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/large/jm-2018-00685m_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00685&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/medium/jm-2018-00685m_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/large/jm-2018-00685m_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Basic side chain containing amino acid derived SFs <b>7</b>–<b>10</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/large/jm-2018-00685m_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00685&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/medium/jm-2018-00685m_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/large/jm-2018-00685m_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Arginine Derived Sulfonyl Fluoride (<b>7</b>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/large/jm-2018-00685m_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00685&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/medium/jm-2018-00685m_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/large/jm-2018-00685m_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Syntheses of Azido Precursor Amino Acids <b>19</b>, <b>22</b>, and <b>27</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/large/jm-2018-00685m_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00685&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/medium/jm-2018-00685m_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/large/jm-2018-00685m_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Completion of the Synthesis of Basic Side Chain Containing Amino Acid Derived SFs <b>8</b>–<b>10</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/large/jm-2018-00685m_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00685&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/medium/jm-2018-00685m_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/large/jm-2018-00685m_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Syntheses of the Peptides Necessary for Incorporation of the Amino Acid Derived SFs</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/large/jm-2018-00685m_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00685&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/medium/jm-2018-00685m_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/large/jm-2018-00685m_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of the Peptide Sulfonyl Fluorides (PSFs) and Overview of the Structures of the Inhibitors<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/large/jm-2018-00685m_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00685&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>All amino and guanidine functionalities are protonated.</p></p></figure><figure data-id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/medium/jm-2018-00685m_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/large/jm-2018-00685m_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. In vitro evaluation of PSFs using human constitutive 20S proteasome. Fluorogenic substrates were selective for the respective trypsin-like (Bz-VGR-AMC) or chymotrypsin-like (Suc-LLVY-AMC) subunit. Top: Arginine derived PSFs. Bottom: Lysine, aminophenylalanine and 4-aminomethylphenylalanine derived PSF. Left: Trypsin-like residual enzyme activity. Right: Chymotrypsin-like residual enzyme activity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/large/jm-2018-00685m_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00685&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/medium/jm-2018-00685m_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/large/jm-2018-00685m_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. In vitro evaluation of PSFs using human immuno 20S proteasome. Fluorogenic substrates were selective for the respective trypsin-like (Bz-VGR-AMC) or chymotrypsin-like (Suc-LLVY-AMC) subunit. Top: Arginine derived PSFs. Bottom: Lysine, aminophenylalanine and 4-aminomethylphenylalanine derived PSF. Left: Trypsin-like residual enzyme activity. Right: Chymotrypsin-like residual enzyme activity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/large/jm-2018-00685m_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00685&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/medium/jm-2018-00685m_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/large/jm-2018-00685m_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. PBS buffer stability test at pH 6.5, 7.4, and 8.0. Hydrolysis of selected PSFs was measured via analytical HPLC over 12 h.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00685/20180622/images/large/jm-2018-00685m_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00685&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i54">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62265" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62265" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 29 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weissman, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shabek, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciechanover, A.</span></span> <span> </span><span class="NLM_article-title">The predator becomes the prey: regulating the ubiquitin system by ubiquitylation and degradation</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">605</span>– <span class="NLM_lpage">620</span>, <span class="refDoi"> DOI: 10.1038/nrm3173</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=10.1038%2Fnrm3173" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=21860393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVGlu7fO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=605-620&author=A.+M.+Weissmanauthor=N.+Shabekauthor=A.+Ciechanover&title=The+predator+becomes+the+prey%3A+regulating+the+ubiquitin+system+by+ubiquitylation+and+degradation&doi=10.1038%2Fnrm3173"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The predator becomes the prey: regulating the ubiquitin system by ubiquitylation and degradation</span></div><div class="casAuthors">Weissman, Allan M.; Shabek, Nitzan; Ciechanover, Aaron</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">605-620</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Ubiquitination regulates essentially all of the intracellular processes in eukaryotes through highly specific modification of numerous cellular proteins, which is often tightly regulated in a spatial and temporal manner.  Although most often assocd. with proteasomal degrdn., ubiquitination frequently serves non-proteolytic functions.  In light of its central roles in cellular regulation, it has not been surprising to find that many of the components of the ubiquitin system itself are regulated by ubiquitination.  This observation has broad implications for pathophysiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGEQ3hfu3FRbVg90H21EOLACvtfcHk0lj90b9NtKtcIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVGlu7fO&md5=56c961541e0de728154db71ff2797e41</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrm3173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm3173%26sid%3Dliteratum%253Aachs%26aulast%3DWeissman%26aufirst%3DA.%2BM.%26aulast%3DShabek%26aufirst%3DN.%26aulast%3DCiechanover%26aufirst%3DA.%26atitle%3DThe%2520predator%2520becomes%2520the%2520prey%253A%2520regulating%2520the%2520ubiquitin%2520system%2520by%2520ubiquitylation%2520and%2520degradation%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2011%26volume%3D12%26spage%3D605%26epage%3D620%26doi%3D10.1038%2Fnrm3173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferrington, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregerson, D. S.</span></span> <span> </span><span class="NLM_article-title">Immunoproteasomes: Structure, function, and antigen presentation</span>. <i>Prog. Mol. Biol. Transl. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">75</span>– <span class="NLM_lpage">112</span>, <span class="refDoi"> DOI: 10.1016/B978-0-12-397863-9.00003-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=10.1016%2FB978-0-12-397863-9.00003-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=22727420" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsF2jtr7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=75-112&author=D.+A.+Ferringtonauthor=D.+S.+Gregerson&title=Immunoproteasomes%3A+Structure%2C+function%2C+and+antigen+presentation&doi=10.1016%2FB978-0-12-397863-9.00003-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Immunoproteasomes: structure, function, and antigen presentation</span></div><div class="casAuthors">Ferrington, Deborah A.; Gregerson, Dale S.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Molecular Biology and Translational Science</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">Proteasomal System in Aging and Disease</span>),
    <span class="NLM_cas:pages">75-112, 1 plate</span>CODEN:
                <span class="NLM_cas:coden">PNARC5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Immunoproteasomes contain replacements for the three catalytic subunits of std. proteasomes.  In most cells, oxidative stress and proinflammatory cytokines are stimuli that lead to elevated prodn. of immunoproteasomes.  Immune system cells, esp. antigen-presenting cells, express a higher basal level of immunoproteasomes.  A well-described function of immunoproteasomes is to generate peptides with a hydrophobic C terminus that can be processed to fit in the groove of MHC class I mols.  This display of peptides on the cell surface allows surveillance by CD8 T cells of the adaptive immune system for pathogen-infected cells.  Functions of immunoproteasomes, other than generating peptides for antigen presentation, are emerging from studies in immunoproteasome-deficient mice, and are complemented by recently described diseases linked to mutations or single-nucleotide polymorphisms in immunoproteasome subunits.  Thus, this growing body of literature suggests a more pleiotropic role in cell function for the immunoproteasome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB-ms47z5YWbVg90H21EOLACvtfcHk0lj90b9NtKtcIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsF2jtr7E&md5=dbddd6a20fe829739bb2acd037619376</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-397863-9.00003-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-397863-9.00003-1%26sid%3Dliteratum%253Aachs%26aulast%3DFerrington%26aufirst%3DD.%2BA.%26aulast%3DGregerson%26aufirst%3DD.%2BS.%26atitle%3DImmunoproteasomes%253A%2520Structure%252C%2520function%252C%2520and%2520antigen%2520presentation%26jtitle%3DProg.%2520Mol.%2520Biol.%2520Transl.%2520Sci.%26date%3D2012%26volume%3D109%26spage%3D75%26epage%3D112%26doi%3D10.1016%2FB978-0-12-397863-9.00003-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Groettrup, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirk, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basler, M.</span></span> <span> </span><span class="NLM_article-title">Proteasomes in immune cells: more than peptide producers?</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">73</span>– <span class="NLM_lpage">78</span>, <span class="refDoi"> DOI: 10.1038/nri2687</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=10.1038%2Fnri2687" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=20010787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFChtbnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=73-78&author=M.+Groettrupauthor=C.+J.+Kirkauthor=M.+Basler&title=Proteasomes+in+immune+cells%3A+more+than+peptide+producers%3F&doi=10.1038%2Fnri2687"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Proteasomes in immune cells: more than peptide producers?</span></div><div class="casAuthors">Groettrup, Marcus; Kirk, Christopher J.; Basler, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-78</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  When cells are stimulated with pro-inflammatory cytokines, most of their constitutively expressed proteasomes are replaced with immunoproteasomes, which increase the prodn. of peptides for presentation on MHC class I mols.  In addn., cortical thymic epithelial cells selectively express a type of proteasome known as the thymoproteasome that is required for the pos. selection of thymocytes.  Here, we discuss how these specialized types of proteasome shape the T cell receptor repertoire of cytotoxic T lymphocytes and propose that immunoproteasomes have functions, in addn. to antigen processing, that influence cytokine prodn. and T cell differentiation, survival and function.  We also discuss how inhibitors of immunoproteasomes can suppress undesired T cell responses in autoimmune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomQzel5QNbpbVg90H21EOLACvtfcHk0lj90b9NtKtcIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFChtbnI&md5=e11dedb3a06970299bc4c69b92edaf8a</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnri2687&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2687%26sid%3Dliteratum%253Aachs%26aulast%3DGroettrup%26aufirst%3DM.%26aulast%3DKirk%26aufirst%3DC.%2BJ.%26aulast%3DBasler%26aufirst%3DM.%26atitle%3DProteasomes%2520in%2520immune%2520cells%253A%2520more%2520than%2520peptide%2520producers%253F%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2010%26volume%3D10%26spage%3D73%26epage%3D78%26doi%3D10.1038%2Fnri2687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donoghue, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Linden, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foe, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tilley, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craik, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Fonseca, P. C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogyo, M.</span></span> <span> </span><span class="NLM_article-title">Structure- and function-based design of Plasmodium-selective proteasome inhibitors</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>530</i></span>,  <span class="NLM_fpage">233</span>– <span class="NLM_lpage">236</span>, <span class="refDoi"> DOI: 10.1038/nature16936</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=10.1038%2Fnature16936" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=26863983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=1%3ACAS%3A528%3ADC%252BC28XisVyrsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=530&publication_year=2016&pages=233-236&author=H.+Liauthor=A.+J.+O%E2%80%99Donoghueauthor=W.+A.+van+der+Lindenauthor=S.+C.+Xieauthor=E.+Yooauthor=I.+T.+Foeauthor=L.+Tilleyauthor=C.+S.+Craikauthor=P.+C.+A.+da+Fonsecaauthor=M.+Bogyo&title=Structure-+and+function-based+design+of+Plasmodium-selective+proteasome+inhibitors&doi=10.1038%2Fnature16936"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Structure- and function-based design of Plasmodium-selective proteasome inhibitors</span></div><div class="casAuthors">Li, Hao; O'Donoghue, Anthony J.; van der Linden, Wouter A.; Xie, Stanley C.; Yoo, Euna; Foe, Ian T.; Tilley, Leann; Craik, Charles S.; da Fonseca, Paula C. A.; Bogyo, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">530</span>
        (<span class="NLM_cas:issue">7589</span>),
    <span class="NLM_cas:pages">233-236</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The proteasome is a multi-component protease complex responsible for regulating key processes such as the cell cycle and antigen presentation.  Compds. that target the proteasome are potentially valuable tools for the treatment of pathogens that depend on proteasome function for survival and replication.  In particular, proteasome inhibitors have been shown to be toxic for the malaria parasite Plasmodium falciparum at all stages of its life cycle.  Most compds. that have been tested against the parasite also inhibit the mammalian proteasome, resulting in toxicity that precludes their use as therapeutic agents.  Therefore, better definition of the substrate specificity and structural properties of the Plasmodium proteasome could enable the development of compds. with sufficient selectivity to allow their use as anti-malarial agents.  To accomplish this goal, here the authors use a substrate profiling method to uncover differences in the specificities of the human and P. falciparum proteasome.  The authors design inhibitors based on amino-acid preferences specific to the parasite proteasome, and find that they preferentially inhibit the β2-subunit.  The authors det. the structure of the P. falciparum 20S proteasome bound to the inhibitor using cryo-electron microscopy and single-particle anal., to a resoln. of 3.6 Å.  These data reveal the unusually open P. falciparum β2 active site and provide valuable information about active-site architecture that can be used to further refine inhibitor design.  Furthermore, consistent with the recent finding that the proteasome is important for stress pathways assocd. with resistance of artemisinin family anti-malarials, the authors observe growth inhibition synergism with low doses of this β2-selective inhibitor in artemisinin-sensitive and -resistant parasites.  Finally, the authors demonstrate that a parasite-selective inhibitor could be used to attenuate parasite growth in vivo without appreciable toxicity to the host.  Thus, the Plasmodium proteasome is a chem. tractable target that could be exploited by next-generation anti-malarial agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriK0Li_WncVrVg90H21EOLACvtfcHk0liZKRFtIn9wlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisVyrsr8%253D&md5=f24a562efb64dd533a7dbcfeff4171af</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnature16936&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature16936%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26aulast%3DO%25E2%2580%2599Donoghue%26aufirst%3DA.%2BJ.%26aulast%3Dvan%2Bder%2BLinden%26aufirst%3DW.%2BA.%26aulast%3DXie%26aufirst%3DS.%2BC.%26aulast%3DYoo%26aufirst%3DE.%26aulast%3DFoe%26aufirst%3DI.%2BT.%26aulast%3DTilley%26aufirst%3DL.%26aulast%3DCraik%26aufirst%3DC.%2BS.%26aulast%3Dda%2BFonseca%26aufirst%3DP.%2BC.%2BA.%26aulast%3DBogyo%26aufirst%3DM.%26atitle%3DStructure-%2520and%2520function-based%2520design%2520of%2520Plasmodium-selective%2520proteasome%2520inhibitors%26jtitle%3DNature%26date%3D2016%26volume%3D530%26spage%3D233%26epage%3D236%26doi%3D10.1038%2Fnature16936" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guterman, L.</span></span> <span> </span><span class="NLM_article-title">Covalent drugs form long-lived ties</span>. <i>Chem. Eng. News</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>89</i></span> (<span class="NLM_issue">36</span>),  <span class="NLM_fpage">19</span>– <span class="NLM_lpage">26</span>, <span class="refDoi"> DOI: 10.1021/cen-v089n036.p019</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cen-v089n036.p019" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2011&pages=19-26&issue=36&author=L.+Guterman&title=Covalent+drugs+form+long-lived+ties&doi=10.1021%2Fcen-v089n036.p019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fcen-v089n036.p019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcen-v089n036.p019%26sid%3Dliteratum%253Aachs%26aulast%3DGuterman%26aufirst%3DL.%26atitle%3DCovalent%2520drugs%2520form%2520long-lived%2520ties%26jtitle%3DChem.%2520Eng.%2520News%26date%3D2011%26volume%3D89%26issue%3D36%26spage%3D19%26epage%3D26%26doi%3D10.1021%2Fcen-v089n036.p019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hideshima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K. C.</span></span> <span> </span><span class="NLM_article-title">Bortezomib (PS-341): A novel, first-in-class proteasome inhibitor for the treatment of multiple myeloma and other cancers</span>. <i>Cancer Control</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">361</span>– <span class="NLM_lpage">369</span>, <span class="refDoi"> DOI: 10.1177/107327480301000502</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=10.1177%2F107327480301000502" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=361-369&issue=5&author=P.+Richardsonauthor=T.+Hideshimaauthor=K.+C.+Anderson&title=Bortezomib+%28PS-341%29%3A+A+novel%2C+first-in-class+proteasome+inhibitor+for+the+treatment+of+multiple+myeloma+and+other+cancers&doi=10.1177%2F107327480301000502"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1177%2F107327480301000502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F107327480301000502%26sid%3Dliteratum%253Aachs%26aulast%3DRichardson%26aufirst%3DP.%26aulast%3DHideshima%26aufirst%3DT.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26atitle%3DBortezomib%2520%2528PS-341%2529%253A%2520A%2520novel%252C%2520first-in-class%2520proteasome%2520inhibitor%2520for%2520the%2520treatment%2520of%2520multiple%2520myeloma%2520and%2520other%2520cancers%26jtitle%3DCancer%2520Control%26date%3D2003%26volume%3D10%26issue%3D5%26spage%3D361%26epage%3D369%26doi%3D10.1177%2F107327480301000502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Demo, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirk, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aujay, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchholz, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dajee, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laidig, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parlati, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shenk, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smyth, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vallone, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woo, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molineaux, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, M. K.</span></span> <span> </span><span class="NLM_article-title">Antitumor activity of PR-171, a novel irreversible inhibitor of the proteasome</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>67</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">6383</span>– <span class="NLM_lpage">6391</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-06-4086</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=10.1158%2F0008-5472.CAN-06-4086" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=17616698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnsVyqtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=6383-6391&issue=13&author=S.+D.+Demoauthor=C.+J.+Kirkauthor=M.+A.+Aujayauthor=T.+J.+Buchholzauthor=M.+Dajeeauthor=M.+N.+Hoauthor=J.+Jiangauthor=G.+J.+Laidigauthor=E.+R.+Lewisauthor=F.+M.+Parlatiauthor=K.+D.+Shenkauthor=M.+S.+Smythauthor=C.+M.+Sunauthor=M.+K.+Valloneauthor=T.+M.+Wooauthor=C.+J.+Molineauxauthor=M.+K.+Bennett&title=Antitumor+activity+of+PR-171%2C+a+novel+irreversible+inhibitor+of+the+proteasome&doi=10.1158%2F0008-5472.CAN-06-4086"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Antitumor Activity of PR-171, a Novel Irreversible Inhibitor of the Proteasome</span></div><div class="casAuthors">Demo, Susan D.; Kirk, Christopher J.; Aujay, Monette A.; Buchholz, Tonia J.; Dajee, Maya; Ho, Mark N.; Jiang, Jing; Laidig, Guy J.; Lewis, Evan R.; Parlati, Francesco; Shenk, Kevin D.; Smyth, Mark S.; Sun, Congcong M.; Vallone, Marcy K.; Woo, Tina M.; Molineaux, Christopher J.; Bennett, Mark K.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6383-6391</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Clin. studies with bortezomib have validated the proteasome as a therapeutic target for the treatment of multiple myeloma and non-Hodgkin's lymphoma.  However, significant toxicities have restricted the intensity of bortezomib dosing.  Here we describe the antitumor activity of PR-171, a novel epoxyketone-based irreversible proteasome inhibitor that is currently in clin. development.  In comparison to bortezomib, PR-171 exhibits equal potency but greater selectivity for the chymotrypsin-like activity of the proteasome.  In cell culture, PR-171 is more cytotoxic than bortezomib following brief treatments that mimic the in vivo pharmacokinetics of both mols.  Hematol. tumor cells exhibit the greatest sensitivity to brief exposure, whereas solid tumor cells and nontransformed cell types are less sensitive to such treatments.  Cellular consequences of PR-171 treatment include the accumulation of proteasome substrates and induction of cell cycle arrest and/or apoptosis.  Administration of PR-171 to animals results in the dose-dependent inhibition of the chymotrypsin-like proteasome activity in all tissues examd. with the exception of the brain.  PR-171 is well tolerated when administered for either 2 or 5 consecutive days at doses resulting in >80% proteasome inhibition in blood and most tissues.  In human tumor xenograft models, PR-171 mediates an antitumor response that is both dose and schedule dependent.  The antitumor efficacy of PR-171 delivered on 2 consecutive days is stronger than that of bortezomib administered on its clin. dosing schedule.  These studies show the tolerability, efficacy, and dosing flexibility of PR-171 and provide validation for the clin. testing of PR-171 in the treatment of hematol. malignancies using dose-intensive schedules.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquzP-VJ4DNRbVg90H21EOLACvtfcHk0liZKRFtIn9wlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnsVyqtLY%253D&md5=301bcab3e60cbfd518b2f88fb479fa79</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-06-4086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-06-4086%26sid%3Dliteratum%253Aachs%26aulast%3DDemo%26aufirst%3DS.%2BD.%26aulast%3DKirk%26aufirst%3DC.%2BJ.%26aulast%3DAujay%26aufirst%3DM.%2BA.%26aulast%3DBuchholz%26aufirst%3DT.%2BJ.%26aulast%3DDajee%26aufirst%3DM.%26aulast%3DHo%26aufirst%3DM.%2BN.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DLaidig%26aufirst%3DG.%2BJ.%26aulast%3DLewis%26aufirst%3DE.%2BR.%26aulast%3DParlati%26aufirst%3DF.%2BM.%26aulast%3DShenk%26aufirst%3DK.%2BD.%26aulast%3DSmyth%26aufirst%3DM.%2BS.%26aulast%3DSun%26aufirst%3DC.%2BM.%26aulast%3DVallone%26aufirst%3DM.%2BK.%26aulast%3DWoo%26aufirst%3DT.%2BM.%26aulast%3DMolineaux%26aufirst%3DC.%2BJ.%26aulast%3DBennett%26aufirst%3DM.%2BK.%26atitle%3DAntitumor%2520activity%2520of%2520PR-171%252C%2520a%2520novel%2520irreversible%2520inhibitor%2520of%2520the%2520proteasome%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26issue%3D13%26spage%3D6383%26epage%3D6391%26doi%3D10.1158%2F0008-5472.CAN-06-4086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ettari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Previti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bitto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grasso, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zappalà, M.</span></span> <span> </span><span class="NLM_article-title">Immunoproteasome-selective inhibitors: a promising strategy tot treat hematologic malignancies, autoimmune and inflammatory diseases</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1217</span>– <span class="NLM_lpage">1238</span>, <span class="refDoi"> DOI: 10.2174/0929867323666160318173706</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=10.2174%2F0929867323666160318173706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=26965184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=1%3ACAS%3A528%3ADC%252BC28XnvFantL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=1217-1238&author=R.+Ettariauthor=S.+Previtiauthor=A.+Bittoauthor=S.+Grassoauthor=M.+Zappal%C3%A0&title=Immunoproteasome-selective+inhibitors%3A+a+promising+strategy+tot+treat+hematologic+malignancies%2C+autoimmune+and+inflammatory+diseases&doi=10.2174%2F0929867323666160318173706"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Immunoproteasome-Selective Inhibitors: A Promising Strategy to Treat Hematologic Malignancies, Autoimmune and Inflammatory Diseases</span></div><div class="casAuthors">Ettari, Roberta; Previti, Santo; Bitto, Alessandra; Grasso, Silvana; Zappala, Maria</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1217-1238</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The immunoproteasome is predominantly expressed in monocytes and lymphocytes and is responsible for the generation of antigenic peptides for cell-mediated immunity.  Upon the exposure of inflammatory cytokines IFN- and TNF-, constitutive subunits can be replaced by the synthesis of the immuno-core particles 1i, 2i and 5i.  Recent studies demonstrated that the immunoproteasome function is not only limited to MHC class I presentation, but it is also implicated in a no. of pathol. disorders including hematol. malignancies, inflammatory and autoimmune diseases.  At present the com. available proteasome inhibitors Bortezomib and Carfilzomib, which have been validated in multiple myeloma and other diseases, appear to target both the constitutive and immunoproteasomes indiscriminately.  This lack of specificity may, in part, explain some of the side effects of these agents.  In contrast, by selectively targeting the immunoproteasome, it may be possible to keep the antimyeloma and antilymphoma efficacy unchanged and, at the same time, to increase the therapeutic index.  The aim of this review article is to discuss the most promising immunoproteasome core particle-selective inhibitors which have been developed in the recent years, with a particular attention to their structural features, mechanism of action and therapeutic application.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5l0W-68DjTrVg90H21EOLACvtfcHk0lhVYhTLRW4kLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnvFantL8%253D&md5=cf860690368abed30995bff82044750e</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2174%2F0929867323666160318173706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867323666160318173706%26sid%3Dliteratum%253Aachs%26aulast%3DEttari%26aufirst%3DR.%26aulast%3DPreviti%26aufirst%3DS.%26aulast%3DBitto%26aufirst%3DA.%26aulast%3DGrasso%26aufirst%3DS.%26aulast%3DZappal%25C3%25A0%26aufirst%3DM.%26atitle%3DImmunoproteasome-selective%2520inhibitors%253A%2520a%2520promising%2520strategy%2520tot%2520treat%2520hematologic%2520malignancies%252C%2520autoimmune%2520and%2520inflammatory%2520diseases%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2016%26volume%3D23%26spage%3D1217%26epage%3D1238%26doi%3D10.2174%2F0929867323666160318173706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bensinger, W. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmerman, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reeder, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berenson, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Bacco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niesvizky, R.</span></span> <span> </span><span class="NLM_article-title">Phase 1 study of weekly dosing with the investigational oral proteasome inhibitor ixazomib in relapsed/refractory multiple myeloma</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>124</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1047</span>– <span class="NLM_lpage">1055</span>, <span class="refDoi"> DOI: 10.1182/blood-2014-01-548941</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=10.1182%2Fblood-2014-01-548941" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2014&pages=1047-1055&issue=7&author=S.+K.+Kumarauthor=W.+I.+Bensingerauthor=T.+M.+Zimmermanauthor=C.+B.+Reederauthor=J.+R.+Berensonauthor=D.+Bergauthor=A.-M.+Huiauthor=N.+Guptaauthor=A.+Di+Baccoauthor=J.+Yuauthor=Y.+Shouauthor=R.+Niesvizky&title=Phase+1+study+of+weekly+dosing+with+the+investigational+oral+proteasome+inhibitor+ixazomib+in+relapsed%2Frefractory+multiple+myeloma&doi=10.1182%2Fblood-2014-01-548941"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1182%2Fblood-2014-01-548941&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2014-01-548941%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DS.%2BK.%26aulast%3DBensinger%26aufirst%3DW.%2BI.%26aulast%3DZimmerman%26aufirst%3DT.%2BM.%26aulast%3DReeder%26aufirst%3DC.%2BB.%26aulast%3DBerenson%26aufirst%3DJ.%2BR.%26aulast%3DBerg%26aufirst%3DD.%26aulast%3DHui%26aufirst%3DA.-M.%26aulast%3DGupta%26aufirst%3DN.%26aulast%3DDi%2BBacco%26aufirst%3DA.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DShou%26aufirst%3DY.%26aulast%3DNiesvizky%26aufirst%3DR.%26atitle%3DPhase%25201%2520study%2520of%2520weekly%2520dosing%2520with%2520the%2520investigational%2520oral%2520proteasome%2520inhibitor%2520ixazomib%2520in%2520relapsed%252Frefractory%2520multiple%2520myeloma%26jtitle%3DBlood%26date%3D2014%26volume%3D124%26issue%3D7%26spage%3D1047%26epage%3D1055%26doi%3D10.1182%2Fblood-2014-01-548941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghazarian, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luderer, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusdono, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azab, A. K.</span></span> <span> </span><span class="NLM_article-title">Spotlight on ixazomib: potential in the treatment of multiple myeloma</span>. <i>Drug Des., Dev. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">217</span>– <span class="NLM_lpage">226</span>, <span class="refDoi"> DOI: 10.2147/DDDT.S93602</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=10.2147%2FDDDT.S93602" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=26811670" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmtFOntbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2016&pages=217-226&author=B.+Muzauthor=R.+N.+Ghazarianauthor=M.+Ouauthor=M.+J.+Ludererauthor=H.+D.+Kusdonoauthor=A.+K.+Azab&title=Spotlight+on+ixazomib%3A+potential+in+the+treatment+of+multiple+myeloma&doi=10.2147%2FDDDT.S93602"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Spotlight on ixazomib: potential in the treatment of multiple myeloma</span></div><div class="casAuthors">Muz, Barbara; Ghazarian, Rachel Nicole; Ou, Monica; Luderer, Micah John; Kusdono, Hubert Daniel; Azab, Abdel Kareem</div><div class="citationInfo"><span class="NLM_cas:title">Drug Design, Development and Therapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">217-226</span>CODEN:
                <span class="NLM_cas:coden">DDDTAQ</span>;
        ISSN:<span class="NLM_cas:issn">1177-8881</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Despite the significant therapeutic advances achieved with proteasome inhibitors (PIs) such as bortezomib and carfilzomib in prolonging the survival of patients with multiple myeloma, the development of drug resistance, peripheral neuropathy, and pharmacokinetic limitations continue to pose major challenges when using these compds.  Ixazomib is a second-generation PI with improved activity over other PIs.  Unlike bortezomib and carfilzomib, which are administered by injection, ixazomib is the first oral PI approved by US Food and Drug Administration.  This review discusses the biochem. properties, mechanisms of action, preclin. efficacy, and clin. trial results leading to the US Food and Drug Administration approval of ixazomib.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_kCBu0zA5zbVg90H21EOLACvtfcHk0lhVYhTLRW4kLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmtFOntbw%253D&md5=44626d99cf4fadac652b833b953028d1</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2147%2FDDDT.S93602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FDDDT.S93602%26sid%3Dliteratum%253Aachs%26aulast%3DMuz%26aufirst%3DB.%26aulast%3DGhazarian%26aufirst%3DR.%2BN.%26aulast%3DOu%26aufirst%3DM.%26aulast%3DLuderer%26aufirst%3DM.%2BJ.%26aulast%3DKusdono%26aufirst%3DH.%2BD.%26aulast%3DAzab%26aufirst%3DA.%2BK.%26atitle%3DSpotlight%2520on%2520ixazomib%253A%2520potential%2520in%2520the%2520treatment%2520of%2520multiple%2520myeloma%26jtitle%3DDrug%2520Des.%252C%2520Dev.%2520Ther.%26date%3D2016%26volume%3D10%26spage%3D217%26epage%3D226%26doi%3D10.2147%2FDDDT.S93602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Infante, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendelson, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burris, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bendell, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolcher, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillenwater, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arastu-Kapur, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papadopoulos, K. P.</span></span> <span> </span><span class="NLM_article-title">A first-in-human dose-escalation study of the oral proteasome inhibitor oprozomib in patients with advanced solid tumors</span>. <i>Invest. New Drugs</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">216</span>– <span class="NLM_lpage">224</span>, <span class="refDoi"> DOI: 10.1007/s10637-016-0327-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=10.1007%2Fs10637-016-0327-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=26924128" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=1%3ACAS%3A528%3ADC%252BC28XjslCrtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2016&pages=216-224&author=J.+R.+Infanteauthor=D.+S.+Mendelsonauthor=H.+A.+Burrisauthor=J.+C.+Bendellauthor=A.+W.+Tolcherauthor=M.+S.+Gordonauthor=H.+H.+Gillenwaterauthor=S.+Arastu-Kapurauthor=H.+S.+Wongauthor=K.+P.+Papadopoulos&title=A+first-in-human+dose-escalation+study+of+the+oral+proteasome+inhibitor+oprozomib+in+patients+with+advanced+solid+tumors&doi=10.1007%2Fs10637-016-0327-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">A first-in-human dose-escalation study of the oral proteasome inhibitor oprozomib in patients with advanced solid tumors</span></div><div class="casAuthors">Infante, Jeffrey R.; Mendelson, David S.; Burris, Howard A., III; Bendell, Johanna C.; Tolcher, Anthony W.; Gordon, Michael S.; Gillenwater, Heidi H.; Arastu-Kapur, Shirin; Wong, Hansen L.; Papadopoulos, Kyriakos P.</div><div class="citationInfo"><span class="NLM_cas:title">Investigational New Drugs</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">216-224</span>CODEN:
                <span class="NLM_cas:coden">INNDDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-6997</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">To det. the dose-limiting toxicities (DLTs), max. tolerated dose (MTD), safety, and pharmacokinetic and pharmacodynamic profiles of the tripeptide epoxyketone proteasome inhibitor oprozomib in patients with advanced refractory or recurrent solid tumors.  Patients received escalating once daily (QD) or split doses of oprozomib on days 1-5 of 14-day cycles (C).  The split-dose arm was implemented and compared in fasted (C1) and fed (C2) states.  Pharmacokinetic samples were collected during C1 and C2.  Proteasome inhibition was evaluated in red blood cells and peripheral blood mononuclear cells.  Forty-four patients (QD, n = 25; split dose, n = 19) were enrolled.  The most common primary tumor types were non-small cell lung cancer (18 %) and colorectal cancer (16%).  In the 180-mg QD cohort, two patients experienced DLTs: grade 3 vomiting and dehydration; grade 3 hypophosphatemia (n = 1 each).  In the split-dose group, three DLTs were obsd. 180-mg cohort: grade 3 hypophosphatemia; 210-mg cohort: grade 5 gastrointestinal hemorrhage and grade 3 hallucinations (n = 1 each).  In the QD and split-dose groups, the MTD was 150 and 180 mg, resp.  Common adverse events (all grades) included nausea (91%), vomiting (86%), and diarrhea (61%).  Peak concns. and total exposure of oprozomib generally increased with the increasing dose.  Oprozomib induced dose-dependent proteasome inhibition.  Best response was stable disease.  While generally low-grade, clin. relevant gastrointestinal toxicities occurred frequently with this oprozomib formulation.  Despite dose-dependent increases in pharmacokinetics and pharmacodynamics, single-agent oprozomib had minimal antitumor activity in this patient population with advanced solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrW2c034hrkubVg90H21EOLACvtfcHk0lgSk8-oWaNKnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjslCrtr0%253D&md5=e54838bb160c0886d08c5d0b8cb81a6a</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs10637-016-0327-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10637-016-0327-x%26sid%3Dliteratum%253Aachs%26aulast%3DInfante%26aufirst%3DJ.%2BR.%26aulast%3DMendelson%26aufirst%3DD.%2BS.%26aulast%3DBurris%26aufirst%3DH.%2BA.%26aulast%3DBendell%26aufirst%3DJ.%2BC.%26aulast%3DTolcher%26aufirst%3DA.%2BW.%26aulast%3DGordon%26aufirst%3DM.%2BS.%26aulast%3DGillenwater%26aufirst%3DH.%2BH.%26aulast%3DArastu-Kapur%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DH.%2BS.%26aulast%3DPapadopoulos%26aufirst%3DK.%2BP.%26atitle%3DA%2520first-in-human%2520dose-escalation%2520study%2520of%2520the%2520oral%2520proteasome%2520inhibitor%2520oprozomib%2520in%2520patients%2520with%2520advanced%2520solid%2520tumors%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2016%26volume%3D34%26spage%3D216%26epage%3D224%26doi%3D10.1007%2Fs10637-016-0327-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bader, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geurink, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weyburne, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirabella, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silzle, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shabaneh, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Linden, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Bruin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haile, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Rooden, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appenzeller, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kisselev, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overkleeft, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Driessen, C.</span></span> <span> </span><span class="NLM_article-title">The novel β2-selective proteasome inhibitor LU-102 synergizes with bortezomib and carfilzomib to overcome proteasome inhibitor resistance of myeloma cells</span>. <i>Haematologica</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>100</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1350</span>– <span class="NLM_lpage">1360</span>, <span class="refDoi"> DOI: 10.3324/haematol.2014.109421</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=10.3324%2Fhaematol.2014.109421" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2015&pages=1350-1360&issue=10&author=M.+Krausauthor=J.+Baderauthor=P.+P.+Geurinkauthor=E.+S.+Weyburneauthor=A.+C.+Mirabellaauthor=T.+Silzleauthor=T.+B.+Shabanehauthor=W.+A.+van+der+Lindenauthor=G.+de+Bruinauthor=S.+R.+Haileauthor=E.+van+Roodenauthor=C.+Appenzellerauthor=N.+Liauthor=A.+F.+Kisselevauthor=H.+Overkleeftauthor=C.+Driessen&title=The+novel+%CE%B22-selective+proteasome+inhibitor+LU-102+synergizes+with+bortezomib+and+carfilzomib+to+overcome+proteasome+inhibitor+resistance+of+myeloma+cells&doi=10.3324%2Fhaematol.2014.109421"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.3324%2Fhaematol.2014.109421&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3324%252Fhaematol.2014.109421%26sid%3Dliteratum%253Aachs%26aulast%3DKraus%26aufirst%3DM.%26aulast%3DBader%26aufirst%3DJ.%26aulast%3DGeurink%26aufirst%3DP.%2BP.%26aulast%3DWeyburne%26aufirst%3DE.%2BS.%26aulast%3DMirabella%26aufirst%3DA.%2BC.%26aulast%3DSilzle%26aufirst%3DT.%26aulast%3DShabaneh%26aufirst%3DT.%2BB.%26aulast%3Dvan%2Bder%2BLinden%26aufirst%3DW.%2BA.%26aulast%3Dde%2BBruin%26aufirst%3DG.%26aulast%3DHaile%26aufirst%3DS.%2BR.%26aulast%3Dvan%2BRooden%26aufirst%3DE.%26aulast%3DAppenzeller%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DKisselev%26aufirst%3DA.%2BF.%26aulast%3DOverkleeft%26aufirst%3DH.%26aulast%3DDriessen%26aufirst%3DC.%26atitle%3DThe%2520novel%2520%25CE%25B22-selective%2520proteasome%2520inhibitor%2520LU-102%2520synergizes%2520with%2520bortezomib%2520and%2520carfilzomib%2520to%2520overcome%2520proteasome%2520inhibitor%2520resistance%2520of%2520myeloma%2520cells%26jtitle%3DHaematologica%26date%3D2015%26volume%3D100%26issue%3D10%26spage%3D1350%26epage%3D1360%26doi%3D10.3324%2Fhaematol.2014.109421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besse, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bader, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geurink, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Bruin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kisselev, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overkleeft, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Driessen, C.</span></span> <span> </span><span class="NLM_article-title">The novel β2-selective proteasome inhibitor LU-102 decreases phosphorylation of I kappa B and induces highly synergistic cytotoxicity in combination with ibrutinib in multiple myeloma cells</span>. <i>Cancer Chemother. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">383</span>– <span class="NLM_lpage">396</span>, <span class="refDoi"> DOI: 10.1007/s00280-015-2801-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=10.1007%2Fs00280-015-2801-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=26099967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFSjsb%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2015&pages=383-396&author=J.+Krausauthor=M.+Krausauthor=N.+Liuauthor=L.+Besseauthor=J.+Baderauthor=P.+P.+Geurinkauthor=G.+de+Bruinauthor=A.+F.+Kisselevauthor=H.+Overkleeftauthor=C.+Driessen&title=The+novel+%CE%B22-selective+proteasome+inhibitor+LU-102+decreases+phosphorylation+of+I+kappa+B+and+induces+highly+synergistic+cytotoxicity+in+combination+with+ibrutinib+in+multiple+myeloma+cells&doi=10.1007%2Fs00280-015-2801-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The novel β2-selective proteasome inhibitor LU-102 decreases phosphorylation of I kappa B and induces highly synergistic cytotoxicity in combination with ibrutinib in multiple myeloma cells</span></div><div class="casAuthors">Kraus, Johannes; Kraus, Marianne; Liu, Nora; Besse, Lenka; Bader, Jurgen; Geurink, Paul P.; de Bruin, Gerjan; Kisselev, Alexei F.; Overkleeft, Herman; Driessen, Christoph</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">383-396</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: Proteasome-inhibiting drugs (PI) are gaining importance in hematol. oncol.  The proteasome carries three proteolytically active subunits (β1, β2, β5).  All established PI (bortezomib and carfilzomib), as well as exptl. drugs in the field (dalanzomib, oprozomib, and ixazomib), by design target the rate-limiting β5 subunit.  It is unknown whether β2-selective proteasome inhibition can also be exploited toward anticancer treatment.  Combining PI with the pan B-cell-directed Bruton tyrosine kinase inhibitor ibrutinib appears a natural option for future improved treatment of multiple myeloma (MM) and B-cell lymphomas.  However, bortezomib induces phosphorylation of IκB and activation of NF-κB in MM cells, while ibrutinib inhibits the IκB/NF-κB axis, suggesting antagonistic signaling.  A β2-selective proteasome inhibitor may lack such antagonistic signaling effects.  Methods: We recently introduced LU-102, the first β2-selective PI available for preclin. testing.  We here compare bortezomib with carfilzomib and LU-102 in MM and MCL in vitro with regard to their effects on pIκB/NF-κB signaling and their cytotoxic activity in combination with ibrutinib.  Results: LU-102 reduced phosphorylation of IκB, in contrast to bortezomib and carfilzomib, and was a superior inhibitor of NF-κB activation in MM cells.  This translated into highly synergistic cytotoxicity between LU-102 and ibrutinib, which was able to overcome BTZ resistance and CFZ resistance.  By contrast, BTZ lacked consistent synergistic cytotoxicity with ibrutinib.  Conclusion: Ibrutinib is highly synergistic with β2-selective proteasome inhibition against MM and MCL in vitro.  Novel β2-selective proteasome inhibitors may be exploited to overcome bortezomib/carfilzomib resistance and boost the activity of BTK inhibitors against B-cell-derived malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEpYl5-cKkhbVg90H21EOLACvtfcHk0lgmgRBW4o2VKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFSjsb%252FE&md5=f3492abb2e88fcf0b401dfaaaa9d4d84</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1007%2Fs00280-015-2801-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-015-2801-0%26sid%3Dliteratum%253Aachs%26aulast%3DKraus%26aufirst%3DJ.%26aulast%3DKraus%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DBesse%26aufirst%3DL.%26aulast%3DBader%26aufirst%3DJ.%26aulast%3DGeurink%26aufirst%3DP.%2BP.%26aulast%3Dde%2BBruin%26aufirst%3DG.%26aulast%3DKisselev%26aufirst%3DA.%2BF.%26aulast%3DOverkleeft%26aufirst%3DH.%26aulast%3DDriessen%26aufirst%3DC.%26atitle%3DThe%2520novel%2520%25CE%25B22-selective%2520proteasome%2520inhibitor%2520LU-102%2520decreases%2520phosphorylation%2520of%2520I%2520kappa%2520B%2520and%2520induces%2520highly%2520synergistic%2520cytotoxicity%2520in%2520combination%2520with%2520ibrutinib%2520in%2520multiple%2520myeloma%2520cells%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2015%26volume%3D76%26spage%3D383%26epage%3D396%26doi%3D10.1007%2Fs00280-015-2801-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Brouwer, A.
J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceylan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonker, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Linden, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liskamp, R. M. J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of novel irreversible serine protease inhibitors using amino acid based sulfonyl fluorides as an electrophilic trap</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2397</span>– <span class="NLM_lpage">2406</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2011.02.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=10.1016%2Fj.bmc.2011.02.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=21421320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvFehtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=2397-2406&author=A.%0AJ.+Brouwerauthor=T.+Ceylanauthor=A.+M.+Jonkerauthor=T.+van+der+Lindenauthor=R.+M.+J.+Liskamp&title=Synthesis+and+biological+evaluation+of+novel+irreversible+serine+protease+inhibitors+using+amino+acid+based+sulfonyl+fluorides+as+an+electrophilic+trap&doi=10.1016%2Fj.bmc.2011.02.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14a</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of novel irreversible serine protease inhibitors using amino acid based sulfonyl fluorides as an electrophilic trap</span></div><div class="casAuthors">Brouwer, Arwin J.; Ceylan, Tarik; Jonker, Anika M.; van der Linden, Tima; Liskamp, Rob M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2397-2406</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We have designed and synthesized novel irreversible serine protease inhibitors contg. aliph. sulfonyl fluorides as an electrophilic trap.  These substituted taurine sulfonyl fluorides derived from taurine or protected amino acids were conveniently synthesized from β-aminoethanesulfonyl chlorides using KF/18-crown-6 or from β-aminoethanesulfonates using DAST.  Their potency of irreversible inhibition of serine proteases is described in different enzyme assays using chymotrypsin leading to binding affinities up to 22 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4DO41CYAqhbVg90H21EOLACvtfcHk0lgmgRBW4o2VKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvFehtb4%253D&md5=866261a6647666a422a1c21cd373ea09</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2011.02.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2011.02.014%26sid%3Dliteratum%253Aachs%26aulast%3DBrouwer%26aufirst%3DA.%2BJ.%26aulast%3DCeylan%26aufirst%3DT.%26aulast%3DJonker%26aufirst%3DA.%2BM.%26aulast%3Dvan%2Bder%2BLinden%26aufirst%3DT.%26aulast%3DLiskamp%26aufirst%3DR.%2BM.%2BJ.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520irreversible%2520serine%2520protease%2520inhibitors%2520using%2520amino%2520acid%2520based%2520sulfonyl%2520fluorides%2520as%2520an%2520electrophilic%2520trap%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D2397%26epage%3D2406%26doi%3D10.1016%2Fj.bmc.2011.02.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Brouwer, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceylan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Linden, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liskamp, R. M. J.</span></span> <span> </span><span class="NLM_article-title">Synthesis of β-aminoethane sulfonyl fluorides or 2-substituted taurine sulfonyl fluorides as potential protease inhibitors</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">3391</span>– <span class="NLM_lpage">3393</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2009.02.130</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=10.1016%2Fj.tetlet.2009.02.130" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=3391-3393&author=A.+J.+Brouwerauthor=T.+Ceylanauthor=T.+van+der+Lindenauthor=R.+M.+J.+Liskamp&title=Synthesis+of+%CE%B2-aminoethane+sulfonyl+fluorides+or+2-substituted+taurine+sulfonyl+fluorides+as+potential+protease+inhibitors&doi=10.1016%2Fj.tetlet.2009.02.130"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2009.02.130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2009.02.130%26sid%3Dliteratum%253Aachs%26aulast%3DBrouwer%26aufirst%3DA.%2BJ.%26aulast%3DCeylan%26aufirst%3DT.%26aulast%3Dvan%2Bder%2BLinden%26aufirst%3DT.%26aulast%3DLiskamp%26aufirst%3DR.%2BM.%2BJ.%26atitle%3DSynthesis%2520of%2520%25CE%25B2-aminoethane%2520sulfonyl%2520fluorides%2520or%25202-substituted%2520taurine%2520sulfonyl%2520fluorides%2520as%2520potential%2520protease%2520inhibitors%26jtitle%3DTetrahedron%2520Lett.%26date%3D2009%26volume%3D50%26spage%3D3391%26epage%3D3393%26doi%3D10.1016%2Fj.tetlet.2009.02.130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brouwer, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werkhoven, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallastegui, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemmink, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florea, B. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groll, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overkleeft, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liskamp, R. M. J.</span></span> <span> </span><span class="NLM_article-title">Peptido sulfonyl fluorides as new powerful proteasome inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">10995</span>– <span class="NLM_lpage">11003</span>, <span class="refDoi"> DOI: 10.1021/jm301443r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301443r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslalurjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10995-11003&author=A.+J.+Brouwerauthor=A.+Jonkerauthor=P.+Werkhovenauthor=E.+Kuoauthor=N.+Liauthor=N.+Gallasteguiauthor=J.+Kemminkauthor=B.+I.+Floreaauthor=M.+Grollauthor=H.+S.+Overkleeftauthor=R.+M.+J.+Liskamp&title=Peptido+sulfonyl+fluorides+as+new+powerful+proteasome+inhibitors&doi=10.1021%2Fjm301443r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Peptido sulfonyl fluorides as new powerful proteasome inhibitors</span></div><div class="casAuthors">Brouwer, Arwin J.; Jonker, Anika; Werkhoven, Paul; Kuo, Ethan; Li, Nan; Gallastegui, Nerea; Kemmink, Johan; Florea, Bogdan I.; Groll, Michael; Overkleeft, Herman S.; Liskamp, Rob M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10995-11003</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new class of potent proteasome inhibitors is described, of which the members contain an amino acid inspired sulfonyl fluoride as the electrophilic trap.  In total, 24 peptido sulfonyl fluoride inhibitors have been designed and synthesized, which were inspired by the backbone sequences of the proteasome inhibitors bortezomib, epoxomicin, and Cbz-Leu3-aldehyde.  Nine of them were very potent proteasome inhibitors, the best of which had an IC50 of 7 nM.  A no. of the peptido sulfonyl fluoride inhibitors were found to be highly selective for the β5 proteasome subunit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMpjkcOVPvyLVg90H21EOLACvtfcHk0ljkUWlbM9C-5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslalurjE&md5=e84873c90746c6642013c03b51b40bcf</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm301443r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301443r%26sid%3Dliteratum%253Aachs%26aulast%3DBrouwer%26aufirst%3DA.%2BJ.%26aulast%3DJonker%26aufirst%3DA.%26aulast%3DWerkhoven%26aufirst%3DP.%26aulast%3DKuo%26aufirst%3DE.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DGallastegui%26aufirst%3DN.%26aulast%3DKemmink%26aufirst%3DJ.%26aulast%3DFlorea%26aufirst%3DB.%2BI.%26aulast%3DGroll%26aufirst%3DM.%26aulast%3DOverkleeft%26aufirst%3DH.%2BS.%26aulast%3DLiskamp%26aufirst%3DR.%2BM.%2BJ.%26atitle%3DPeptido%2520sulfonyl%2520fluorides%2520as%2520new%2520powerful%2520proteasome%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10995%26epage%3D11003%26doi%3D10.1021%2Fjm301443r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dubiella, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gersch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brouwer, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sieber, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krüger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liskamp, R. M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groll, M.</span></span> <span> </span><span class="NLM_article-title">Selective inhibition of the immunoproteasome by ligand-induced crosslinking of the active site</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">11969</span>– <span class="NLM_lpage">11973</span>, <span class="refDoi"> DOI: 10.1002/anie.201406964</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=10.1002%2Fanie.201406964" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslOkurfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=11969-11973&author=C.+Dubiellaauthor=H.+Cuiauthor=M.+Gerschauthor=A.+J.+Brouwerauthor=S.+A.+Sieberauthor=A.+Kr%C3%BCgerauthor=R.+M.+J.+Liskampauthor=M.+Groll&title=Selective+inhibition+of+the+immunoproteasome+by+ligand-induced+crosslinking+of+the+active+site&doi=10.1002%2Fanie.201406964"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Inhibition of the Immunoproteasome by Ligand-Induced Crosslinking of the Active Site</span></div><div class="casAuthors">Dubiella, Christian; Cui, Haissi; Gersch, Malte; Brouwer, Arwin J.; Sieber, Stephan A.; Krueger, Achim; Liskamp, Rob M. J.; Groll, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">11969-11973</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The concept of proteasome inhibition ranks among the latest achievements in the treatment of blood cancer and represents a promising strategy for modulating autoimmune diseases.  In this study, we describe peptidic sulfonyl fluoride inhibitors that selectively block the catalytic β5 subunit of the immunoproteasome by inducing only marginal cytotoxic effects.  Structural and mass spectrometric analyses revealed a novel reaction mechanism involving polarity inversion and irreversible crosslinking of the proteasomal active site.  We thus identified the sulfonyl fluoride headgroup for the development and optimization of immunoproteasome selective compds. and their possible application in autoimmune disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnN6CJub2ORrVg90H21EOLACvtfcHk0ljkUWlbM9C-5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslOkurfM&md5=00d726fdbc6f2e391f9650516b2d6c30</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2Fanie.201406964&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201406964%26sid%3Dliteratum%253Aachs%26aulast%3DDubiella%26aufirst%3DC.%26aulast%3DCui%26aufirst%3DH.%26aulast%3DGersch%26aufirst%3DM.%26aulast%3DBrouwer%26aufirst%3DA.%2BJ.%26aulast%3DSieber%26aufirst%3DS.%2BA.%26aulast%3DKr%25C3%25BCger%26aufirst%3DA.%26aulast%3DLiskamp%26aufirst%3DR.%2BM.%2BJ.%26aulast%3DGroll%26aufirst%3DM.%26atitle%3DSelective%2520inhibition%2520of%2520the%2520immunoproteasome%2520by%2520ligand-induced%2520crosslinking%2520of%2520the%2520active%2520site%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26spage%3D11969%26epage%3D11973%26doi%3D10.1002%2Fanie.201406964" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Narayanan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, L. H.</span></span> <span> </span><span class="NLM_article-title">Sulfonyl fluorides as privileged warheads in chemical biology</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">2650</span>– <span class="NLM_lpage">2659</span>, <span class="refDoi"> DOI: 10.1039/C5SC00408J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=10.1039%2FC5SC00408J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=28706662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=1%3ACAS%3A528%3ADC%252BC2MXksVamurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=2650-2659&author=A.+Narayananauthor=L.+H.+Jones&title=Sulfonyl+fluorides+as+privileged+warheads+in+chemical+biology&doi=10.1039%2FC5SC00408J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfonyl fluorides as privileged warheads in chemical biology</span></div><div class="casAuthors">Narayanan, Arjun; Jones, Lyn H.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2650-2659</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Sulfonyl fluoride electrophiles have found significant utility as reactive probes in chem. biol. and mol. pharmacol.  As warheads they possess the right balance of biocompatibility (including aq. stability) and protein reactivity.  Their functionality is privileged in this regard as they are known to modify not only reactive serines (resulting in their common use as protease inhibitors), but also context-specific threonine, lysine, tyrosine, cysteine and histidine residues.  This review describes the application of sulfonyl fluoride probes across various areas of research and explores new approaches that could further enhance the chem. biol. toolkit.  We believe that sulfonyl fluoride probes will find greater utility in areas such as covalent enzyme inhibition, target identification and validation, and the mapping of enzyme binding sites, substrates and protein-protein interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAuadIMxOl2bVg90H21EOLACvtfcHk0lgUXedoU4JE_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXksVamurc%253D&md5=0009feb4068e912b4784fb8411cdb702</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1039%2FC5SC00408J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5SC00408J%26sid%3Dliteratum%253Aachs%26aulast%3DNarayanan%26aufirst%3DA.%26aulast%3DJones%26aufirst%3DL.%2BH.%26atitle%3DSulfonyl%2520fluorides%2520as%2520privileged%2520warheads%2520in%2520chemical%2520biology%26jtitle%3DChem.%2520Sci.%26date%3D2015%26volume%3D6%26spage%3D2650%26epage%3D2659%26doi%3D10.1039%2FC5SC00408J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fadeyi, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parikh, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kyne, R. E.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Doherty, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niessen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinrich, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kath, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, R. P.</span></span> <span> </span><span class="NLM_article-title">Chemoselective preparation of clickable aryl sulfonyl fluoride monomers: a toolbox of highly functionalized intermediates for chemical biology probe synthesis</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1925</span>– <span class="NLM_lpage">1930</span>, <span class="refDoi"> DOI: 10.1002/cbic.201600427</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=10.1002%2Fcbic.201600427" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=27504718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlSgtrbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=1925-1930&author=O.+Fadeyiauthor=M.+D.+Parikhauthor=M.+Z.+Chenauthor=R.+E.+Kyneauthor=A.+P.+Taylorauthor=I.+O%E2%80%99Dohertyauthor=S.+E.+Kaiserauthor=S.+Barbasauthor=S.+Niessenauthor=M.+Shiauthor=S.+L.+Weinrichauthor=J.+C.+Kathauthor=L.+H.+Jonesauthor=R.+P.+Robinson&title=Chemoselective+preparation+of+clickable+aryl+sulfonyl+fluoride+monomers%3A+a+toolbox+of+highly+functionalized+intermediates+for+chemical+biology+probe+synthesis&doi=10.1002%2Fcbic.201600427"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Chemoselective Preparation of "Clickable" Aryl Sulfonyl Fluoride Monomers:A Toolbox of Highly Functionalized Intermediates for Chemical Biology Probe Synthesis</span></div><div class="casAuthors">Fadeyi, Olugbeminiyi; Parikh, Mihir; Chen, Ming; Kyne, Robert, Jr.; Taylor, Alexandria; O'Doherty, Inish; Kaiser, Stephen; Barbas, Sabrina; Niessen, Sherry; Shi, Manli; Weinrich, Scott L.; Kath, John; Jones, Lyn; Robinson, Ralph Pelton</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">1925-1930</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Sulfonyl fluoride (SF)-based activity probes have become important tools in chem. biol.  Herein, exploiting the relative chem. stability of SF to carry out a no. of unprecedented SF-sparing functional group manipulations, we report the chemoselective synthesis of a toolbox of highly functionalized aryl SF monomers that we have used to quickly prep. SF chem. biol. probes.  In addn. to SF, the monomers bear an embedded click handle (a terminal alkyne that can perform copper(I)-mediated azide alkyne cycloaddn.).  The monomers can be used either as fragments to prep. clickable SF analogs of drugs (biol. active compds.) bearing an aryl ring or, alternatively, attached to drugs as "minimalist" clickable aryl SF substituents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1JOeVX049cbVg90H21EOLACvtfcHk0lgUXedoU4JE_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlSgtrbF&md5=e22b5d1593713c1a5547d02b9c25db20</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201600427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201600427%26sid%3Dliteratum%253Aachs%26aulast%3DFadeyi%26aufirst%3DO.%26aulast%3DParikh%26aufirst%3DM.%2BD.%26aulast%3DChen%26aufirst%3DM.%2BZ.%26aulast%3DKyne%26aufirst%3DR.%2BE.%26aulast%3DTaylor%26aufirst%3DA.%2BP.%26aulast%3DO%25E2%2580%2599Doherty%26aufirst%3DI.%26aulast%3DKaiser%26aufirst%3DS.%2BE.%26aulast%3DBarbas%26aufirst%3DS.%26aulast%3DNiessen%26aufirst%3DS.%26aulast%3DShi%26aufirst%3DM.%26aulast%3DWeinrich%26aufirst%3DS.%2BL.%26aulast%3DKath%26aufirst%3DJ.%2BC.%26aulast%3DJones%26aufirst%3DL.%2BH.%26aulast%3DRobinson%26aufirst%3DR.%2BP.%26atitle%3DChemoselective%2520preparation%2520of%2520clickable%2520aryl%2520sulfonyl%2520fluoride%2520monomers%253A%2520a%2520toolbox%2520of%2520highly%2520functionalized%2520intermediates%2520for%2520chemical%2520biology%2520probe%2520synthesis%26jtitle%3DChemBioChem%26date%3D2016%26volume%3D17%26spage%3D1925%26epage%3D1930%26doi%3D10.1002%2Fcbic.201600427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geurink, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Linden, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirabella, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallastegui, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Bruin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blom, A. E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voges, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mock, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florea, B. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Marel, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Driessen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der
Stelt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groll, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overkleeft, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kisselev, A. F.</span></span> <span> </span><span class="NLM_article-title">Incorporation of non-natural amino acids improves cell permeability and potency of specific inhibitors of proteasome trypsin-like sites</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">1262</span>– <span class="NLM_lpage">1275</span>, <span class="refDoi"> DOI: 10.1021/jm3016987</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3016987" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=1%3ACAS%3A528%3ADC%252BC3sXns1elsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1262-1275&author=P.+P.+Geurinkauthor=W.+A.+van+der+Lindenauthor=A.+C.+Mirabellaauthor=N.+Gallasteguiauthor=G.+de+Bruinauthor=A.+E.+M.+Blomauthor=M.+J.+Vogesauthor=E.+D.+Mockauthor=B.+I.+Floreaauthor=G.+A.+van+der+Marelauthor=C.+Driessenauthor=M.+van+der%0ASteltauthor=M.+Grollauthor=H.+S.+Overkleeftauthor=A.+F.+Kisselev&title=Incorporation+of+non-natural+amino+acids+improves+cell+permeability+and+potency+of+specific+inhibitors+of+proteasome+trypsin-like+sites&doi=10.1021%2Fjm3016987"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Incorporation of non-natural amino acids improves cell permeability and potency of specific inhibitors of proteasome trypsin-like sites</span></div><div class="casAuthors">Geurink, Paul P.; van der Linden, Wouter A.; Mirabella, Anne C.; Gallastegui, Nerea; de Bruin, Gerjan; Blom, Annet E. M.; Voges, Mathias J.; Mock, Elliot D.; Florea, Bogdan I.; van der Marel, Gijs A.; Driessen, Christoph; van der Stelt, Mario; Groll, Michael; Overkleeft, Herman S.; Kisselev, Alexei F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1262-1275</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Proteasomes degrade the majority of proteins in mammalian cells by a concerted action of three distinct pairs of active sites.  The chymotrypsin-like sites are targets of antimyeloma agents bortezomib and carfilzomib.  Inhibitors of the trypsin-like site sensitize multiple myeloma cells to these agents.  Here we describe systematic effort to develop inhibitors with improved potency and cell permeability, yielding azido-Phe-Leu-Leu-4-aminomethyl-Phe-Me vinyl sulfone (I), LU-102, and a fluorescent activity-based probe for this site.  X-ray structures of I and related inhibitors complexed with yeast proteasomes revealed the structural basis for specificity.  Nontoxic to myeloma cells when used as a single agent, I sensitized them to bortezomib and carfilzomib.  This sensitizing effect was much stronger than the synergistic effects of histone acetylase inhibitors or additive effects of doxorubicin and dexamethasone, raising the possibility that combinations of inhibitors of the trypsin-like site with bortezomib or carfilzomib would have stronger antineoplastic activity than combinations currently used clin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxViO9vvFJBrVg90H21EOLACvtfcHk0lh2ABmNPKiJkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXns1elsQ%253D%253D&md5=e33ffb2dfb4b09bb9342cd0b63d31add</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm3016987&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3016987%26sid%3Dliteratum%253Aachs%26aulast%3DGeurink%26aufirst%3DP.%2BP.%26aulast%3Dvan%2Bder%2BLinden%26aufirst%3DW.%2BA.%26aulast%3DMirabella%26aufirst%3DA.%2BC.%26aulast%3DGallastegui%26aufirst%3DN.%26aulast%3Dde%2BBruin%26aufirst%3DG.%26aulast%3DBlom%26aufirst%3DA.%2BE.%2BM.%26aulast%3DVoges%26aufirst%3DM.%2BJ.%26aulast%3DMock%26aufirst%3DE.%2BD.%26aulast%3DFlorea%26aufirst%3DB.%2BI.%26aulast%3Dvan%2Bder%2BMarel%26aufirst%3DG.%2BA.%26aulast%3DDriessen%26aufirst%3DC.%26aulast%3Dvan%2Bder%2BStelt%26aufirst%3DM.%26aulast%3DGroll%26aufirst%3DM.%26aulast%3DOverkleeft%26aufirst%3DH.%2BS.%26aulast%3DKisselev%26aufirst%3DA.%2BF.%26atitle%3DIncorporation%2520of%2520non-natural%2520amino%2520acids%2520improves%2520cell%2520permeability%2520and%2520potency%2520of%2520specific%2520inhibitors%2520of%2520proteasome%2520trypsin-like%2520sites%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D1262%26epage%3D1275%26doi%3D10.1021%2Fjm3016987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brouwer, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrero Álvarez, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciaffoni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van de Langemheen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liskamp, R. M. J.</span></span> <span> </span><span class="NLM_article-title">Proteasome inhibition by new dual warhead containing peptido vinyl sulfonyl fluorides</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3429</span>– <span class="NLM_lpage">3435</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.05.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=10.1016%2Fj.bmc.2016.05.042" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=3429-3435&author=A.+J.+Brouwerauthor=N.+Herrero+%C3%81lvarezauthor=A.+Ciaffoniauthor=H.+van+de+Langemheenauthor=R.+M.+J.+Liskamp&title=Proteasome+inhibition+by+new+dual+warhead+containing+peptido+vinyl+sulfonyl+fluorides&doi=10.1016%2Fj.bmc.2016.05.042"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.05.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.05.042%26sid%3Dliteratum%253Aachs%26aulast%3DBrouwer%26aufirst%3DA.%2BJ.%26aulast%3DHerrero%2B%25C3%2581lvarez%26aufirst%3DN.%26aulast%3DCiaffoni%26aufirst%3DA.%26aulast%3Dvan%2Bde%2BLangemheen%26aufirst%3DH.%26aulast%3DLiskamp%26aufirst%3DR.%2BM.%2BJ.%26atitle%3DProteasome%2520inhibition%2520by%2520new%2520dual%2520warhead%2520containing%2520peptido%2520vinyl%2520sulfonyl%2520fluorides%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D3429%26epage%3D3435%26doi%3D10.1016%2Fj.bmc.2016.05.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gilfillan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artschwager, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harkiss, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liskamp, R. M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis of pyrazole containing α-amino acids <i>via</i> a highly regio-selective condensation/aza-Michael reaction of β-aryl α,β-unsaturated ketones</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">4514</span>– <span class="NLM_lpage">4523</span>, <span class="refDoi"> DOI: 10.1039/C5OB00364D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=10.1039%2FC5OB00364D" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2015&pages=4514-4523&author=L.+Gilfillanauthor=R.+Artschwagerauthor=A.+H.+Harkissauthor=R.+M.+J.+Liskampauthor=A.+Sutherland&title=Synthesis+of+pyrazole+containing+%CE%B1-amino+acids+via+a+highly+regio-selective+condensation%2Faza-Michael+reaction+of+%CE%B2-aryl+%CE%B1%2C%CE%B2-unsaturated+ketones&doi=10.1039%2FC5OB00364D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1039%2FC5OB00364D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5OB00364D%26sid%3Dliteratum%253Aachs%26aulast%3DGilfillan%26aufirst%3DL.%26aulast%3DArtschwager%26aufirst%3DR.%26aulast%3DHarkiss%26aufirst%3DA.%2BH.%26aulast%3DLiskamp%26aufirst%3DR.%2BM.%2BJ.%26aulast%3DSutherland%26aufirst%3DA.%26atitle%3DSynthesis%2520of%2520pyrazole%2520containing%2520%25CE%25B1-amino%2520acids%2520via%2520a%2520highly%2520regio-selective%2520condensation%252Faza-Michael%2520reaction%2520of%2520%25CE%25B2-aryl%2520%25CE%25B1%252C%25CE%25B2-unsaturated%2520ketones%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2015%26volume%3D13%26spage%3D4514%26epage%3D4523%26doi%3D10.1039%2FC5OB00364D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goddard-Borger, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stick, R. V.</span></span> <span> </span><span class="NLM_article-title">An efficient, inexpensive, and shelf-stable diazotransfer reagent: imidazole-1-sulfonyl azide hydrochloride</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">3797</span>– <span class="NLM_lpage">800</span>, <span class="refDoi"> DOI: 10.1021/ol701581g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol701581g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsVeltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=3797-800&issue=19&author=E.+D.+Goddard-Borgerauthor=R.+V.+Stick&title=An+efficient%2C+inexpensive%2C+and+shelf-stable+diazotransfer+reagent%3A+imidazole-1-sulfonyl+azide+hydrochloride&doi=10.1021%2Fol701581g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">An Efficient, Inexpensive, and Shelf-Stable Diazotransfer Reagent: Imidazole-1-sulfonyl Azide Hydrochloride</span></div><div class="casAuthors">Goddard-Borger, Ethan D.; Stick, Robert V.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3797-3800</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The design and synthesis of a new diazotransfer reagent, imidazole-1-sulfonyl azide hydrochloride, are reported.  This reagent has proven to equal triflyl azide in its ability to act as a "diazo donor" in the conversion of both primary amines into azides and activated methylene substrates into diazo compds.  Crucially, this reagent can be prepd. in a one-pot reaction on a large scale from inexpensive materials, is shelf-stable, and is conveniently cryst.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp47A7S4vCoO7Vg90H21EOLACvtfcHk0lh2ABmNPKiJkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsVeltro%253D&md5=f664d543b21303c0101ddedd9cc37744</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fol701581g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol701581g%26sid%3Dliteratum%253Aachs%26aulast%3DGoddard-Borger%26aufirst%3DE.%2BD.%26aulast%3DStick%26aufirst%3DR.%2BV.%26atitle%3DAn%2520efficient%252C%2520inexpensive%252C%2520and%2520shelf-stable%2520diazotransfer%2520reagent%253A%2520imidazole-1-sulfonyl%2520azide%2520hydrochloride%26jtitle%3DOrg.%2520Lett.%26date%3D2007%26volume%3D9%26issue%3D19%26spage%3D3797%26epage%3D800%26doi%3D10.1021%2Fol701581g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kirk, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, M. A.</span></span> <span> </span><span class="NLM_article-title">D-homo-steroids. Part III. The preparation of D-homoandrostane derivatives: a study of the reactions of steroidal C(17)-spiro-oxirans and their derivatives</span>. <i>J. Chem. Soc. C</i> <span class="NLM_year" style="font-weight: bold;">1971</span>,  <span class="NLM_fpage">414</span>, <span class="refDoi"> DOI: 10.1039/j39710000414</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=10.1039%2Fj39710000414" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=1%3ACAS%3A528%3ADyaE3MXhtFahu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1971&pages=414&author=D.+N.+Kirkauthor=M.+A.+Wilson&title=D-homo-steroids.+Part+III.+The+preparation+of+D-homoandrostane+derivatives%3A+a+study+of+the+reactions+of+steroidal+C%2817%29-spiro-oxirans+and+their+derivatives&doi=10.1039%2Fj39710000414"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">D-Homo steroids.  III.  Preparation of D-homoandrostane derivatives: reactions of steroidal C 17 spirooxiranes and their derivatives</span></div><div class="casAuthors">Kirk, David N.; Wilson, Malcolm Alan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Chemical Society [Section] C:  Organic</span>
        (<span class="NLM_cas:date">1971</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">414-24</span>CODEN:
                <span class="NLM_cas:coden">JSOOAX</span>;
        ISSN:<span class="NLM_cas:issn">0022-4952</span>.
    </div><div class="casAbstract">In HCONMe2-B(OH)3, epoxides react with azide ions to give hydroxy azides, which are reduced by Zn dust or Cr(II) to amine salts in acid media.  C-17 spirooxiranes (e.g. I) by these reactions gave hydroxy amines which were converted to D-homosteroids (e.g. II, R1 = O, R2 = H2; R1 = H2, R2 = O) by HNO2.  The ketone mixt. (III, R1 = O, R2 = H2, R3 = β-OH,H; R1 = H2, R2 = O, R3 = β-OH,H) was prepd. similarly and reduced (Huang-Minlon), and the product oxidized to D-homo-5α-androstan-7-one (III, R1 = R2 = H2, R3 = O).  Also prepd. was D-homodehydroepiandrosterone.  I with guanidine gave an iminospirooxazolidinone (IV); I with benzylamine gave 20-(benzylamino)-21-nor-17α-pregn-5-ene-3β,-17β-diol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBbXWWbjIL4rVg90H21EOLACvtfcHk0lg-827GlBQDew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3MXhtFahu78%253D&md5=8ef253bef91d9e4993c498deb55e9494</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1039%2Fj39710000414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fj39710000414%26sid%3Dliteratum%253Aachs%26aulast%3DKirk%26aufirst%3DD.%2BN.%26aulast%3DWilson%26aufirst%3DM.%2BA.%26atitle%3DD-homo-steroids.%2520Part%2520III.%2520The%2520preparation%2520of%2520D-homoandrostane%2520derivatives%253A%2520a%2520study%2520of%2520the%2520reactions%2520of%2520steroidal%2520C%252817%2529-spiro-oxirans%2520and%2520their%2520derivatives%26jtitle%3DJ.%2520Chem.%2520Soc.%2520C%26date%3D1971%26spage%3D414%26doi%3D10.1039%2Fj39710000414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">El-Faham, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al Marhoon, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Megeed, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albericio, F.</span></span> <span> </span><span class="NLM_article-title">OxymaPure/DIC: An efficient reagent for the synthesis of a novel Series of 4-[2-(2-acetylaminophenyl)-2-oxo-acetylamino] benzoyl amino acid ester derivatives</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">14747</span>– <span class="NLM_lpage">14759</span>, <span class="refDoi"> DOI: 10.3390/molecules181214747</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=10.3390%2Fmolecules181214747" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=14747-14759&author=A.+El-Fahamauthor=Z.+Al+Marhoonauthor=A.+Abdel-Megeedauthor=F.+Albericio&title=OxymaPure%2FDIC%3A+An+efficient+reagent+for+the+synthesis+of+a+novel+Series+of+4-%5B2-%282-acetylaminophenyl%29-2-oxo-acetylamino%5D+benzoyl+amino+acid+ester+derivatives&doi=10.3390%2Fmolecules181214747"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.3390%2Fmolecules181214747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules181214747%26sid%3Dliteratum%253Aachs%26aulast%3DEl-Faham%26aufirst%3DA.%26aulast%3DAl%2BMarhoon%26aufirst%3DZ.%26aulast%3DAbdel-Megeed%26aufirst%3DA.%26aulast%3DAlbericio%26aufirst%3DF.%26atitle%3DOxymaPure%252FDIC%253A%2520An%2520efficient%2520reagent%2520for%2520the%2520synthesis%2520of%2520a%2520novel%2520Series%2520of%25204-%255B2-%25282-acetylaminophenyl%2529-2-oxo-acetylamino%255D%2520benzoyl%2520amino%2520acid%2520ester%2520derivatives%26jtitle%3DMolecules%26date%3D2013%26volume%3D18%26spage%3D14747%26epage%3D14759%26doi%3D10.3390%2Fmolecules181214747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">El-Faham, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albericio, F.</span></span> <span> </span><span class="NLM_article-title">Peptide coupling reagents, more than a letter soup</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">6557</span>– <span class="NLM_lpage">6602</span>, <span class="refDoi"> DOI: 10.1021/cr100048w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr100048w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVyhu7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2011&pages=6557-6602&author=A.+El-Fahamauthor=F.+Albericio&title=Peptide+coupling+reagents%2C+more+than+a+letter+soup&doi=10.1021%2Fcr100048w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide Coupling Reagents, More than a Letter Soup</span></div><div class="casAuthors">El-Faham, Ayman; Albericio, Fernando</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">6557-6602</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The prepn. and uses of carbodiimides, anhydrides (sym. and mixed), active esters, acylazoles, acyl azides, acid halides, acid fluorides, phosphonium salts, aminium/uronium salts, organophosphorus compds., organosulfur compds., triazine reagents, pyridinium reagents, polymer-supported reagents as coupling reagents in peptide synthesis are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9DDv3PT7yrLVg90H21EOLACvtfcHk0lg-827GlBQDew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVyhu7zO&md5=461d8c78dffcbf16a390fc78abd33cac</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fcr100048w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr100048w%26sid%3Dliteratum%253Aachs%26aulast%3DEl-Faham%26aufirst%3DA.%26aulast%3DAlbericio%26aufirst%3DF.%26atitle%3DPeptide%2520coupling%2520reagents%252C%2520more%2520than%2520a%2520letter%2520soup%26jtitle%3DChem.%2520Rev.%26date%3D2011%26volume%3D111%26spage%3D6557%26epage%3D6602%26doi%3D10.1021%2Fcr100048w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="note"><p class="first last">Several transformations (e.g., oxidation, reduction, hydrolysis, etc.) can be carried out in the presence of an aromatic SF moiety, which is indicative of the difference in stability of aliphatic and aromatic SFs.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="note"><p class="first last">Recently it was found in peptidovinyl sulfonyl fluorides (PVSFs) that although a PVSF may be more reactive than a peptidosulfonyl fluoride (PSF), the sulfonyl fluoride warhead part may occupy a less favorable P<sub>1</sub>′ position because it is further positioned from the P<sub>1</sub> side chain, leading to a reduced inhibition.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="note"><p class="first last">There was no specific reason for synthesis of one tripeptide on the solid phase and the other tripeptide in solution. Either method can be used for both tripeptides.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="note"><p class="first last">The final deprotection step was removal of the side-chain Cbz-protecting group of the amino protected sulfonyl fluoride, which also would remove any terminal Cbz-protecting group.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i50"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00685">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_40150"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b00685">10.1021/acs.jmedchem.8b00685</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Analytical and preparative HPLC-columns; synthesis of peptides required for incorporation of aminosulfonyl fluoride derivatives; synthesis of precursors of aminosulfonyl fluorides (<b>28</b>–<b>30</b>, <b>32</b>–<b>36</b>); synthesis of aminosulfonyl fluorides (<b>40</b>–<b>42</b>); synthesis of protected peptide sulfonyl fluorides; proton, carbon, and fluoride NMR spectra; HPLC traces of peptide sulfonyl fluorides (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00685/suppl_file/jm8b00685_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00685/suppl_file/jm8b00685_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00685/suppl_file/jm8b00685_si_001.pdf">jm8b00685_si_001.pdf (10.43 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00685/suppl_file/jm8b00685_si_002.csv">jm8b00685_si_002.csv (2.6 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b00685&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00685%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-12%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b00685" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679963564fc92374","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
